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Abstract
Bionanomaterials are exciting materials with applications both in diagnostics and treat-
ment of a broad spectrum of diseases. Binding to colloidal structures, such as gold
nanoparticles (AuNPs), is known to affect protein conformation. Such alterations in con-
formation can potentially alter the function and bio-invasiveness of the biopolymer. This
implies that a better understanding of the structure/function relationship of proteins can
be achieved by deliberately altering protein conformation by modifying them with gold
nanoparticles. The acquired protein-gold nanoconstructs may then achieve protein-like
properties, gold-like properties, a bit of both, or even brand new properties. A better un-
derstanding of the relationship between structure and function for proteins is important
because several diseases, such as Alzheimer’s disease, sickle cell anemia, and some types
of cancers, are due to errors in protein folding. Lately, the interest for ﬂuorescent protein-
stabilized gold nanoclusters (AuNCs) has increased. AuNCs introduce ﬂuorescent probes
simultaneously as protein conformation can be altered. Gold nanoconstructs (AuNPs,
AuNCs, or mixtures of the two) present the ability to stabilize and study protein folding
intermediates that would otherwise be too unstable to study.
In this thesis, several proteins modiﬁed by gold-nanoconstructs, such as AuNPs and
AuNCs, have been studied. The aim has been to investigate whether it is possible to
combine proteins and gold to make new materials with properties not present in either
constituent alone. In this thesis such properties are often referred to as "emergent proper-
ties". Of the proteins studied, alpha-lactalbumin (aLa) has been the main focus, because
of its link to Human Alpha-lactalbumin Made LEthal to Tumor cells (HAMLET), and
its bovine analogue BAMLET. Both of which are promising candidates as anti cancer
therapeutic agents.
A palette of optical techniques such as UV-vis and ﬂuorescence spectroscopy, ζ-
potential measurements, dynamic light scattering, and circular dichroism were used to
characterize gold nanoconstructs, protein-gold nanoconstructs and concomitant changes
in protein conformation. Additionally, the size of gold nanoconstructs were studied with
scanning transmission electron microscopy. Langmuir- and Gibbs monolayers studies,
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Brewster Angle Microscopy, Digital Video Imaging and Atomic Force Microscopy were
used to observe changes in interfacial activity as well as ability to induce ﬁlm miscibility
for the new constructs. Trypan blue assays were used to study the protein-gold nanocon-
structs’ ability to induce cell death in cancer cell samples.
The results showed that protein-AuNPs possess membrane afﬁnity properties not seen
for any single constituents alone. Bionanomaterials with protein-stabilized AuNCs or
AuNPs provide for an inherent optical marker that can be used for imaging and diagnos-
tics. These bionanomaterials also provided a tunability in protein structure, which can be
used to understand more about the protein structure/function relationship. Depending on
the synthesis-protocol used for the formation of protein-gold nanoconstructs, it was possi-
ble to make small (~8 Au atoms, Au8) and large (~25 Au atoms, Au25) protein-stabilized
AuNCs, AuNPs stabilized by covalently bound protein-AuNCs, and even to manipu-
late hydrophobic and hydrophilic properties of the resulting protein-gold nanoconstructs.
Langmuir studies of hydrophilic aLa-gold nanoconstructs showed that the protein-gold
nanoconstruct induced increased lipid interaction as compared to native aLa. For this
reason, cell-viability studies of native bovine aLa, hydrophilic bovine aLa-gold nanocon-
structs and BAMLET were compared. The results were very promising as the hydrophilic
aLa-gold nanoconstructs showed an ability to kill cancer cells close to the efﬁciency of
BAMLET.
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11. Motivation
Bionanotechnology is a rapidly advancing ﬁeld within medical research and includes dif-
ferent proteins and other biomacromolecules combined with different types of nanoma-
terials. Such materials can be metal or polymer nanoparticles, nanowires, carbon nan-
otubes, metal nanoclusters and more.1–3 Their small sizes provide these materials with
unique optical, chemical and physical properties not seen for larger materials, making
bionanomaterials highly suited for e.g. bioimaging, biosensors, X-ray contrast, targeted
drug delivery, cancer treatment and diagnostics.2–13 The choice of nanomaterials for this
thesis have been restricted to gold nanoparticles and nanoclusters. This selection is based
on the optical properties of nano-sized gold, which enables the use of simple analyzing
techniques, the fact that proteins can easily be conjugated to gold, and good biocompati-
bility.
Proteins are involved in many physiological processes, such as muscle structure, reg-
ulation of blood sugar level, digestion of food, transportation of oxygen and transfer of
important signals (e.g. neurological signals). Some times proteins are over- or underex-
pressed, incorrectly post-translationally modiﬁed, or misfolded. This may have serious
consequences. For example, genetically-caused underexpression of the tumor suppress-
ing protein p53 make people predisposed to cancer and can cause development of several
independent tumors in a variety of tissues.14 Protein misfolding and aggregation are con-
nected to several diseases like Alheimerz’s disease and other neurodegenerative disorders,
as well as complicating the administration of therapeutic proteins.15,16 A better under-
standing of the connection between the protein fold and the subsequent consequences can
aid in the development of better therapeutics and diagnostic tools.16 Important informa-
tion about this connection can be elucidated by studying the altered protein conformation
in bionanomaterials.
This thesis aims to contribute to an enhanced understanding of the structure/function
relationship by using gold nanoparticles (AuNPs) and gold nanoclusters (AuNCs) as fold-
ing templates for a selection of proteins. Additionally, it is likely that the protein-gold
nanoconstructs themselves can be used both for diagnostics and treatment. Examples of
such use are transport of drugs over the cell membrane, and optical probes in bioimaging.
2 2. Proteins
2. Proteins
The purpose of this chapter is to provide some basic background information about pro-
teins. Such knowledge is important to achive a proper understanding of what happens
with proteins when they are conjugated to gold nanoconstructs.
2.1 Protein structure
Proteins are made up by long polypeptide chains (primary structure, Figure 2.1 a) of L-
α-amino acids combined uniquely for each type of protein.17
Figure 2.1: (a) A small section of the primary structure. R = amino acid side chain. (b) Examples
of motifs of secondary structure. (c) Tertiary structure of aLa. (d) Quaternary structure of insulin
hexamer (adapted from Michael Tyka).18
The polypeptide chain can coil itself into secondary structure motifs connected by loops
and turns (Figure 2.1 b). The secondary structure α-helices are formed when one amino
acid residue (n) forms a hydrogen bond with the amino acid four residues ahead (n+4),
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while β-sheets are formed due to H-bonds between longer strands of the peptide laying
either parallel, anti-parallel, or a mixture of these, to each other. β-sheets are normally
more hydrophobic than α-helices.17,19 While α-helices and β-sheets are the most well
known, other secondary structure motifs exists as well, such as the 310-helix. In a 310-
helix amino acid residue n and n+3 are connected.20 The secondary structure motifs are
spatially ordered into a tertiary structure (illustrated by alpha-lactalbumin (aLa) in Fig-
ure 2.1 c) dependent on type of protein and the surrounding media. For globular, water
soluble proteins the secondary structure will bend and fold in such a way that the hy-
drophobic groups will be buried inside the interior of the protein, away from water, while
the hydrophilic groups will turn outwards. The protein structure is stabilized by hydrogen
bonds, van der Waals forces, and disulﬁde bridges. A disruption of the tertiary struc-
ture can deactivate the protein, decrease protein activity or even change the protein func-
tion.17,21,22 The active form of several proteins, e.g. insulin and haemoglobin, consists of
several tertiary structured polypeptide chains linked together to a quaternary structure, as
illustrated by insulin in Figure 2.1 d.17
2.1.1 Molten globules
Traditionally, there has been a perception that a protein only can exist as either a set of
folded conformations or a set of unfolded conformations, depending on the surrounding
conditions. These conformations were assumed to be strictly separated by energy barri-
ers.21 The assumption was that in the native state the proteins coil up in compact, rigid
structures, while the denatured state is ﬂexible. However, in the early 1980’s the molten
globular (MG) state was discovered.23 MG states have no deﬁned three-dimensional
structure, but they are compact and have secondary structure content, often reported to
be similar to that of the native protein.24 The presence of a stable MG state give the
proteins a greater ability to ﬂip and bend when interacting with interfaces.
One of the most studied MG-state forming proteins is aLa.23,25,26 Human alpha-
lactalbumin is an important whey protein in breast milk, where it is a part of the lactose
synthase protein complex.27 By binding to a galactosyltransferase protein, aLa alters the
speciﬁcity of the galactosyltransferase from N-acetyl-D-glucosamine to glucose, and en-
ables lactose synthesis. This milk protein contains an α- and a β-domain, separated by a
deep cleft.28 Four α-helices and two 310-helices constitute α-domain, while the β-domain
is built up by one 310-helix, a series of loops and an antiparallel β-sheet.28 Flexible, MG-
forming aLa is structurally very similar to the rigid protein lysozyme (LYZ), which has
the same genetic origin.29 Dependent on species, lysozyme differs much in amino acid
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sequence but the 3D-structure is always very similar. The lysozyme structure is rich
in α-helices, and especially two domains separated by a polysaccharide binding cleft is
conserved between the different species.30 The α-helices are mainly found in the largest
domain, while the smaller one consists of β-sheets. The best conserved structural motifs
in lysozyme is the central α-helix containing the acid catalyst glutamic acid, and the β-
hairpin close to the catalytic site.30 If the helices and sheets in aLa and LYZ are disrupted,
protein conformation and function might be altered.
2.2 Protein function
There are many different types of proteins and the variation in function is large. Some
proteins are important for structure and support (e.g. myosin in muscles and ﬁbrin in
blood clots), others are important for signaling (e.g. somatotropin, which is a growth
hormone), transport (e.g. haemoglobin transports oxygen) and protection (e.g. antibodies
detect pathogens).17 To better understand how some of these proteins function, different
models have been developed. Enzymes are proteins that catalyzes the transformation
of one or more substrates into one or more products. Due to high activation energy,
some of these reactions would never take place without proteins as catalyzers. The two
main models used to explain protein-substrate interactions is the lock-and-key-model and
the induced-ﬁt model (Figure 2.2).17 The lock-and-key model (Figure 2.2 a) depicts the
Figure 2.2: The main models for how proteins (enzymes) interact with their substrates. (a) Lock-
and-key model. (b) Induced-ﬁt model.
substrate as a key that ﬁts perfectly into the protein lock, and is mostly used to describe
rigid proteins. Several proteins are partly or even almost completely without secondary
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structure motifs. These proteins are better explained by the induced-ﬁt model, in which
the protein is believed to be more ﬂexible and able to adapt to the shape of the substrate
(Figure 2.2 b). Several proteins might be best explained by an intermediate of these two
models.
2.3 Protein structure/function relationship
If the active sites are blocked, or the protein is structurally altered, the substrate might be
hindered from interacting properly with the protein and the product will not be formed.17
Small structural alterations in ﬂexible proteins might inﬂuence the protein function less
than for more rigid proteins, as the former may twist and bend so that the substrate still
ﬁts.
There are several factors that can alter the tertiary structure of a protein, e.g. mutations
in the amino acid sequence, pH, temperature, polarity of the solvent, and adsorption to
interfaces.17,19,20 Changes in temperature and pH can disrupt hydrogen bonds, van der
Waals interactions and electrostatic bonds, thus making the protein unfold and potentially
reduce its activity. Changes in pH can also lead to decreased activity as the charge of
amino acids is altered. This is especially important if the charge is altered in the active
site. To keep track of which changes might occur as the pH, temperature, and solvent
polarity changes, or amino acids are replaced, it helps to divide the amino acids into
different groups. How this is done varies, but one example is given in Table 2.1.
Table 2.1: An example of how to divide the amino acids in different groups dependent on func-
tionalities.20 Charge signs of the charged amino acids at neutral pH are given in brackets.
Hydrophobic Charged Polar
Glycine Aspartic acid [-] Serine
Alanine Glutamic acid [-] Threonine
Valine Lysine [+] Tyrosine
Phenylalanine Arginine [+] Histidine
Proline Cysteine
Methionine Asparagine
Isoleucine Glutamine
Leucine Tryptophan
Mutations in the DNA sequence can cause changes in the protein structure.31 Alter-
ations in stop and start codons can have very severe consequences, as the peptide sequence
then can be very different from what was intended. Smaller mutation can lead to an ex-
change of single amino acids. Dependent on the location of the amino acid within the
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protein, and what type of amino acids are exchanged, the consequences of the muta-
tions varies. An alteration of the amino acid sequence in the active site of the protein
can be more severe than if the exchange happens in a non-important part of the pro-
tein. Changing one amino acid with a similar amino acid (like exchanging glycine with
alanine) would have little effect, while exchanging amino acids with opposite charge or
different hydrophobicity can have severe consequences for the protein folding.20 One ex-
ample is sickle-cell anemia caused by hydrophilic glutamic acid in the β-globin chain of
haemoglobin being replaced by hydrophobic valine. This error makes the haemoglobin
aggregate, and less elastic and charactersitic sickle shaped red blood cells are formed.20
Sickle cell-anemia results in poor oxygen transportation, vessel occlusion and ischemia.
However, the disease has the beneﬁt of imparting malaria resistance, hence being most
common in regions in Africa where malaria is widespread. Moreover, the different sec-
ondary structural motifs in proteins (see section 2.1, page 2 for details) have varying
rigidity.17,19,20 The random coil is very ﬂexible, and any problems due to alterations of
amino acids in this type of region, is likely to be overcome by the coils ability to twist and
bend. The α-helices are more structured, due to interactions between amino acid residues
that are close to one another in the primary structure.19 Thus, a change in structure in the
α-helix is more severe than changes in the random coil. The transformation from normal
erythrocytes to sickle-cells is due to structural changes in α-helices found in globin folds
in haemoglobin.20 β-sheets are even more structured than α-helices because they also in-
teract with amino acids that are further away in the primary structure.20 Thus, changes in
the β-sheets may have more severe effects on protein structure and function than changes
in α-helices.
In ailments such as Alzheimer’s disease, Parkinson’s disease and other neurodegener-
ative dementia, one of the major problems is the time-dependent convertion of α-helices
into intermolecular β-sheet assemblies of intrinsically unfolded proteins. This misfolding
exposes hydrophobic groups that are normally buried in the interior of the protein, and
makes the proteins aggregate and form large arrangements of proteins called preﬁbrils.
These are stabilized by intermolecular β-sheets (Figure 2.3). The preﬁbrils are belived
to be neurotoxic by themselves, but also take part in neurotoxic amyloid plaque forma-
tion.15,16,32–34 The amyloid plaques deposit on neurons in the brain, prohibiting crucial
nerve signals from passing through. The consequences can be reduced cognitive abili-
ties, reduced movement control, reduced learning ability, and memory loss.15,33 A better
understanding of how the reduced dimensionality at interfaces act as folding templates
can aid the development of early diagnostic tools or efﬁcient therapeutics for such protein
misfolding diseases.16,35–37
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Figure 2.3: Monomeric proteins are destabilized, made conformationally labile and form dimers.
The dimers are then aggregated into tetramers. The aggregation continues and intermolecular β-
sheets are formed. The preﬁbrils can evolve further to ﬁbrils, and form amyloid plaques. Adapted
from Giurleo.32
While structural changes in proteins often can be harmful, there are some exceptions.
One example of this is Human Alpha-lactalbumin Made LEthal to Tumor cells (HAM-
LET). This oleic acid stabilized non-native form of the protein is known to kill cancer
cells, while sparing healthy mature cells.21,38
2.4 HAMLET - conformationally modulated aLa for use
in medicine
Several types of materials and molecules can be used to alter protein conformation or
function to create constructs which can be used in medical research. HAMLET is an
example of how combining substances can produce surprising results; the oleic acid be-
comes solubilized and deliverable, while the polypeptide chain may expose motifs hidden
in the folded protein that are disruptive to the cell in combination with the stress from the
oleic acid.
HAMLET is formed when human alpha-lactalbumin is complexed with several oleic
acid molecules. The complex is able to induce cell death in tumor cells, but not in healthy
cells.21 HAMLET causes DNA fragmentation in the nucleus and also interacts with mi-
tochondria and other organelles in the cell.38–41 The interaction with mitochondria causes
release of cytochrome c and thus induce activation of the caspase cascade.42,43 Caspases
are proteolytic enzymes that target and destroy speciﬁc proteins, such as proteins that are
supposed to maintain the cell.17 In the caspase cascade a series of caspases are activated,
and by destroying vital proteins they are essential for apoptosis.
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In the complex, calsium depleted aLa (type III) is held in a molten globular form by
oleic acid.21,44 Svensson et al.45 showed in 2003 that aLa unfolding is a requirement to
form HAMLET and necessary, but not sufﬁcient to cause apoptosis. Despite that Ca2+-
bound aLa (type I) cannot be converted to HAMLET, they also found that oleic acid
probably stabilizes the altered conformation without interfering with the Ca2+ site.21,45
This early study implies that both the protein and the oleic acid is necessary to form the
HAMLET-complex. From the mid 1990’s to the present, a lot of effort has been put down
in studying how HAMLET function, and which component is the most important one.
This led to two main explanation models for HAMLET. One where the protein simply is
a carrier of the fatty acids, and that the fatty acids are what kills the cells. And another
where it is the conformational changes in aLa that enables HAMLET to enter cells and
cause cell death, while oleic acid is just a stabilizer to keep the protein in the correct
folding state.
Permyakov et al.41 have made oleic acid complexes with bovine β-lactoglobulin and
pike parvalbumin, and compared their ability to kill Streptococcus pneumoniae and hu-
man epidermoid larynx carcinoma (HEp-2) with HAMLET. In their study they point out
that the human aLa part of the HAMLET can be exchanged with aLa from bovine, equine,
porcine, or caprine and still cause cell death.41 These proteins have 76 - 79% structural
similarities with human aLa. Oleic acid modiﬁed equine lysozyme is also found to induce
cell death.46 This could imply that oleic acid is more improtant to the HAMLET effect,
than aLa. Earlier studies also show that the exchange of oleic acid C18:1 with C16 or C20
cis-oleic acids makes the complex less active, or not active at all.40,41,44 Moreover, in the
studies by Permyakov et al.41 β-lactoglobulin and pike parvalbumin complexed with oleic
acid kill both Streptococcus pneumoniae and HEp-2 more efﬁciently than HAMLET. Half
of the human epidermoid larynx carcinoma cells are killed at ~200 μM oleic acid, which
is similar to when the protein-oleic acid complexes are present.
These studies show the importance of oleic acid, but there are also studies on similar
effects caused by other fatty acids. Tuei et al.47 modifed human and bovine serum albu-
min (HSA and BSA) with several types of fatty acids and then tested the cell-viability.
This study show that HSA/BSA modiﬁed with palmitate and stearate induce more cell
death than when modiﬁed with oleate. Which implies that the fatty acid does not need to
be oleic acid, and that saturated fatty acids have a more severe effect on cell-viability than
unsaturated ones.
The protein might not need to be aLa, and the conformational stabilizer might not
need to be oleic acid, but several researchers have proposed that the whole protein-fatty
acid complex is important to target cancer cells and cause apoptosis. Lišková et al.48
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have done studies with β-lactoglobulin and sodium oleate which show that the degree of
apoptosis is dependent on the concentration of sodium oleate, but not the concentration
of β-lactoglobulin. However, they also show that the trends in cytotoxicity for BAM-
LET and the β-lactoglobulin-sodium oleate complex varies between different types of
cell lines. This suggests that the protein part of the complexes is important for interaction
with different types of cells, and contributes to the total cytotoxicity. Moreover, HAM-
LET possesses membrane affecting properties enabling disruption of vesicle- and model
cell membranes. This kind of membrane interaction is not seen for native aLa or constitu-
tively unfolded Cys-Ala aLa mutants.49 This suggest that aLa must be stabilized with e.g.
oleic acid to achieve the membrane affecting properties observed for HAMLET.21,45,49
Membrane interaction or disruption of the membrane could be an initial step in killing
the cells. When vesicles are made from intact tumor cells the interaction seemes to be
selective to speciﬁc patches, but HAMLET is not transported into synthetic membrane
vesicles.40,49 This can indicate that cellular uptake of HAMLET occurs via speciﬁc inter-
action between the construct and reseptors at cancer cell surfaces, and may be the reason
why HAMLET affect cancer cells more than healthy cells. Several studies also imply that
both the protein and the fatty acid are needed for HAMLET to speciﬁcally enter cancer
cells and kill them.27,50–52
It might be that HAMLET dissociates inside the cell or in the membrane, and it is
difﬁcult to know if the further events are caused by the whole HAMLET complex, aLa,
or oleic acid. Thus, further studies on the HAMLET mechanisms are required. To fully
be able to utilize HAMLET and similar constructs as anticancer agents, it must be under-
stood how HAMLET is able to select cancer cells over healthy cells, how the construct
enters the cells, and how it induces cell death. Independent of mechanism, HAMLET is
able to reduce both skin papilloma and bladder cancer,40,53,54 and the bovine version of
HAMLET (BAMLET) possesses many of the same properties as HAMLET.49
10 3. Gold nanoparticles and gold nanoclusters
3. Gold nanoparticles and gold
nanoclusters
Carbon nanotubes, polymer particles, mesoporous silica particles, magnetic nanoparti-
cles (e.g. iron oxide) and other metal nanoparticles are all examples of conformation-
modulating nanomaterials that can be used to alter protein structure.11–13 For the study
presented here, gold nanoconstructs were chosen as modulating tools because they have
optical properties (localized surface plasmon resonance (LSPR) for gold nanoparticles
(AuNPs) and ﬂuorescence for gold nanoclusters (AuNCs)) that allow for the introduction
of an optical marker at the same time as the protein conformation can be changed. Their
optical properties can also be used for characterization of the constructs.55–60 AuNPs have
high chemical stability and can be easily coated with several different organic compounds
e.g. carboxylic acids, amines and proteins (see e.g. review by Glomm and references
therein).7 Finally, by varying the reaction conditions protein-gold nanoconstructs can be
made in a wide range of sizes and shapes, allowing for tunability of the protein confor-
mational changes.7,56–58,61,62 This chapter addresses an introduction to optical properties
of AuNPs and AuNCs, followed by potential use of such constructs in medicine. To be
able to display LSPR in UV-vis spectroscopy, the constructs must be ≥ 3 nm. Based on
the limit for LSPR the assumption that the size of AuNC < 3 nm ≤ AuNP is used to dis-
tinguishing between the two types of gold nanoconstructs here. In some systems AuNC
and AuNPs coexist.
3.1 Optical properties of gold nanoparticles
When gold nanoparticles interact with light, effects like light absorbance and light scatter-
ing are enhanced due to the free electrons in the metal.9 Different sizes and shapes of gold
nanoparticles scatter and absorb light at different wavelengths, and due to the nice colors
that occur, AuNPs have been used for centuries to stain glass61 Gold nanoparticles can
also quench ﬂuorescence as they absorb the resonance energy emitted from ﬂuorescent
species.63 This is a distance-dependent phenomenon that occurs when the emission spec-
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tra of a donor overlaps with the absorbance spectra of an acceptor.63 Small gold nanopar-
ticles absorb light around 520 nm and appear red, while larger particles color aqueous
suspensions purple. These effects are due to localized surface plasmon resonance, which
is a phenomenon where incident light makes the conduction-band electrons collectively
oscillate around the nanoparticle core. This happens when the frequency of the incident
light matches the frequency of the surface electrons.9 The phenomenon is described in
Figure 3.1
Figure 3.1: Collective oscillation of negative electrons around the positive metal core occur when
the frequency of the incident light matches the frequency of the conduction-band electrons and
results in localized surface plasmon resonance (LSPR)6
Frequency and intensity of Rayleigh and Mie scattering for gold nanoparticles are
highly enhanced due to the LSPR.9 Mie scattering is the scattering of electromagnetic ra-
diation by a spherical nanoparticle, and occurs when the wavelength of the incident light
is larger or the same size as the nanoparticle which it interacts with.64,65 The Mie theory
can be applied to both absorbing and nonabsorbing particles. If the particle diameter is
smaller than the wavelength of the light (approximately λ/10), Rayleigh scattering occurs,
and if the particle is larger than the wavelength of the incident light, the scatter is called
Rayleigh-Gans-Debye scattering.65 For the Rayleigh scattering theory to be applied, the
particles must be nonabsorbing and non-interacting. This theory is thus best suited for
gasses and aerosols, and is used to explain the color of the sky.65,66 While Rayleigh scat-
tering is isotropic and scatters light in all directions, Mie-scattering is anisotropic and in
the forward direction.65,67 Since the size, shape, coating and environment of the AuNPs
affect the LSPR, UV-vis spectroscopy can be used to study macromolecule (e.g. polymers
and proteins) adsorption onto the AuNPs, and to study the stability of the system.55,68–71
Shift of LSPR is often discussed within the frames of the Mie-Drude theory. The Drude
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model describes the transport properties of electrons in metals (see Figure 3.2), and en-
ables the interfacial properties of the metal to be interpreted from changes in absorption
of light.69
Figure 3.2: The Drude model describe electrical conduction by electrons that bounce between the
larger, rather immobile, positive ions in a crystal lattice.
This model describes how the free electrons experience damping due to the positive
lattice and applied electromagnetic ﬁeld. The Drude model can be described by eq. 3.1.72
ε(ω) = 1− ω
2
p
ω2+ iγω
(3.1)
Here, γ is the damping constant, i is the imaginary number
√−1, ω is the angular fre-
quency, ωp is the plasmon frequency and ε is the complex dielectric function. The Drude
model is based on the fact that large shifts in the absorption spectra of metal sols can be
observed when changes are made in the double-layer (two parallell layers of charge) at
the interface between the metal particle and solvent.69 This happens whenever the envi-
ronment at the particle surface is altered.
By solving the Maxwell’s equation with respect to electromagnetic light interacting
with small metalic spheres, Gustav Mie explained in the early 1900’s how the colors
of metal colloid suspensions are dependent on the absorbance and scattering of incident
light.60,69 When the Mie-solution is applied to the Drude model, the Mie-Drude theory
can be used to predict changes in LSPR. If the size of the gold core is kept constant, the
equation for the Mie-Drude theory can be simpliﬁed, as shown in eq. 3.2.60,69,73
σext = 4χIm
{
(εs− ε0)(εm+2εs)+(1−φ)(εm− εs)(ε0+2εs)
(εs+2ε0)(εm+2εs)+(1−φ)(2εs−2ε0)(εm− εs)
}
(3.2)
σext is the extinction cross section per particle, Im means that the imaginary solution
of the following part should be applied, εs is the optical dielectric function of the shell
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layer, εm is that of the gold core, and ε0 that of the solvent. φ is the volume fraction of the
shell layer, and χ is the size parameter (given in eq. 3.3).
χ=
2πRε1/20
λ
(3.3)
Here, R is the coated particle radius and λ is the wavelength of incident light. Eq.
3.2 and eq. 3.3 describes how light absorbance is dependent on particle size, solvent
refractive index, interparticle distance, stabilizing ligand shell (type and thickness) and
core charge state. Based on these parameters the Mie-Drude theory is used to predict or
explain how much light is absorbed.68 When the solvent and the size of AuNPs are kept
constant any changes observed must be due to the stabilizing ligand shell (e.g. proteins)
and/or the core charge state.68 To observe these changes with UV-vis spectroscopy, eq.
3.2 can be simpliﬁed to eq. 3.4.
EC(M−1 · cm−1) = σext(3 ·10
−3)Vm
4(2.303R)
(3.4)
Here, EC is the actual extinction coefﬁcient of the particle and is not concentration
dependent, and Vm is the molar volume of gold (~10.4 cm3/mol).
When the distance between gold nanparticles decreases, as when aggregation occurs,
near-ﬁeld coupling is induced and a distinct red shift and a broadening of the LSPR band
are observed in the absorbance spectra.55,71 If the line shape of the UV-vis absorption
spectra is not signiﬁcantly altered upon protein adsorption the protein-gold nanoparticles
have likely remained as single colloids rather than dense ﬂocs. However, protein adsorp-
tion on AuNPs will always lead to a change in the dielectric function of the nanoparticle
resulting in a shift of the LSPR band,68–70 thus giving a good indication about whether
proteins are adsorbed or not, and whether the system is stable.
3.2 Optical properties of gold nanoclusters
AuNPs are large enough to have a big cloud of electrons surrounding them, and this is
needed to create the LSPR effect. However, when the size is reduced to nanoclusters,
the energy levels become more discrete, and the LSPR is lost.74 AuNCs have molecular-
like HOMO-LUMO bandgap openings and the electronic transitions here are smaller in
size than the Fermi wavelength.75,76 This causes AuNCs consistent of a "magic number"
of atoms to luminesce.59,74–76 A "magic number" of atoms is when the clusters have an
amount of "free" electrons that match the spherical shell closing number.61 The spherical
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shell closing number is to clusters, what ﬁlled valence shells are to atoms, and typical
"magic numbers" are n = 8, 11, 13, 18, 22, 25, 28, and more.57,61 While many protein
solutions are more or less colorless when exposed to UV-light at ~365 nm, AuNCs have
a strong ﬂuorescent color (see Figure 3.3). The presence of AuNPs can reduce the ﬂuo-
rescence observed from AuNCs due to energy transfer from AuNCs to AuNPs.
Figure 3.3: Images of protein and protein-gold nanoconstruct solutions illuminated with UV-light
(λex = 365 nm). (a) BSA in buffer, (b) BSA-gold nanoclusters in buffer, (c) Transferrin-gold
nanoclusters, also in buffer.
AuNCs can be studied with steady-state ﬂuorescence.57 When excited with a light
source with λex = 370 nm, earlier studies have concluded that small protein-stabilized
gold nanoclusters (8 Au atoms, Au8) emit at λem = 450 nm, while larger nanoclusters (25
Au atoms, Au25) show emission at λem = 685 nm.57 When λex = 450 nm small AuNCs
are not excited, but larger AuNCs are. By choosing higher excitation wavelengths, it is
thus possible to study ﬂuorescence from larger AuNCs, exclusively.
3.3 Use of nano-sized gold in medicine
Gold in many shapes and sizes has been used for medical purposes for centuries, and is
well incorporated in traditional Chinese medicine.4 Gold teeth are in the upper size range
of gold constructs used in medicine. Teeth made of gold are possible because gold is
nontoxic, in addition to not being prone to oxidation in air or water. At the other end
of the size range, gold ions have been used for 80 years to treat rheumatoid arthritis.77
This section will mainly focus on gold in the size range corresponding to nanoparticles
and nanoclusters. It is important to keep in mind that when gold nanoconstructs are used
in medicine, some of the observed effects can be due to the molecules conjugated to
gold, and not necessarily gold itself.4 In some cases the gold and coating combined have
properties which are not observed for any of the constituents alone. The nano-size itself
imparts gold nanoconstructs with unique properties. Their chemistry and physical prop-
erties often deviate signiﬁcantly from both atomic behaviour as well as bulk behaviour.
If the particles are smaller than ~200 nm they can enter cells through endocytosis, and
if they are smaller than ~40 nm they can even enter the cell nucleus.7 For uptake from
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the vasculature, the diameter must be less than 70 nm.7,78 The small size makes the gold
nanoparticles less affected by gravity, and thus less susceptible to sedimentation.65 More-
over, small colloids have large surface areas compared to their size, thus many of the
physical and chemical properties of these colloids are linked to their surface properties.65
The surface chemistry of AuNPs allow for functionalization with several different com-
pounds, such as polymers, DNA, proteins, and others. Thus, modiﬁed AuNPs can be
tailored to different environments and tasks.7,8 By combining AuNPs or AuNCs with dif-
ferent biological macromolecules, like proteins or peptides, it might be possible to make
new bionanomaterials with emergent properties that can aid in medical research.
3.3.1 Gold nanoparticles in medicine
The unique optical properties of AuNPs and their ability to adsorb organic compounds
and alter protein conformation have made these colloids much studied for intracellular
delivery.7,79–82 Gold nanoparticles can carry proteins, siRNA, DNA, peptides as well as
small organic compounds and penetrate into individual cells.79–81,83–85 Transport of such
molecules into cells may be important for treatment and diagnostics of e.g. cancer, and
AuNPs can be cost-efﬁcient and safe alternatives to traditional viral vectors.81 The siR-
NAs are potential promising therapeutic candidates, as they can be used to silence disease-
causing genes.84,86 To be able to silence genes, siRNA must enter the nucleus without
being degraded during transport.86,87 Layer-by-layer modiﬁed AuNPs have proven to be
well suited vectors for safe transport of siRNA.84,85,87 The AuNPs are functionalized with
a hydrophilic polymer (e.g. poly(ethylene glycol)), then the siRNA is linked to this ini-
tial polymer layer, before another layer of polymer (this polymer can be the same as the
ﬁrst one) is added to create a protective layer around the whole construct.84,85,87 By using
gold nanoparticles as scaffolds for proteins and other biomolecules, the optical proper-
ties of nanosized gold can be used as a diagnostic tool to track the nanoparticle construct
and the surronding physicochemical environment. When using immunogold electron mi-
croscopy, speciﬁc antigens are detected and their location can be visualized by antibodies
modiﬁed with colloidal gold.4 Due to the enhanced permeability and retention effect in
tumors, AuNPs in the size range 10-100 nm often accumulate in tumor tissues, and the
light scattering properties of AuNPs can thus be used for imaging of cancer cells.9,13 To
improve studies of cells using different types of microscopy, BSA-AuNPs are modiﬁed
with a variety of polypetides. This enhances cellular uptake and improves the chance of
the AuNPs reaching the nucleus.80 For spherical AuNPs excitation of LSPR occur using
light in the visible region. This light is not able to penetrate deep into the skin, but if the
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shape of the nanoparticles is altered to e.g. rods, near infrared light can collectively oscil-
late electrons to induce photothermal properties. Cancer cells can then be killed through
hyperthermia while the effects on non-targeted cells are minimal.13
Modiﬁed AuNPs can be used for much more than diagnosis of cancer. They can also
be used for diagnosis of syphilis, sensing of narcotics, antidoping tests, pregnancy tests,
and more.88,89
Gold nanoconstructs at the size-border between AuNPs and AuNCs can be used as
X-ray contrast agents.10 In Figure 3.4 1.9 nm gold nanoconstructs as contrast agent for X-
ray, is compared to traditional iodine contrast agent (Omnipaque). Gold provides higher
contrast at lower X-ray dosages than iodine, and due to slower clearance rate, images can
be collected over a longer peroide of time.
Figure 3.4: X-ray image obtained 60 minutes after intravenous injection with (a) 1.9 nm gold-
nanoconstructs and (b) iodine contrast agent.10
Despite the extensive research on biomolecules conjugated to AuNPs for drug de-
livery and diagnostic purposes, little is known about how the adsorption prosess alters
conformation and function of e.g. proteins.83
3.3.2 Protein-gold nanoclusters in medicine
Gold nanoclusters do not possess the same plasmonic properties as gold nanoparticles but
they do, however, present ﬂuorescent properties.56,57,74 This is described in more details
in section 5.5, page 31. AuNCs can be stabilized by polymers, peptides, DNA, thiols,
etc. (see review by Shiang et al.74 and references therein). Studies on protein-stabilized
AuNCs so far have used the proteins only as AuNC stabilizer, and articles published on
the medical applications of protein-AuNCs have hitherto mainly focused on the prop-
erties of the gold itself.56,57,74,90,91 Recently published results by Chen et al.90 show
how lysozyme-AuNCs can be used to detect glutathione, which can be an indicator of
brain damage and other diseases, in a single drop of blood. The sensing of glutathione is
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based on the fact that it quenches ﬂuorescence from AuNCs.90 Quenching of AuNC ﬂu-
orescence can also be used for sensing IgG (antibodies connected to breast cancer), and
several other proteins as well.74 Hu et al.92 have used BSA-AuNCs to detect trypsin by
studying the alteration of ﬂuorescence as the protease digests BSA. This technique can be
used to measure elevated levels of proteases, which may be connected to neurodegenera-
tive diseases, cancer and inﬂammations. Acute myeloid leukaemia can be discovered at
an earlier stage by using ﬂow cytometric detection of BSA-AuNCs conjugated with CD33
mono-clonal antibodies to detect CD33 myeloid antigens.75 Protein-AuNCs can also be
used for cellular imaging.5,74 Zhang et al.93 have used BSA-AuNCs to develop a ﬂuores-
cence imaging technique to detect altered levels of serum proteins. Their aim was to ﬁnd
a method to distinguish healthy people from people with liver diseases. This new method
for sensing serum proteins is 7-14 times more sensitive than traditional methods. Folic
acid conjugated BSA-AuNCs have been tested and proved promising for cancer imag-
ing.76 Guével et al.94 have made very stable BSA-AuNCs by covering them with silica,
and it is likely that these constructs can be used to image lung cancer. Other protein-
AuNCs have also showed promising results for tumor imaging and therapy as well.91 The
protein-AuNCs can be conjugated with antibodies to speciﬁcally ﬁnd cancer cells, and
then their ﬂuorescence can be utilized to image tumors.
The relatively new ﬁeld of probing protein-AuNCs for medical use is expanding
rapidly. So far most of the studies are done on BSA-stabilized AuNCs and few other
proteins have been studied for this purpose. Most of the studies focus on how the ﬂuores-
cent properties of the AuNCs can be used in diagnostics and targeted drug delivery, and
few focus on how protein conformation and function are altered.
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4. Protein modiﬁcation with gold
nanoconstructs
The two main methods for manipulating proteins with gold presented here are protein
adsorption onto gold nanoparticles, and formation of gold nanoclusters within the protein,
both with subsequent changes in protein conformation (Figure 4.1). The following chapter
deals with how these bionanomaterials can be utilized for medical purposes.
Figure 4.1: (a) Modiﬁcation of proteins using AuNPs. (b) Modiﬁcation of proteins using AuNCs.
In some cases modiﬁcation of proteins with AuNCs leads to formation of protein-AuNC stabilized
AuNPs.
4.1 Protein adsorption onto gold nanoparticles
There are several studies on the adsorption of polypeptides onto gold surfaces.3,83,87,95–97
Adsorption to surfaces and interfaces can occur either through weak electrostatic, van
der Waals and hydrophobic forces (physisorption), or through strong electrostatic inter-
actions and covalent bonds (chemisorption). Physisorption is normally characterized by
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high adsorption rates and the formation of multilayers, while chemisorption normally is
characterized by lower adsorption rates resulting in monolayer formation.7 When proteins
adsorb onto gold nanoparticles they have to go through a three-step procedure: 1 - trans-
port toward the surface through diffusion or convection, 2 - attachment to the surface, and
3 - spreading on the surface (see Figure 4.2 a).96,98
Figure 4.2: (a) The process of adsorption of proteins onto surfaces are divided into: 1 - transport
towards the surface, 2 - binding to the surface, and 3 - spreading on the surface. (b) Degree of
protein unfolding at the interface depends on protein concentration.96
If the last step in the adsorption prosess leads to exposure of hydrophobic- or func-
tional groups, the spreading could lead to denaturation of the protein.7 Depending on the
type of interaction, curvature of the surface and reaction conditions in general, different
conformational changes can occur. Partial unfolding of water-soluble globular proteins
may lead to exposure of more hydrophobic groups, which can induce increased inter-
facial activity. Despite the fact that proteins are often immobilized by adsorption onto
different materials, the full picture of how adsorption might alter protein conformation
and function is still unclear.
As a protein adsorbs to a surface, several sub-processes occur with the protein and
the adsorbent. These are deﬁned as; (i) changes in hydration states of the adsorbent and
the protein surface, (ii) redistribution of charged groups, both chemical (medium change
for transferred ions) and electrical (overlap of electric ﬁelds), and (iii) rearrangements in
protein structure. For the latter, the structural stability of the protein molecule comprises
an important parameter.99 As has been shown by e.g. Glomm et al.,96 the properties of
the adsorbed layer, such as adsorbed amount, layer thickness and adlayer ﬂexibility, can
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also be tuned through control of the deposition kinetics (Figure 4.2 b, page 19). This can
be controlled through variations in protein concentration, ﬂow-rate and pressure. As the
protein concentration increases, each protein will have less time to spread (step 3 in Figure
4.2 a) before more proteins arrive through steps 1 and 2. In other words, at low protein
concentrations (or low pressures/ﬂow-rates) the proteins can spread more at the surface
than what they may under higher protein concentrations, pressures or ﬂow-rates. Size
and coating of the gold nanoparticle, temperature, pH, solvent (type and ionic strength),
surface curvature, type of particle and choice of protein are other possible variables.
Larger particles have less curvature than smaller ones, which might lead to differences
in available surface area as well. Earlier studies indicate that small nanoparticles promote
retention of native-like protein structure, while larger nanoparticles tend to give more
spreading and unfolding.1,100,101 However, there are also examples of the opposite effects
occurring.102
Stable gold nanoparticles in suspensions are not bare but covered with a stabilizing
agent such as citrate or other ligands. This means that normally two adsorption hypoth-
esis must be concidered: the electrostatic hypothesis and the displacement hypothesis.7
The electrostatic hypothesis involves pH-dependent attraction between charged groups in
the passivating layer on the AuNP surface and oppositely charged groups in the adsor-
bant, while the displacement hypothesis involves displacement of the passivating layer.
For proteins, amino groups from lysine and thiol groups from cysteine can interact di-
rectly with the gold surface.7,13,103,104 There are many ways to synthesize AuNPs, such
as disintegration of gold nanorods or reduction of gold salts using reducing agents or
radiation.105–108 The gold nanoparticles used in papers I and II are initially citrate sta-
bilized. They are bought commercialy and synthesized as described by Turkevich.105
In this method, sodium citrate reduces hydrogen tetrachloroaurate(III) at 100 ◦C to form
uniform and stable AuNPs. In addition to be the reducing agent, citrate also functions
as a passivating and stabilizing agent of the AuNPs formed. A study by Brewer et al.95
concluded that when citrate is present, BSA binds electrostatically to the citrate layer on
the gold surfaces. In addition, adsorption behavior studies of eight different proteins onto
citrate-covered AuNPs concluded that binding of proteins occur through charged patches
on the protein and the adsorbent, ﬁtting with the electrostatic hypothesis.96 Moreover,
the global charge of the protein is less important, provided that the proteins have local
positive patches that can interact with the negatively charged citrate at a given pH. Since
the amino acids have different pKa-values, the hydrophobic and electrostatic forces can
be manipulated by adjusting pH in the bulk solution.
Several issues can occur when gold nanoparticles are used to modify proteins: 1 - The
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structural changes in the protein can be larger than desired. In general this is manifested
as low tunability in the degree of unfolding. 2 - Normally more than one protein adsorb
to each AuNP, making any observed chemical and physical properties dependent on the
whole construct, not the individual protein. 3 - The total size of the construct can be
too large for cellular uptake (~100-200 nm, dependent on uptake method), and thereby
preventing usage of the construct as a drug vector.
4.2 Protein modiﬁcation using gold nanoclusters
Many of the obstacles when using AuNPs to modify proteins can be surpassed by using
smaller modifying entities such as AuNCs. The deﬁnition of gold nanoclusters varies
between research ﬁelds,56–58,61 but in this thesis gold nanoclusters are deﬁned to be made
up from a few atoms to tens of atoms, and having diameters less than 3 nm.
In theory, the size of the gold nanoconstructs can be tuned from nanoclusters to
nanoparticles by varying the concentration of reducing agent and gold precursor. The
reducing agent can either be the amino acid residues themselves, or an added reducing
agent.56,57 Varying reaction time or the temperature can also inﬂuence the type of protein-
gold nanoconstructs formed. The wide range of possible protein-gold nanoconstructs
allows for controlled protein-modiﬁcation, and it might be possibile to study to what ex-
tent protein conformation may change before the protein function is compromised. Such
studies can improve the understanding of protein misfolding diseases such as Alzheim-
rer’s disease. Also, AuNCs are ﬂuorescent, and an inherent optical marker can be of great
beneﬁt for diagnostic purposes.
In HAMLET-research it is difﬁcult to know if the conformational changes of the pro-
tein causes the anti-cancer properties, or if the protein simply transports oleic acid (section
2.4, page 7). In HAMLET, oleic acid is reversibly bound to aLa, and the construct might
dissociate. However, in aLa-AuNCs, the conformation modulating entity would be cova-
lently bound to aLa. Thus, any observed effects must be due to the whole construct as
such.
Earlier studies on protein-gold nanoclusters have mainly focused on the synthesis of
the gold nanoclusters and the ﬂuorescent properties of the gold,56–58 but few have studied
the conformational and functional changes in the protein. How the synthesis of gold
nanoclusters whithin the protein affects proteins with different properties is also scarcely
studied. Even the study by Chen et al.,90 where lysozyme-Au8 constructs were used to
detect glutathione (section 3.3.2, page 16), focused on the properties of the AuNC, not on
the altered structure of lysozyme. In this thesis, both the structural changes in the protein,
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as well as the resulting optical properties of the protein-gold nanoconstructs formed have
been taken into consideration. The protein-gold nanoconstructs are also studied to see if
they have any emergent properties not found in either protein or gold alone. The AuNCs
also allow for a different method for modifying proteins as compared to adsorption onto
AuNPs.
4.3 Toxicity of gold nanoparticles
The increased use of gold nanoparticles in medicine gives rise to a demand for an in-
creased knowledge about potential toxicity of AuNP-constructs. In 2005 Connor et al.109
published results showing that AuNPs can be taken up by human cells without inducing
cytotoxic effects. However, it is known that nanoparticles behave differently than both
their bulk and atomic counterparts, and that they are likely to interact with biological
systems (e.g. biomolecules such as proteins and lipids) in ways currently not under-
stood.110,111 Toxicology of AuNPs is very complex. A study performed by Uboldi et
al.,112 shows that the concentration of contaminants, such as excess sodium citrate, on
the surface of gold nanoparticles can be important for inducing cytotoxicity in vitro, but
not for the uptake of AuNPs in human ATII-like cell lines. Recently Choi et al.113 pub-
lished in vitro results with serum protein-coated citrate-reduced AuNPs causing apoptosis
in human lung adenocarcinoma cells. The cell death show some concentration depen-
dence (0-60 μg/ml), but no difference between 24h and 72h exposure was observed. At
the maximum concentration of AuNPs approximately 50% of the cells died. Moreover,
increased negative charge of the AuNPs seems to be more lethal than a lower charge. In an
in vivo study using AuNPs as X-ray contrast agents in mice, the AuNPs were found to be
non-toxic.10 However, zebra ﬁsh experience alteration of genome composition and dys-
function at a sub-cellular level after being fed with low dosage (36-106 ng gold/ﬁsh/day)
of gold nanoparticles.114 Earlier studies on mice also show that intravenously adminis-
tered citrate-covered AuNPs accumulate in the liver, lungs, spleen, kidneys, heart and
stomach.115 The distribution of AuNPs in the mice is dependent on the particle size, and
the smallest (15 nm) AuNPs tested were found in all the mentioned organs. The concen-
tration in the brain was also quite high. However, Sonavane et al.115 only studied the
distribution of the introduced gold, not how the present gold affected the mice.
Some of the above results are conﬂicting, and to get a full picture of the toxicity of
AuNPs, more in vitro and in vivo experiments are needed. The toxicity of gold nanopar-
ticles is probably dependent on size and shape of the particle, the species and charge of
the coating layer, purity of the suspension, concentration, and means of administration
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(through the skin, through inhalation, intravenously, etc.).
4.4 Toxicity of gold nanoclusters
In recent years, the interest for using gold nanoclusters for medical applications has in-
creased, and just as for gold nanoparticles, the knowledge of their toxicity is at present
inadequate. Since the use of AuNCs for medical research is a much younger ﬁeld than
similar use of AuNPs, possible toxic effects from AuNCs are even less known. In several
cases, AuNCs are used as ﬂuorescent probes to determine the concentration of different
target species in blood samples, such as glutathione,90 serum proteins,93 trypsin,92 and
CD33 myeloid antigens.75 In these cases, the AuNCs are never actually introduced to the
body, making potential toxicity less essential. However, if the AuNCs are to be used to
image tissues or as therapeutics, the toxicology is of great importance. A study by Wang et
al.,4 shows that when the AuNC concentration is kept below 500 nM their gold nanoclus-
ters do not reduce cell-viability. This is very promising for using AuNCs as ﬂuorescent
probes, since biocompatibility is of great importance for medical usage. Furthermore,
Chen et al.91 have made BSA-AuNCs conjugated with methionine (Met). The Met is
added to increase speciﬁcity toward cancer cells. The BSA-AuNC-Met are labeled with
either MPA (MPA is a ﬂuorescent hydrophilic derivative of indocyanine green made by
Chen et al.) or DOX (Doxorubicin, an anti-cancer drug). BSA-AuNC, BSA-AuNC-Met,
and BSA-AuNC-Met-MPA are tested in cell-viability studies using both healthy cells and
different cancer cell-lines. Even at high dosages of the three constructs (1 mM), 80%
of the cells survived. In vivo studies in mice also show low toxicity of the AuNC con-
structs.91 Chen et al. observed some discoloration of the liver due to BSA-AuNC, but the
other constructs showed no harmful effects on the mice. The in vivo studies also shows
that Met-labeled constructs targeted cancer cells instead of healthy cells. The uptake ef-
ﬁciency also vary between the different types of cancer tumors. In vivo studies with the
DOX-modiﬁed constructs showed that BSA-AuNC-Met-DOX is taken up more in can-
cer cells than in healthy cells, and kill cancer cells more efﬁciently than pure DOX does.
Moreover, BSA-AuNC-Met-DOX uptake in healthy cells is less than what is observed for
pure DOX. In short, Chen et al. has created a non-toxic protein-AuNC construct which
can be used to image tumors safely (BSA-AuNC-Met-MPA), and a AuNC-cancer drug
construct (BSA-AuNC-Met-DOX) that is more selective towards cancer cells, as well as
being more efﬁcient as a cancer therapeutic, than the original drug. As for AuNPs, the
toxicity of AuNCs is probably highly dependent on the conjugated species, concentration,
and route of administration.
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This chapter provides some theory, and brief descriptions of the experimental techniques
most relevant to the work presented in this thesis.∗ The description of the different tech-
niques are focused on their speciﬁc use for the presented work, not necessarily their gen-
eral use.
5.1 UV-vis spectroscopy
Ultra violet-visual light (UV-vis) spectroscopy is one of the most basic characterization
techniques and can provide information about gold nanoconstructs, protein-gold nanocon-
structs, adsorption, protein concentration and protein activity. The method is based on
different species (chromophores) absorbing light at different wavelengths depending on
the type of energy transition occurring. Molecules in solutions can contain several chro-
mophores, and several transitions are possible, but π→ π∗ is the most common.116
UV-vis measurements are often used to determine concentration of proteins in solution
via the Beer-Lambert law (eq. 5.1).117
A = log
(
I0
I
)
= εcl (5.1)
Equation 5.1 shows that the absorbance (A) is proportional to the sample concentra-
tion (c) in mol/L. At the given wavelength the molar extinction coefﬁcient (ε) is a measure
of how strongly the compound absorbs. I0 is the light intensity before the light has passed
through the sample, and I is the light intensity afterwards.
Shift in the UV-vis absorption maxima can be used to study induced changes in
certain systems, such as changes in the micro-environment for proteins as the protein
fold is altered.117,118 The changes can e.g. be differences in the solvent polarity (solva-
tochromism), or the viscosity of the system (rigidochromism).119 Protein UV-absorbance
is mainly due to Trp, for which absorbance is very environment dependent. A blue shift in
∗The AFM and STEM studies were executed by Ph.D. Gurvinder Singh, while Ida Maria Rundgren and
Hanzhen Wen performed the cell-viability studies.
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absorbance spectra indicates a more polar environment for Trp, while a red shift indicates
more non-polar surroundings.117 When proteins unfold in water, a blue shift is normally
observed.118
Due to AuNPs strong absorption band, caused by LSPR (see section 3.1, page 10),
UV-vis spectroscopy can also be used to prove the presence of gold nanoparticles, and
to characterize them. Changes in this absorption band can be used to observe protein
adsorption onto AuNPs.7,72,120 As polypeptides adsorb onto AuNPs the absorbance max-
ima shifts to higher wavelengths (red shift).55 This can normally be observed by the naked
eye, as such a shift will cause the suspension to appear more purple in color. If aggregates
are formed, the line shape will broaden as well.55
Protein adsorption onto gold can also be measured through changes in size and ζ-
potential, by using dynamic light scattering (DLS).
5.2 Dynamic light scattering
The size distribution of nanoparticles in suspension can be measured by dynamic light
scattering (DLS). When light hits small particles, the light will be scattered in different
directions, with different intensities and different degrees of polarization in all directions,
and this can be detected by a detector placed at a speciﬁc angle with respect to the incident
beam.66,67 The emerging pattern is dependent on both the refractive index of the particle,
solvent, as well as the particle size.67 An illustration of the scattering pattern is given in
Figure 5.1.
Browninan motions of the particle cause the intensity of the scattered light to ﬂuctu-
ate over time, and an autocorrelation function can be made. The autocorrelation func-
tion C(s,td) models the decay between the highest intensity value [i(s,0)]2 and its lowest
asymptotic value [i(s)]2 as a function of delay time (td) (see Figure 5.2).65,121 This func-
tion decays exponentially with the time delay.121 The exponential delay is dependent on
the particles diffusion coefﬁcients, which in turn can be used to ﬁnd the particle’s hydro-
dynamic diameter using the Stokes-Einstein relationship (eq. 5.2).65,121 For eq. 5.2 to be
valid, the particle is assumed to be spherical and solid.
D =
kBT
6πηRH
(5.2)
Here, D is the self diffusion coefﬁcient of the particle, kB is the Boltzmanns’ constant,
T is temperature, RH is the hydrodynamic radius of the particle, and η is the viscosity of
the suspension ﬂuid.
5.2. DYNAMIC LIGHT SCATTERING 27
Figure 5.1: Illustration of the intensity of scattered light with time. The intensity ﬂuctuates around
an average value.
Figure 5.2: Schematic illustration of the variation of the autocorrelation C(s,td) with delay time
td . Adapted from Hiemenz.65
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DLS can be used to measure sizes of particles in the range from ~2 nm to ~1 μm. Here,
DLS was used to conﬁrm adsorption of proteins on AuNPs, introduction of AuNCs inside
proteins, and to observe if aggregation of these constructs occured. All these events will
lead to an increase in the measured size. DLS allows for rapid size measurements with
little sample preparations. However, it is important to be aware that DLS measurements
have some limitations regarding accuracy. DLS can only measure very dilute samples
or samples that scatter light weakly, which is not necessarily true for gold nanoparti-
cles.65,122 AuNPs with 60 nm diameter actually scatters light 200-300 times more than
polystyrene beads of similar size.123 Depending on the size of AuNPs studied, it is also
important to choose the detection angle with care. (Not all instruments allow for an ad-
justment of the detection angle.) Small particles scatter little light in the forward direction,
while larger AuNPs and aggregates scatter little light backwards and in the 90◦ angle, but
much in the forward direction.66,123 This is especially important to keep in mind if the
suspension is expected to be polydisperse. Khlebtsov has written a paper about the ben-
eﬁts and drawbacks of using DLS for AuNP studies, like the appearance of false peaks,
and also provide some solutions to problems that can occur.124 Furthermore, the Stokes-
Einstein relationship assumes that the particles are solid and spherical,121 which is not
always true for proteins. Many of the samples studied here contained proteins, or gold
nanoconstrucst covered with proteins. Moreover, accurate calculations of size from DLS
require monodisperse suspensions.67,121 Since solutions rarely are monodisperse, differ-
ent numerical algorithms are needed to ﬁt the data, and it is important to choose the correct
one to achieve the correct size.121 Some examples of models that can be used are the gen-
eral purpose (GP) analysis algorithm or the multiple narrow peak (MNP) algorithm. The
latter was mostly used here.
Despite these obstacles, DLS-measurements provide more than sufﬁcient information
about particle/aggregation state for the work presented here as the method was not used
to measure exact size. Rather, DLS was used to observe changes in size upon protein
adsorption onto gold, or modiﬁcation of proteins with AuNCs. DLS also provided for a
quick check to study the stability of the samples, such as potential aggregation. DLS is
often used to study the stability of protein-gold conjugates. Jans et al.123 have used the
changes in size observed through DLS to study the interaction between protein A-gold
nanoparticles with IgG, and Hermanson have explained how DLS can be used to study
protein stabilization of citrate covered AuNPs.123,125 Gold nanoparticles have also been
used as DLS probes in detection of arsenic,126 and for cancer biomarker detection.127
Dynamic light scattering can also be used to ﬁnd the charge of nanoparticles by mea-
suring the ζ-potential.
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5.3 Zeta-potential
The goal of the ζ-potential measurements was mainly to conﬁrm protein adsorption onto
gold nanoparticles, alterations in protein structure when modiﬁed with different gold
species, and to monitor system stability.
The electrophoretic mobility is a measure of the speed at which charged particles
travel as they move from one electrode to an other when exposed to an electric ﬁeld, and
can be used to calculate the ζ-potential.128 When a particle moves in the electric ﬁeld,
there will be a slipping plane between the particle and the surrounding solution, creating
an electrical potential relative to the bulk solution. This electrical potential is the deﬁnition
of the ζ-potential.128 The slipping layer is normally at, or just outside, the Stern layer (see
Figure 5.3).
Figure 5.3: Schematic illustration of the ζ-potential (adapted from Stenius128)
As proteins adsorb onto gold nanoparticles, or when proteins are modiﬁed with gold
nanoclusters, the charge proﬁle of the constructs will change. ζ-potential measurements
are often used to characterize AuNPs after particle synthesis or after adsorption of adlay-
ers.95,115,129 A high charge, i.e. |25|-|30| mV, normally implies a higher colloidal stability
due to electrostatic repulsion. To get information about system stability, it is also possible
to observe if the ζ-potential changes over time. The Helmholtz-Smoluchowski equation
(eq. 5.3) is the most common to calculate the ζ-potential.
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ζ=
uEη
ε0εr
(5.3)
Here, ζ is the zeta-potential, uE is the electrophoretic mobility, η is the viscosity, ε0 is
the permittivity of free space, and εr is the dielectric constant of the dispersion medium.
However, this equation is only valid if the thickness of the double layer is thin enough
as compared to the particle radius.65,128 The ratio between the particle radius and the
thickness of the double layer is often designated as κa. High κa values is designated to
imply thin double layers, and the Helmholtz-Smoluchowski equation (eq. 5.3) can be
used. However, if the double layer is thick compared to the particle radius, the Hückel
equation (eq. 5.4) should be used instead.
ζ=
3uEη
2ε
(5.4)
Here, ε is the dielectric constant, which equals ε0 times εr in eq. 5.3. Both the size
of the particles, and the ionic strength of the solution can change κa. Normally, larger
particles in polar media can be explained by the Helmholtz-Smoluchowski equation, and
smaller particles in non-polar media can be explained by the Hückel equation.65 Here
small particles in polar media were used, which means that these systems cannot be ade-
quately explained by either of the equations. In addition, the fact that the ionic strength of
the solution can change the κa, makes the ζ-potentials measured inaccurate for high saline
samples such as buffer solutions. However, these issues can be surpassed. The difference
between eq. 5.3 and eq. 5.4 is a factor of 1.5, and by using the same equation for all
measurements the acquired results are comparable. The Helmholtz-Smoluchowski equa-
tion was used for all samples in this study. The aim with the ζ-potential measurements
was to observe differences in the system before and after proteins were manipulated with
gold. For all samples that were directly compared, the ionic strength was constant. Since
only relative values were of interest, small inaccuracies in ζ-potential were not deemed to
represent a problem.
5.4 Scanning transmission electron microscopy
The accuracy of size estimation of gold nanoparticles using UV-vis and DLS can be sys-
tem dependent, meaning that the results can vary with e.g. concentrations and choise of
solvent. For this reason, scanning transmission electron microscopy (STEM) was used to
determine the exact size of the AuNPs formed during synthesis of protein-gold nanocon-
structs (papers III and V).
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When measuring STEM, the beam from an electron gun (Figure 5.4) is ﬁrst focused
and partially demagniﬁed through two condenser lenses, before a ﬁnal objective lense pro-
vides more demagniﬁcation.130 The point of demagniﬁcation is to form an atomic-scale
probe at the sample. Aberrations from the objective lens dominate the optical system,
so to avoid blurring of the probe an objective aperture is adjusted so that the impact of
the aberrations is reduced. The scan coils are used to scan the probe over the sample.
The occurring scattering pattern can be detected in several different ways. Here, bright
ﬁeld detection was used. In this mode only transmitted electrons which are scattered from
the sample at low angles compared to the optic axis, are detected.130 The ﬁnal image is
created as the scattered signals are plotted as a function of the probe position. For more
information about STEM, please refer to Nellist, Wall, and Browning.130–132
Figure 5.4: STEM instrumentation shown schematically. Adapted from Nellist.130
5.5 Steady-state ﬂuorescence
Although UV-vis, ζ-potential measurements and DLS size measurements can be used
to conﬁrm protein adsorption onto AuNPs, they reveal little about the conformational
changes in the adsorbed layer or the conformational changes in proteins as they are ma-
nipulated with AuNCs. Conformational changes can be studied using ﬂuorescence, which
is the emission of light from the singlet excited state (S). Singlet state means that the
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electron in the exited state is paired (opposite spin) with the electron in the ground state,
resulting in a zero net electronic spin. Phosphorescence, which is another type of lumines-
cence, occurs from the triplet excited state (T).63 The processes that take place between
absorption and emission of light are normally illustrated by Jablonski diagrams (Figure
5.5).
Figure 5.5: Example of a Jablonski diagram. Adapted from Lakowicz63
Fluorophores are usually excited to a higher vibrational level of S1 or S2 (Figure 5.5),
and then rapidly relaxed to the lowest vibrational level of S1. After this internal con-
version, the ﬂuorophore can either return to S0 and ﬂuoresce, or undergo an intersystem
crossing to T1. As seen from Figure 5.5 the energy of the emission is less than the absorp-
tion energy. This is called a Stokes shift and can be inﬂuenced by solvent effects, changes
in viscosity, excited-state reactions, complex formation and energy transfer.
Here, steady-state ﬂuorescence was used to conﬁrm the formation of AuNCs, estimate
AuNC size based on size-dependent shifts in emission, and estimate relative relationship
between small and large AuNCs when AuNCs of several different sizes were made. This
technique was also used to study changes in protein conformation, when proteins were
manipulated with AuNCs or AuNPs. Both intrinsic and extrinsic ﬂuorophores were used
to study these conformational changes.
The aromatic amino acids tryptophan (Trp), tyrosine (Tyr), and phenylalanine (Phe)
are all intrinsic ﬂuorophores in proteins. However, when λex = 295 nm the emission
observed is mainly caused by Trp. Trp is well suited to study conformational changes,
because its emission is highly sensitive to its local environment.63 Blue shifts in Trp
emission reveal a more hydrophobic environment (buried inside the protein/shielded from
polar solvent), while red shifts indicate more hydrophilic surroundings (directed towards
water/polar solvent). As proteins adsorb onto gold, or gold nanoclusters are formed within
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the protein, electron or energy transfers from protein to gold result in quenching of the Trp
emission, and a decrease in ﬂuorescence intensity. With only one Trp present the emission
spectrum is simple to interpret, but different proteins have different numbers of Trp. The
Trps can be present in different environments depending on where in the proteins they
are located. This makes the interpretation of Trp emission for protein-gold nanoclusters
complex. Emission maxima of Trp is dependent on the environment surrounding it, and
a shift in emission maxima is usually due to conformational changes such as unfolding.
But a decrease in intensity can be due to both energy transfer to the gold species, and
quenching as Trp-residues get more exposed to the solvent. Some of these interpretation
challenges can be elucidated by adding an extrinsic probe. In papers I and II 1-anilino-8-
naphthalene sulfonate (ANS), which is commonly used to study protein conformational
changes,133–138 was used for this task. ANS is weakly or non-ﬂuorescent in water, while
exposure to a less polar environment results in an increased quantum yield of the probe, as
well as a shift of the emission proﬁle. When the protein unfolds, the emission from ANS
will decrease as the ﬂuorophore goes from being associated with hydrophobic patches
on the protein, to being more exposed to water.63 Here, ANS was used to study protein
unfolding upon adsorption onto AuNPs, but it was not possible to use ANS in studies
with AuNCs because ANS and AuNCs are exited at the same wavelength (λex = 370 nm),
and small AuNCs also emitt at the same wavelength as ANS (around 450-470 nm). ANS
can also be an energy donor, so that the ANS emission is quenched by the large AuNCs
(acceptor).
Steady-state ﬂuorescence can also be used to estimate the approximate size and abun-
dance of gold nanoclusters. As explained in section 3.2, page 13, AuNCs consistent of a
"magic number" of atoms, ﬂuoresce when exited at 370 nm.57 Small AuNCs then emit at
λem ~450 nm, while larger nanoclusters (25 Au atoms, Au25) show emission at λem ~685
nm. The emission wavelength is dependent on the size of the AuNCs, and the ﬂuorescence
intensity will be dependent on the cluster concentration.
A steady-state spectrum is an average of the time-resolved phenomena over the inten-
sity decay of the sample.63 Some information is lost in this averaging process, but this
can be regained by time-resolved measurements, such as time-correlated single-photon
counting (TCSPC). One example where TCSPC provides information lost in steady-state
measurements, is when two Trps have different lifetimes, but are difﬁcult to separate in
an steady-state emission spectrum.
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5.6 Time-correlated single-photon counting
Time-correlated single-photon counting (TCSPC) was used to gain more information
about the conformational changes in proteins, when manipulated with different gold nanocon-
structs.
The main information gained from TCSPC are lifetimes (T) and populations (B),
which can be calculated from the decay ﬁt shown in eq. 5.5.139
Y (t) =
N
∑
i=1
Aie−kit (5.5)
Here, Y(t) is the decay over time, Ai is the amplitude/fraction/population, ki is the
rate constant for each component, respectively, and N is the total number of luminescent
contributers. A decay ﬁt would look similar to that shown in Figure 5.6.
Figure 5.6: Example of ﬁtted TCSPC decay as function of time.
Trp has a long lifetime when buried inside the hydrophobic interior of the protein and
a short lifetime if close to a quencher, for example water. Thus, changes in lifetime, and
population distribution between the lifetimes if more than one is observed, give infor-
mation about the local environment of the Trp-residues. If the lifetime decreases, it is
plausible that the protein has unfolded, exposing normally shielded Trp to water. Some-
times the lifetimes stay the same, and only the populations change. If the population
changes in favor of the shortest lifetime, this too implies that more Trp is exposed to
quencher and can imply unfolding.140 If the lifetimes become longer, or the population of
the longest lifetime increases, this indicates that more Trp is shielded from quencher and
can be a sign of aggregation. Aggregation or ﬂocculation would bury Trp that is on the
surface of the folded protein inside larger protein aggregates or ﬂocs, shielding the Trp
from water. When a protein contains more than one Trp, the lifetimes obtained does not
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necessarily represent each singular Trp-residue, but are gained from a mathematical ﬁt of
the decay curve (Figure 5.6).63,139 BSA and aLa contain 3 Trps each, while LYZ contains
5 Trps, but for most of the proteins studied here, two lifetimes were obtained from the
mathematical ﬁt and precautions were taken as the data was interpreted. Even though
interpretation sometimes must be done with care, TCSPC provide important information
and the method is easy to use. A schematic overview of TCSPC electronics is given in
Figure 5.7.
Figure 5.7: Schematic overview of the electronic set-up for TCSPC. Adapted from Lakowicz.63
A light emitting diode (LED) sends out pulses that excite the sample. As the pulse
leaves the light source, a signal is passed through a constant function discriminator (CFD)
which accurately measures when the pulse arrives (starts the stop watch). The signal is
then converted to voltage by the time-to-amplitude converter (TAC), which starts a voltage
ramp. The ramp is stopped as a single photon is detected in the CDF which sends a stop
signal to the TAC (stops the stop watch). The voltage is linear to time, and is ampliﬁed
by a programmable gain ampliﬁer (PGA) and converted to a number using an analog-
to-digital converter (ADC). A window discriminator (WD) suppresses the signal if it is
outside the accepted voltage range. This is to reduce false readings. As the name time-
correlated single-photon counting implies, the photons are counted rather than measured.
The TAC needs to be reset to zero each time, and to avoid problems with premature
arrivals of photons the procedure is often done in reverse mode. The voltage ramp is
started in the TAC when the emitted photon enters, and stopped when the second excited
photon arrives.63
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5.7 Circular dichroism
Different types of ﬂuorescence provide for indirect information about changes in con-
formation as proteins are manipulated with gold nanoconstructs, but reveal little about
whether it is the secondary or only the tertiary structure that is altered. Circular dichroism
(CD) can be used to gain more details about the conformational changes in the protein.
The principle behind CD-measurements is that compounds containing structural asym-
metry, like chiral compounds and proteins, absorb right- and left circularly polarized light
to different extents.141 When the difference in absorption coefﬁcients for the left- and the
right circularly polarized light is given as a function of the incident light, a CD spectrum
is created.142 Compounds with no regular structure will result in zero CD signal. Figure
5.8 shows an example of left circularly polarized light.
Figure 5.8: Left circularly polarized light. The light propagates in the z-direction and the electrical
ﬁeld vectors rotate in the x-y plane. (Reprinted with permission from Professor Furche.142)
CD measurements in the far-UV region (< 250 nm) provides information about the
secondary structure of the protein.143 Alterations in protein conformation, such as ran-
dom disorder or transformation of α-helixes into β-sheets, can be observed as changes in
recorded the CD-spectra.144,145 The ratio between signal intensities at 200/220 nm was
also studied to make sure that observed spectral changes were actually due to alterations
in protein conformation, not attenuation of the signal by the presence of gold nanocon-
structs.
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5.8 Langmuir-trough studies
One of the major goals of this study was to obtain constructs that could be candidates for
targeted drug delivery. For such constructs, interfacial activity and lipid interactions are
important properties. Langmuir-trough studies, and additional techniques connected to
this technique, were the main methods used to study interfacial activity.
Films at an air-water surface formed by water insoluble species, such as lipids, are
called Langmuir monolayer ﬁlms. Water soluble species (e.g. many proteins) form ﬁlms
called Gibbs monolayers.146,147 Langmuir phospholipid monolayer ﬁlms at air-water sur-
faces are well established model systems for biological membranes, mimicking the inter-
face between phospholipids and the surrounding aqueous media.148–151 Combined with
other techniques, these model systems can be used to study the composition and distribu-
tion of lipids in mixed lipid ﬁlms, and how additives affect this distribution and ﬁlm mor-
phology.152–154 Here, Langmuir-trough experiments were used to study air-water surface
activity of native proteins, gold nanoparticles and protein-gold nanoconstructs. Interfacial
interactions with phospholipid ﬁlms were studied for the same species. Both equilibrium
measurements and compression/decompression isotherms were obtained with this tech-
nique.
There are several ways to execute Langmuir experiments, and in this study both the
Injected method (Figure 5.9 a and b) and the Subphase method (Figure 5.9 c and d) were
used for introduction of proteins and other species to the trough.148 For both methods
Figure 5.9: The upper panel (a and b) illustrates the Injected method, and the lower panel (c and
d) illustrates the Subphase method.
the subphase is poured into the trough, and then the surfactant (dissolved in an organic
solvent, usually CHCl3) is spread on top. The choice of spreading agent can inﬂuence on
the Langmuir isotherms obtained, and it is important that the spreading solvent solvates
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the lipid well, does not mix with the subphase, and evaporates quickly.155 The barriers
can be moved to control the molecular arrangement and orientation at the surface. A Wil-
helmy plate or a paper probe is used to monitor the surface pressure. When the Subphase
method (Figure 5.9 c and d) is used to study the interaction between proteins in subphase
and lipid ﬁlms, the protein is already dissolved in the subphase when the lipid is spread
on top. Thus, amphiphilic proteins will already be present at the surface as the lipid is
introduced, and a mixed protein-lipid ﬁlm can be formed. This mixed ﬁlm can be avoided
by using the Injected method (Figure 5.9 a and b), wherein the lipid is spread on a protein
free subphase, and the protein is introduced ﬁrst after the lipid ﬁlm is compressed to the
desired degree. The different ways of introducing the protein can have severe effect on
the results achieved.148 In addition to introduction protocol, adjustments of the physic-
ochemical properties of the subphase, such as pH, temperature and ionic strength, can
affect the results. For most of the studies here, phosphate buffers at pH 7.4 were used to
mimic physiological conditions.
To interpret the data from Langmuir monolayer experiments it is helpful to know the
different phase transitions which might occur during ﬁlm compressions (see Figure 5.10).
As a rigid ﬁlm is compressed, such as phospholipid monolayers, the surface pressure will
Figure 5.10: A generalized isotherm of a Langmuir monolayer. (Adapted from Kaganer151)
increase rapidly. If the ﬁlm is less rigid, or contains water soluble species, the surface
pressure increases more slowly. This behavior is quite common for proteins. Interactions
between proteins and lipids can be studied by observing changes in the compressibility of
the mixed ﬁlm compared to pure systems. Langmuir monolayer studies provide informa-
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tion about ﬁlm behavior, but it is difﬁcult to understand exactly how lipids and proteins
are distributed in the ﬁlm. To obtain insight into ﬁlm miscibility, the ﬁlms can be studied
with different types of microscopy directly at the interface or after being transferred to a
solid surface.
5.8.1 Langmuir depositions
Two ways of transferring ﬁlms from the air-water surface to solid surfaces are Langmuir-
Blodgett (LB) and Langmuir-Schaefer (LS) depositions (Figure 5.11). Both types of de-
positions have advantages and drawbacks. The LB method can be used to make sequential
deposistions and the transfer number can be calculated. The disadvantage is that the pres-
ence of solvent in the deposited layer can cause ﬁlm runoff from the substrate. This is
avoided in the LS deposition, but then it is not possible to make sequential depositions,
and the transfer number is not known. Langmuir-Blodgett depositions were studied with
Digital Video Microscopy, and Langmuir-Schaefer depositions were studied with Atomic
Force Microscopy.
Figure 5.11: (a) Langmuir-Blodgett deposition and (b) Langmuir-Schaefer deposition.
To avoid any of the problems due to tranfer onto a solid surface, the ﬁlm can be studied
directly at the interface using Brewster Angle Microscopy (BAM).
5.9 Brewster Angle Microscopy
To obtain a visual understanding of distribution of lipids and proteins in the ﬁlm, Brewster
Angle Microscopy (BAM) was used. Examples of BAM images are given in Figure 6.2,
page 45. The Brewster Angle (53◦ for water) is dependent on the refractive index of
the system, and at this angle incident plane-polarized light is not reﬂected.156 At the
beginning of the Langmuir experiment, the laser light source and the camera is adjusted
to the Brewster Angle of the subphase, and a completely dark image is achived. Lipids
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and proteins change the refractive index and reﬂect light. The brightness of the different
areas in the picture will then vary with ﬁlm density and type of molecules in the sample
area, making it possible to distinguish between different samples. In Figure 6.2, page 45
the lipids are seen as a dense, darker areas with bright spots, while the proteins are seen
as light gray areas.
5.10 Digital Video Microscopy
The Langmuir-Blodgett depositions were studied using Digital Video Microscopy bire-
fringence. The aim was to study whether the lipids formed liquid crystalline phases, and
if protein-AuNPs could break up these structures. A liquid crystalline phase is deﬁned as
having short-range disorder but some distinct ordering over larger distances, with a liquid-
like state of the alkyl chains.146 When studying the sample through cross-polarized light,
isotropic structures will result in a black image while anisotropic liquid crystals result in
bright images (see paper I for an example).146
5.11 Atomic Force Microscopy
The Langmuir-Schaefer depositions made of protein or protein-gold nanoconstructs in-
teracting with a lipid ﬁlm, can be studied further using Atomic Force Microscopy (AFM).
AFM is a high-resolution type of scanning probe microscopy at the level of atomic-
resolution characterization.157 A schematic presentation of the AFM set-up is shown in
Figure 5.12.
Figure 5.12: A reﬂected laser beam reports changes in cantilever positon to a photodetector while
moving across the surface of the substrate. Adapted from Kada et al.158
The measurements can be done in three different modes; contact mode, noncontact
mode, or tapping mode.157 The latter was used for the measurements presented in paper
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V. In the contact mode the tip of the cantilever is in contact with the sample, measuring
interaction forces, while for the noncontact mode the cantilever is moved slightly away
from the sample while oscillating at/near its natural resonance frequency. The tapping
mode contains aspects from both of the other techniques: the tip of the cantilever oscillates
near its natural resonance frequency and is for a minimal amount of time allowed to
impact with the sample.157 The point of the tapping mode is to keep the tip close enough
to the sample surface to detect short range forces without sticking to it, and can be used
to measure soft samples that are difﬁcult to measure with the contact mode. In tapping
mode a piezoelectric actuator makes the cantilever vibrate with speciﬁc amplitude (20-100
nm). When the tip gets close to the surface, interaction forces will reduce the amplitude
of this oscillation. An optical system detects this alteration, and generates a signal that
makes the piezoelectric element adjust so that a constant distance between cantilever and
sample surface (and thus constant amplitude) is maintained.157 The changes in the vertical
position of the tip is expressed as a function of its lateral position, and this information is
then used to generate the AFM image. In addition to measuring topography, AFM can be
used to study elasticity, hardness, adhesion and surface charge densities.159 For further
information about AFM and it’s use in biochemistry see papers by Jalili et al.,157 Gan,160
Kada et al.,158 and Gadegaard.161
5.12 Cell-viability studies
To test if the aLa-gold nanoconstructs made had HAMLET-/BAMLET-like cancer cell
killing efﬁciency, the cell-viability of HeLa cells in the prescence of aLa, BAMLET,
aLa-gold nanoconstructs, and other possible interferrents were tested in a trypan blue
assay. In this assay dead cells are dyed blue, while living cells remain unstained (Fig-
ure 5.13).162–164 After incubation the number of blue cells were counted using confocal
microscopy.
Figure 5.13: Typan blue colors dead cells, while live cells remain unstained.164
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6. Results and discussion
In this chapter the main highlights from papers I-V are written together, beginning with
proof of concept, via manipulation of different proteins using a variety of gold nanocon-
structs, and ending with a protein-gold nanoconstruct exhibiting similar mortality rates
towards cancer cells as BAMLET. Each section corresponds to the paper with the same
name in List of publications.
Bovine serum albumin (BSA) was chosen for the ﬁrst study because it is readily avail-
able and, despite the big difference in molecular weight compared to aLa, BSA has many
structural and physiological resemblances to alpha-lactalbumin (aLa).
6.1 Emergent membrane-affecting properties of BSA-gold
nanoparticle constructs
Nanoscale, 2011, 3, (4), p. 1788-1797
Because of their optical and biological properties, protein-coated gold nanoparticles
are often studied for potential use in bioimaging and targeted drug delivery.4,7,10,79–85 It
is also known that adsorption onto interfaces may alter protein-conformation.83,165 The
main focus of paper I was to investigate how the adsorption of BSA onto gold nanopar-
ticles with different curvatures would alter BSA conformation, and properties such as in-
terfacial activity. BSA was adsorbed onto both 30 nm and 80 nm citrate covered gold
nanoparticles, and protein-AuNPs were studied with UV-vis spectroscopy, ζ-potential
measurements, steady-state and time-resolved ﬂuorescence. Langmuir monolayer stud-
ies (both Subphase method and Injected method) accompanied by Brewster Angle Mi-
croscopy (BAM), Langmuir-Blodgett deposition and Digital Video Microscopy (DVM)
were used to investigate differences in phospholipid monolayer interactions for protein-
gold nanoparticles compared with native protein.
While UV-vis spectroscopy and ζ-potential measurements conﬁrmed protein adsorp-
tion, these techniques revealed little about the degree of unfolding. Therefore, unfolding
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was studied using steady-state (Figure 6.1) and TCSPC (Table 6.1) ﬂuorescence tech-
niques.
Figure 6.1: (a) Steady-state Trp ﬂuorescence of BSA and BSA-AuNPs (λex = 295 nm). (b)
Steady-state ﬂuorescence of samples with ANS (λex = 388 nm)
The decrease in Trp ﬂuorescence intensity for BSA (Figure 6.1 a), when adsorbed onto
AuNPs, can be both due to protein unfolding, which exposes Trp to water and quenches
the signal, and energy transfer from Trp emission to AuNPs absorption. Also for samples
containing 1-anilino-8-naphthalene sulfonate (ANS) (Figure 6.1 b), there was a AuNP-
size dependent loss of intensity. This can mean that BSA unfolded more on the larger
particles, pushing the ANS from the hydrophobic interior of the protein towards the hy-
drophilic solvent. ANS is a lot less ﬂuorescent in a hydrophilic environment than in a
hydrophobic one.
Table 6.1: Fluorescence lifetimes and corresponding populations of BSA, BSA-AuNPs and sam-
ples with added ANS. T = lifetimes in nanoseconds (ns), B = populations in %a
T1 (ns) B1 (%) T2 (ns) B2 (%) χ2
Protein-gold nanoparticles (λex = 280 nm)
BSA 4.0 23 ± 4 7.1 77 ± 4 0.86
BSA + 30 nm AuNP 3.8 32 ± 3 7.1 68 ± 3 1.21
BSA + 80 nm AuNP 3.7 30 ± 4 6.9 70 ± 4 1.11
ANS and protein-gold nanoparticles (λex = 370 nm)
BSA 4.7 6 ± 1 18.5 94 ± 1 0.99
BSA + 30 nm AuNP 5.7 8.4 ± 0.1 19.0 91.6 ± 0.1 1.00
BSA + 80 nm AuNP 6.6 11.4 ± 0.6 19.1 88.7 ± 0.6 0.98
a For aqueous ANS the lifetime in nanoseconds was T1 = 5.4 ± 0.8, T2 = 18 ± 2, and
T3 = 0.27 with the corresponding populations B1 = 8 ± 1, B2 = 12 ± 2, and B3 = 80 ± 2,
respectively.
Table 6.1 (upper panel) shows that for intrinsic ﬂuorescence there was no signiﬁcant
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changes in lifetimes for the BSA-AuNPs compared to the free protein. However, the
relative population (B1) of the short lifetime (T1) increased (see Table 6.1). The total
available AuNP-surface area was lower in the 80 nm AuNP suspensions than for the
30 nm suspensions, but both of the protein-AuNPs had similar lifetime populations. To
achieve this, BSA must have unfolded more on the larger AuNPs than on the smaller
ones. This is in agreement with the studies by Kane et al.1 For ANS ﬂuorescence in the
lower panel in Table 1 the short lifetime (T1) increases progressively upon adsorption
onto AuNPs and with increasing particle size, whereas the longer lifetime (T2) remained
unchanged for all three systems. The small increase in T1 may be due to close packing of
BSA on the AuNP surfaces, which is expected to increase with increasing core diameter.
The increase in B1 with increasing particle diameter can be caused by a higher degree of
protein unfolding and a subsequent exposure of ANS to water. All in all, the steady-state
ﬂuorescence data combined with the TCSPC data imply that BSA unfolded more on the
larger particles.
After establishing protein adsorption onto AuNPs and concomitant partial unfolding,
native protein, AuNPs, and protein-AuNPs were tested towards Langmuir lipid monolay-
ers. BAM-pictures are shown in Figure 6.2. Using the Injected method it was not easy to
Figure 6.2: BAM images of BSA and BSA-AuNPs interacting with lipid Langmuir ﬁlms. (a)
Injected method with BSA, (b) Subphase method with BSA, and (c) Subphase method with BSA
onto 30 nm AuNP
observe any differences between native protein (Figure 6.2 a) and protein-gold nanocon-
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structs (not shown), but for the Subphase method there were large differences. BSA
interacting with the phospholipid ﬁlm (Figure 6.2 b, page 45) resulted in two distinct do-
mains at high pressure: one corresponding to the lipid (dark regions with bright ﬁelds) and
one corresponding to BSA (light, homogeneous regions). This means that introduction
of BSA via the Subphase method resulted in mixed-ﬁlm behavior, with immiscible lipid-
like and protein-like domains.148 Conversely, using the Subphase method BSA-AuNPs
interacting with the lipid ﬁlm (Figure 6.2 c) show no domain formation at any surface
pressure. Rather, the morphology of the BSA-AuNPs-lipid ﬁlm appear indistinguishable
from that of a BSA ﬁlm only (6.2 b, start), save for some small regular structures to-
wards maximum compression (Figure 6.2 c, lower panel). Paper I demonstrates that BSA
unfolds more on the 80 nm AuNP than on the 30 nm AuNP, and most importantly that
BSA-AuNPs induce a ﬁlm miscibility with L-α-phosphatidylethanolamine not seen for
BSA or AuNP alone. The changes induced by partial unfolding clearly give better ﬁlm
penetration ability, as well as disruption of liquid crystalline domains in the ﬁlm, thereby
inducing ﬁlm miscibility. The emergent membrane-affecting properties of BSA-AuNPs
might enable the constructs to work as drug transporters across cell membranes, or the
constructs might even be used as a medicines by themselves. In general the emergent
properties are interesting from a medical point of view, especially since one of the theo-
ries behind the apoptosis-inducing properties of HAMLET is linked to the conformational
changes in aLa and the high afﬁnity to phospholipid membranes. This is also the reason
why aLa was modiﬁed with AuNPs in paper II.
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6.2 Immobilization onto gold nanoparticles alters
α-lactalbumin interaction with pure and mixed
phospholipid monolayers
Soft Matter, 2011, 7, (24), p. 11501-11509
To get at closer link to HAMLET/BAMLET and medical use, similar protein-gold
nanoparticles were made with aLa as for BSA (paper I). To be able to compare results for
the two proteins, the protein concentration in the aLa experiments were the same as for the
BSA experiments. At these concentrations aLa was not able to stabilize 80 nm AuNPs,
thus only the 30 nm AuNPs were used for this study. The problems with stabilization can
be due to that aLa is much smaller than BSA, and unfolded too much at the AuNPs so
that too many hydrophobic groups were exposed.
HAMLET interacts differently with lipid membranes than aLa does, and this is prob-
ably due to conformational differences between the proteins. As seen for BSA in pa-
per I, it is likely that adsorption of aLa onto AuNPs will alter the protein conformation.
How the conformational changes in aLa affect interaction with lipid ﬁlms can then be
tested towards neutral, negatively charged and mixed neutral:negative phospholipid Lang-
muir monolayers at pH 7.4, where little or no interaction has been reported for native
aLa.166,167
Characterization of aLa-AuNPs was performed using UV-vis and ﬂuorescence (steady-
state and time-resolved, using both intrinsic and extrinsic probes) spectroscopies. Paper
II focuses on the interaction of bovine aLa-modiﬁed 30 nm AuNPs with the three differ-
ent lipid monolayers mentioned above. The resulting equilibria and ﬁlm properties were
studied using surface pressure-area isotherms.
UV-vis measurements of aLa and aLa-AuNPs provided the same information as found
for BSA in paper I, i.e. proteins were adsorbed onto gold, and the protein-gold nanopar-
ticles did not aggregate. Steady-state data is presented in Figure 6.3, page 48 and TCSPC
data is presented in Table 6.2 at the same page. Due to protein excess with respect to
maximum surface coverage, the ﬂuorescence shown in Figure 6.3 emanates from both
free and bound protein. However, since aLa concentration was kept constant, alterations
to the spectral signatures of both Trp and ANS can be attributed to adsorbed protein.
The loss of both Trp and ANS ﬂuorescence intensities (Figure 6.3) were similar to
what was observed for BSA-AuNPs in paper I. The changes in lifetimes and populations
observed in Table 6.2 were also very similar to what was observed for BSA (Table 6.1,
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Figure 6.3: (a) Intrinsic Trp steady-state measurements of aLa and aLa-AuNP, λex = 295 nm. (b)
Extrinsic steady-state measurements of aLa and aLa-AuNP using ANS as extrinsic probe, λex =
370 nm.
page 44) and it is very likely that the changes observed are due to conformational changes
in aLa as it unfolds on AuNPs. Some of the loss in intensity will also be due to en-
ergy transfer from Trp to AuNPs, as AuNPs (acceptor) absorb the energy emitted by Trp
(donor).133–138
Table 6.2: TCSPC of intrinsic emission (Trp, LED 280 nm), and extrinsic emission (ANS, LED
370 nm). T1 and T2 denote lifeteimes, and B1 and B2 are their respective populations.
Intrinsic Extrinsic
aLa aLa-AuNP aLa aLa-AuNP
T1 (ns) 0.86 ± 0.01 0.85 ± 0.04 0.37 ± 0.01 0.35 ± 0.01
T2 (ns) 5.0 ± 0.2 4.6 ± 0.3 7.5 ± 0.2 8.8 ± 0.3
B1 (%) 91.5 ± 0.1 81.3 ± 0.1 86.1 ± 0.1 91.8 ± 0.1
B2 (%) 8.5 ± 0.1 18.7 ± 0.1 13.9 ± 0.1 8.2 ± 0.1
UV-vis-, DLS-, and ﬂuorescence measurements conﬁrmed that aLa had adsorbed onto
the AuNPs and that the protein had partially unfolded at the surface. Then, Gibbs- and
Langmuir monolayers were used to study how the conformational changes altered the
constructs’ surface activity and phospholipid afﬁnity relative to the native protein. The
Injected method was used (described in section 5.8, from page 37) for three different
phospholipid monolayers: (1) neutral (EYPC = L-α-phosphatidylcholine), (2) negatively
charged (PBPS = porcine brain phosphatidylserine), and (3) neutral:negative (1:1) molar
ratio. The equilibria for aLa and aLa-AuNP injected under the different interfaces are
shown in Figure 6.4.
Unmodiﬁed AuNPs precipitated under these conditions, and did not contribute to the
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Figure 6.4: (a) Equilibria for native protein and protein on gold the ﬁrst hour after injection
under an air-water surface.(b) Equilibria for aLa injected under pure and mixed (1:1 molar ratio)
phospholipid monolayers (compressed to 5 mN/m) (c) Same as b, but with aLa-AuNP injected
under the lipid ﬁlms.
increase in surface pressure observed in Figure 6.4. As seen from Figure 6.4 a, the initial
surface pressure increased more rapidly for aLa-AuNP than for native aLa. However, the
ﬁnal surface pressures after one hour of equilibrium were approximately the same. For
the aLa-AuNP experiments there were contributions from both free aLa and aLa-AuNP.
It is likely that the initial rapid increase in surface pressure was due to more surface active
aLa-AuNPs. The observation that the equilibrium pressures were more or less equal for
both systems can be explained by the fact that both samples contained the same amount
of aLa. Compression- and expansion isotherms (see paper II for graph) show no collapse
pressure for the aLa and aLa-AuNP monolayers, meaning that both species were water
soluble. The Gibbs monolayer studies also showed a higher surface pressure throughout
the measurements for aLa-AuNP than for native aLa, indicating a higher surface activity.
When interacting with the three different phospholipid monolayers, aLa and aLa-
AuNP displayed no phospholipid selectivity (Figure 6.4 b and c). However, there was an
increase in surface pressure as aLa and aLa-AuNP were injected under the pre-compressed
phospholipid ﬁlms, indicating interaction between the phospholipid ﬁlm and the injected
species. This means that even though former studies have claimed little or no interaction
between native aLa and lipid ﬁlms at pH 7.4, interactions were observed in these ex-
periments.166,167 These differences in observations of interaction can be attributed to the
introduction method of the protein. While proteins are subjected to a precompressed lipid
ﬁlm when using the Injected method, there is a mixed protein-lipid ﬁlm present at the
surface from the start when the Subphase method is used. (See also section 5.8 from page
37). Here, the Injected method was used, while former studies have used the Subphase
method. The initial rates of surface pressure increase were higher for aLa-AuNP (Figure
6.4 c) than for native aLa (Figure 6.4 b), which is consistent with enhanced hydrophobic
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interaction from partial exposure of hydrophobic residues in the adsorbed protein. Also,
the equilibration of aLa-AuNP towards phospholipid monolayers (Figure 6.4 c) occurs
faster than towards an air-water surface (Figure 6.4 a). Thus, the increased surface migra-
tion rates and the higher saturation plateaus in the presence of a phospholipid monolayer
reveal an enhanced phospholipid afﬁnity for the aLa-AuNPs as compared to native aLa.
Compression and expansion isotherms also indicate that aLa-AuNP intercalates more with
the phospholipid ﬁlm than does native aLa, thereby making the ﬁlms more compressible.
The fact that adsorption of aLa onto gold enhances ﬁlm-penetration may be of value
within studies of i.e. drug delivery systems, and also for a better understanding of protein
based drug candidates where folding seems to matter, such as in the case of HAMLET.
One possible hurdle to further clinical development of HAMLET or similar preparations
may be their tendency to lose potency in many clinical situations, probably due to loss of
oleic acid to scavenger proteins such as serum albumin.168 This would have the effect of
both reverting the protein to its native state and separating the components of HAMLET,
both of which appear to be necessary for activity.40
Even though the increased interaction with phospholipid ﬁlms seen for aLa-AuNP
opens for a very interesting link to HAMLET/BAMLET, there are some problems associ-
ated with the adsorbance of proteins onto AuNPs. How much the conformation changes
is protein dependent, and as several proteins adsorbes onto one AuNP there are more
variables than if single proteins were manipulated. Moreover, an excess of protein was
used in the adsorption process, making it difﬁcult to distinguish between effects from
protein-AuNP and native protein. Removal of excess protein through dialysis may cause
uncertainties in protein concentration. Usually, this problem can be solved by UV-vis de-
termination of protein concentration, but the prescence of gold inﬂuence the protein ab-
sorbance spectrum too much. Centrifugation/resuspension cannot be used either, as such
experiments lead to aggregation of protein-AuNPs. Conformational changes induced by
adsorption onto AuNPs are very large, and sometimes difﬁcult to tune. One joint solution
for both these problems could be protein-stabilized gold nanoclusters (protein-AuNCs).
By varying the amount of reagents and reaction time, it should be possible to control the
extent of conformational changes induced in the protein. All proteins present in the so-
lution are also likely to take part in the reaction, leaving no unmodiﬁed excess protein.
There are other beneﬁts of using aLa-AuNCs as well. Due to intracellular leaching of
oleic acid from HAMLET it is difﬁcult to know whether the anticancer activity observed
is due to the complex as a whole, or due to the single components. In the aLa-AuNC
complex, the AuNCs are covalently bound to the protein and the uncertainties in data
interpretation due to leaching can be circumvented.
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6.3 Tunable photophysical properties, conformation and
function of nano-sized protein-gold constructs
RSC Advances, 2013, 3, (2), p. 482-495
One way of making protein-stabilized AuNCs is by mixing protein, gold precursor
(Hydrogen tetrachloroaurate(III) x 3H2O, TCAA) and reducing agent.57,58 Due to the
addition of extrinsic reducing agent, this method is reffered to as the the extrinsic method.
Figure 6.5 shows the different types of gold nanoconstructs formed.
Figure 6.5: By controlling the reaction conditions, proteins can be modiﬁed with gold nanocon-
structs varying from subnanometer clusters to plasmonic nanoparticles.
In the work presented in paper III, bovine serum albumin (BSA), bovine alpha-
lactalbumin (aLa) and chicken egg white lysozyme (LYZ) were selected for manipulations
with protein-stabilized AuNCs and AuNPs. The proteins were selected so as to allow for
large variety with respect to variables such as size, isoelectric point (pI) and conforma-
tional stability. BSA is a readily available reference protein with the same pI as the much
smaller aLa. This leads to comparable global charge density matching with the Au3+ and
opens for protein size-dependent variations in gold nanocluster stabilization. LYZ is a
classical rigid protein of the same size as aLa, but with a different pI, which allows for
studying how protein charge and rigidity affects gold nanocluster formation and stabi-
lization. In addition, LYZ also provide correlation between unfolding and concomitant
protein function via a simple activity assay.
Sodium borohydride (NaBH4) was used as reducing agent because it cannot stabi-
lize AuNCs or AuNPs by itself, implying that all gold nanoconstructs formed must be
protein-stabilized. The fast reduction rate of NaBH4 also prevents competition from gold
nanoclusters formed within the protein by amino acid residues such as tyrosine acting as
reducing agents.56 By adjusting the ratio between gold precursor and reducing agent, it is
likely that AuNCs of variable sizes are formed, and that these constructs affect the protein
conformation and function to different extents.
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Native proteins, proteins with only reducing agent added, and proteins with both gold
precursor and reducing agent added were studied using UV-vis (Figure 6.6 b) and ﬂuo-
rescence (Figure 6.6 c and d) to investigate the gold nanoconstructs formed as well as
conformational changes in the protein-gold nanoconstructs. Circular dichroism (CD) was
used for further evaluation of changes in conformation (Figure 6.7) while scanning trans-
mission electron microscopy (STEM) was used for size and dispersity studies of the gold
nanoconstructs. The LYZ activity was studied by measuring transmittance as LYZ di-
gested the cell walls of Micrococcus lysodeikticus bacteria.169 The rate of increase in
transmittance reﬂects the activity of the LYZ-AuNCs compared to native LYZ (see Figure
6.8, page 53).
Figure 6.6: (a) Picture of the different BSA-gold nanoconstruct samples studied. (b) UV-vis
spectra for BSA-gold nanoconstruct samples. (c) Steady-state ﬂuorescence of aLa-gold nanocon-
structs, λex = 370 nm. (d) Steady-state ﬂuorescence of aLa and aLa-gold nanoconstructs, λex =
295 nm. Here the abbreviations denote the following; Au = gold, R = Reducing agent, L, M, H =
Low, Medium and High concentrations, respectively.
Immediately after addition of reducing agent, gold nanoconstructs were formed and
induced a color change in the reaction mixture (as depicted by BSA in Figure 6.6). The
red color seen for samples with high content of TCAA is very typical of suspensions
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containing AuNPs. The presence of AuNPs > 3 nm was conﬁrmed by the LSPR band at
~530 nm observed in the UV-vis spectra in Figure 6.6 b. The distortion of the 280 nm
absorbance band indicates the presence of multimeric gold species. Steady-state ﬂuores-
cence with λex = 370 nm (Figure 6.6 c) revealed that mostly small AuNCs (Au8) were
formed. However, low concentration of TCAA combined with medium and high con-
centration of NaBH4 led to the formation of large AuNCs (Au25) with BSA. As shown
in Figure 6.6 d, steady-state ﬂuorescence (λex = 295 nm) imply a tunable conformational
change in the protein as gold nanoconstructs are formed. This conformational tunability
was further conﬁrmed by CD measurements (Figure 6.7).
Figure 6.7: CD-spectra of (a) BSA and BSA-gold nanoconstructs, (b) aLa and aLa-gold nanocon-
structs, and (c) LYZ and LYZ-gold nanoconstructs
Both CD and ﬂuorescence studies showed that NaBH4 disrupt the conformation of
LYZ, while the formation of gold nanoconstructs partially stabilized it. The same trend
was observed for the LYZ cell wall digesting activity data in Figure 6.8.
Figure 6.8: Cell wall digestion activity of lysozyme, Lysozyme with NaBH4 and lysozyme-gold
nanoconstructs at pH 6.2, and 30 ◦C. The change in transmittance starts at 100% and a transmit-
tance increase means that Micrococcus lysodeikticus cell walls are digested. (a) All results, (b) the
dataset for the native protein is removed.
UV-vis, ﬂuorescence and CD results showed that by varying the gold precursor con-
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centration it was possible to tune the constructs from protein-AuNCs to AuNPs stabilized
by protein-AuNCs (Figure 6.5), and by simultaneously changing reducing agent concen-
tration the sizes of both kinds of constructs could be tuned from small and monodisperse
to larger and polydisperse. As an effect of the different construct sizes, the protein struc-
ture was also affected to different extents. For BSA, aLa and LYZ, aLa was the most tun-
able protein, while LYZ was most disrupted. Even though NaBH4 severely disrupts LYZ
conformation, the gold nanoconstructs formed seem to stabilize LYZ enough to main-
tain some cell-wall digesting activity. Although the functions of aLa and BSA were not
assayed, it is reasonable to assume that these proteins may also be prepared with cova-
lent cluster or particle modiﬁcation in a manner that allows retaining at least part of their
function. The spectroscopic data suggests an incremental perturbation of the protein fold,
and it may be that this feature could be used to lock proteins in folding intermediates that
would otherwise not be thermodynamically stable and amendable to investigation. Such a
possibility would be of high relevance for the general study of folding intermediates and
particle-associated states in particular, both problems being relatively inaccessible with
traditional techniques.24 The fact that aLa was the most tunable protein, both regarding
protein conformation and in size of gold nanoconstructs, is very promising for compari-
son with HAMLET activity. It is also possible that aLa-gold nanoconstructs can aid in the
understanding of the mechanism behind HAMLET. The fact that the AuNCs formed are
ﬂuorescent also provides for an optical label. The tunability in conformation and func-
tion combined with an inherent optical label make these protein-gold nanoclusters very
interesting for medical use. It is likely that the constructs can be used for bio-imaging and
biosensors.5,74,90,91 However, NaBH4 had destructive effects on LYZ and to some extent
on aLa and BSA. This suggests that a milder reducing agent, which does not disrupt the
protein by itself, is more preferable.
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6.4 Generally applicable procedure for in situ formation
of ﬂuorescent protein-gold nanoconstructs
RSC Advances, 2012, 2, (31), p. 11704 - 11711
One way to solve the problem observed in paper III with harsh NaBH4 effects on some
proteins in the synthesis of protein-AuNCs, is to utilize the reduction potential of amino
acids already present in the protein through a biomineralization-like synthesis. Since the
reducing agents are intrinsic in the protein, this method is referred to as the intrinsic
method. The method was adapted from Xie et al.56 wherein hydrogen tetrachloroau-
rate(III) x 3H2O (TCAA, 10 mM) is added to an equal volume of BSA (50 mg/ml) at 37
◦C under vigorous stirring. After 2 minutes NaOH (1M, 1/10 the volume of protein) is
added. Xie et al. incubated their reaction mixture for 12 h at 37 ◦C. In the study presented
here, the samples were incubated for 1 week. The amino acid composition of proteins,
and hence their reductive ability, is very diverse. Thus, to make a generally applicable
procedure for in situ formation of ﬂuorescent protein-gold nanoconstructs it was neces-
sary to study a small library of different proteins. The proteins included in this study
were chosen based on differences in size, isoelectric point, ﬂexibility and 3-dimensional
structure. Some of their molecular properties are listed in Table 6.3.
Table 6.3: Molecular properties of the proteins used in this study
Protein Abbreviation Mw (kDa) pI
Bovine serum albumin BSA 67.0 4.7-4.9
Porcine plasma ﬁbrinogen Fib 340.0 N/A
Bovine milk holo alpha-lactalbumin (type I) aLa 14.2 4.5
Chicken egg white lysozyme LYZ 14.3 10.5
Bovine heart cytochrome C CytC 12.4 10.1
Horse heart myoglobin Mb 17.2 6.8-7.0
Bovine milk β-lactoglobulin BLG 18.0 3.5-5.2
Bovine pancreas α-chymotrypsin CTR 25.0 8.8
When the samples were illuminated with UV-light (Figure 6.9, page 56) it was possi-
ble to see from the varying colors that different types of gold nanoconstructs were formed.
The different protein-gold nanoconstructs were further studied with UV-vis measurements
and steady-state ﬂuorescence (λex = 370 nm, Figure 6.10, page 56). Only the a selection
of proteins in the full study is represented in the further discussion. For more details
please consult paper IV. From Figure 6.10 a and b it can be observed that the UV-vis
spectra for the protein-gold nanoconstructs differ in both line shape and intensity as com-
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Figure 6.9: Photograph of aqueous solutions of ﬁve of the proteins used here (concentration 35.5
μM) upon illuminated with UV-light λex = 365 nm.
Figure 6.10: (a) and (b) represent UV-vis spectra of a selection of proteins and protein-gold
nanoconstructs used in this study. (c) and (d) show ﬂuorescence spectra of the same selection of
proteins and protein-gold nanoconstructs (λex = 370 nm).
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pared to the native protein. The broad absorption below ~400 nm is likely due to the
incorporation of gold nanoclusters. For some of the proteins (e.g. aLa) a LSPR band
was also observed at ~550 nm, indicating formation of AuNPs as well. The emission
spectra in Figure 6.10 c and d show that the ratio between small (Au8, λem ~450 nm)
and large (~Au25, λem ~625-675 nm) nanoclusters was dependent on the protein wherein
these were formed. The different types of gold nanoconstructs are likely to affect pro-
tein conformation to different extents, which is why protein conformation was studied
with CD-measurements, steady-state Trp ﬂuorescence (λex = 295 nm) and TCSPC mea-
surements. A selection of CD and steady-state Trp ﬂuorescence data are given in Figure
6.11. The Trp emission proﬁles in Figure 6.11 a and b show a decrease in intensity for
Figure 6.11: (a) and (b) show Trp ﬂuorescence spectra of a selection of proteins and protein-gold
nanoconstructs (λex = 295 nm). (c) and (d) show CD spectra of this selection of proteins and
protein-gold nanoconstructs
all the protein-gold nanoconstructs as compared to the native proteins, but to what extent
the intensities change, varies for the different proteins. The emission proﬁles were also
shifted to longer wavelengths (red shifted). The decrease in intensity can be due to energy
transfer to AuNCs or AuNPs, which corresponds well with the UV-vis spectra in Figure
6.10, page 56. However, some of the reduction in Trp emission intensities and the red
shifts were probably due to Trp being exposed to water as the proteins partially unfolded.
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Also, the alterations in intensities and line shapes in the CD-spectra (Figure 6.11 c and d)
indicated changes in protein conformation.
The type of gold nanostructure formed, the photophysical properties of the protein-
gold nanoconstructs as well as the accompanying conformational changes were found to
be highly protein-dependent. Using a combination of UV-vis spectroscopy and steady-
state ﬂuorescence measurements, three primary sets of gold nanoconstructs formed were
identiﬁed as ﬂuorescent clusters of ~8 and ~25 atoms (small and large AuNCs, respec-
tively) and nanoparticles (AuNPs) of diameters > 3 nm displaying localized surface plas-
mon resonance (LSPR), with all three structures occurring within the same system for the
two milk proteins studied here, aLa and BLG.
By combining the results above with Berti and Burley’s postulated mechanism for nu-
cleic acid and nucleotide-mediated synthesis of inorganic nanoparticles,170 and Feldheim
and Eaton’s SELEX model for biomolecule-mediated crystal formation,171 a mechanism
for protein-gold nanoconstruct formation in four steps can be proposed:
1. Nucleation. Charge density matching between Au3+ and negatively charged amino
acid residues yields high local metal ion concentrations, providing the necessary
microenvironment for triggering the nucleation event. Nucleation occurs via reduc-
tion of the gold precursor by surrounding amino acid residues with a sufﬁciently
high redox potential, including Tyr, Trp and His.
2. Growth. Small nuclei formed close to the protein surface are capped by anionic
amino acid residues, and grow either (i) from inﬂux of Au3+ ions as determined by
charge density matching with negatively charged amino acid residues in the imme-
diate vicinity, eventually leading to overlapping clusters, (ii) from partial unfolding
of the polypeptide chain leading to close contact between adjacent nuclei and sub-
sequent aggregation, (iii) collisions between proteins leading to contact between
exposed nuclei, or (iv) a combination of (i)-(iii).
3. Termination. Termination can occur via depletion of metal precursor from the bulk
phase, but more importantly via capping from anionic amino acid residues in the
case of mechanisms (i) and (ii), or via a combination of electrostatic and steric (i.e.;
electrosteric) capping in the case of mechanism (iii).
4. Passivation and solubilization. The capping ligands - either amino acid residues
or proteins depending on the size and nature of the gold nanoconstructs - suppress
defect surface states by forming covalent bonds (such as in the case of Cys), or
simply by forming complexes with empty orbitals and dangling bonds.
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The general mechanism suggested here accounts for the highly protein-dependent
AuNC formation in that local negative charge, availability of electron-donors and the lo-
cal stability of the secondary structure and overall ﬂexibility of the fold determines where
clusters form and when formation is terminated, as well as their concomitant effect on
the protein. The mechanism is also in agreement with existing literature for comparable
systems.170,171
From paper III and IV it is evident that aLa can easily be manipulated with different
gold nanoconstructs both through the extrinsic method and the intrinsic method. The
altered conformation of the new aLa-Au nanoconstructs are likely to result in emergent
properties. Now two major questions arise. (1) How will the two different protocols affect
aLa function, and (2) will the aLa-gold nanoconstructs formed have similar anticancer
activity as BAMLET?
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6.5 Anticancer activity from gold-alpha-lactalbumin
nanoconstructs?
The Journal of Physical Chemistry C, 2013, 117, (5), p. 2230-223
The main aim of paper V was to investigate the differences in properties between
aLa-gold nanoconstructs made by using two different synthesis routes; (i) - the bio-
mineralization-inspired protocol utilizing the intrinsic reduction potential of amino acid
residues in the protein to reduce the gold precursor (forming aLa-Auint), and (ii) - the pro-
tocol wherein an extrinsic reducing agent was added (forming aLa-Auext). Several aspects
such as type of protein-gold nanoconstruct formed, changes in protein conformation, and
altered interfacial activity were studied. Moreover, to test for emergent properties, aLa-
Auint was compared to BAMLET in HeLa cell-viability studies. In the study presented
here, the mechanism behind HAMLET/BAMLET is not studied directly. Rather, aLa
is modiﬁed with gold nanoconstructs. Maybe the gold nanoconstructs are able to alter
protein conformation similar to how oleic acid alters and stabilizes aLa conformation (see
section 2.4, page 7). The protein-gold nanoconstruct might then exhibit similar anticancer
activity. While oleic acid may dissociate from aLa inside cells, the gold nanoconstructs
are covalently bonded to aLa. Thus, it will be possible to study the effects on cancer cells
of the entire construct, without the possibility of the construct to dissociate, and the con-
comitant confusion around which component is causing the observed effects is avoided.
The formation of different gold nanoconstructs was studied using UV-vis measure-
ments, steady-state ﬂuorescence and STEM, while alterations in protein conformation
were studied using steady-state ﬂuorescence, TCSPC and CD-measurements. Interfacial
activity of protein and protein-gold nanoconstructs were studied using Langmuir mono-
layer studies and AFM. Cell-viability was studied using a trypan blue assay. Character-
ization of the different gold nanoconstructs formed and conformational changes in the
protein were very similar to those in paper III and IV. Therefore, these results will not be
discussed in detail here.
The prescence of LSPR in UV-vis and particles > 3 nm observed by STEM revealed
that the intrinsic procedure led to AuNC-modiﬁed aLa linked together via AuNPs (aLa-
Auint). The lack of similar ﬁndings for aLa-Auext , means the aLa stayed as single proteins
modiﬁed with AuNCs when the extrinsic protocol was used. This is illustrated in Figure
6.12 together with the CD spectra.
Fluorescence data and ζ-potentials implied that larger conformational changes were
induced in aLa-Auint when the gold nanoconstructs were formed, than for aLa-Auext .
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Figure 6.12: (a) The upper route show the formation of aLa-Auint , where singular proteins with
embedded gold nanoclusters are linked together by AuNPs. The lower route show synthesis
of aLa-Auext , which stops at protein-embedded AuNCs. (b) CD-spectra of aLa and aLa-gold
nanoconstructs.
This corresponds well with the changes in intensity observed in the CD-spectra (Figure
6.12 b). Since the relationship of the mean residual ellipticities at 200 nm and 222 nm
changed between the samples, it is likely that the changes in the CD-spectra were due to
changes in protein conformation, and not due to attenuation of the signal by gold species.
All data have implied that the structural changes are larger for aLa-Auint than for aLa-
Auext , and that the two different procedures for introducing gold nanoconstructs in aLa
results in very different complexes (Figure 6.12). To study if the big difference in type of
construct made also resulted in different interfacial activities (Figure 6.13), the constructs
were tested using a standard Langmuir trough set-up and the intercalation of the different
species into lipid ﬁlms were studied with AFM.
Figure 6.13: (a) Air-water surface activity studies of aLa and aLa-Au nanoconstructs at constant
trough area. (b) aLa or aLa-Au nanoconstructs injected under a PBPS lipid ﬁlm pre-compressed
to 10 mN/m. The changes in trough area are recorded over time at constant surface pressure. The
data displayed is corrected for contribution to area changes in the PBPS blank. The X-axis denotes
time after injection of sample.
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Of the three species studied, aLa-Auext reached the highest surface pressure (8 mN/m
after one hour) in the air-water surface studies (Figure 6.13 a, page 61). For native aLa,
half the surface pressure observed for aLa-Auext was obtained, while for aLa-Auint no
signiﬁcant change in surface pressure could be observed within the time frame of the ex-
periment. As the protein/protein-gold nanoconstructs migrate to the surface, hydrophobic
groups will be oriented towards the air and the hydrophilic ones towards the water, and
the surface pressure increases.148,167,172,173 Hydrophobic species travel more quickly to
the surface than less hydrophobic species, and from Figure 6.13, page 61 it can be inter-
preted that aLa-Auext is more hydrophobic than native aLa, while aLa-Auint showed no
air-water surface activity, and is hydrophilic. This difference in surface activity supports
the hypothesis about single aLa-Au in aLa-Auext versus multimeric proteins in aLa-Auint ,
as organization of nanocluster-modiﬁed aLa around a nanoparticle core allows for shield-
ing of hydrophobic residues from the aqueous environment. When the three species were
introduced underneath a lipid monolayer (Figure 6.13 b), aLa-Auext still displayed the
highest interfacial activity. However, aLa-Auint induced a larger increase in trough area
in the presence of lipid as compared to native aLa. Combining the results from Figure
6.13 a and b, it seems that aLa-Auint displays lipid-speciﬁc interaction, in spite of the fact
that both aLa-Auint and the lipid (PBPS) are negatively charged under these conditions.
There are several reports on proteins and lipids of similar charge interacting.174,175 AFM
was used to study morphological changes as species from bulk interact with the lipid ﬁlm.
The AFM images showed that native aLa interacts weakly with the lipid ﬁlm, but does not
intercalate into it. Morover, collapse of the lipid regions was observed for both aLa-Auext
and aLa-Auint through AFM. However, the disruption of the lipid ﬁlm was much more
severe for aLa-Auint . This is in good agreement with the Langmuir trough studies.
Some of the theories about the cancer killing effects seen for HAMLET and BAMLET
are associated with stronger lipid interaction for HAMLET as compared to native aLa.
Since aLa-Auint displayed the most severe effect on the lipid ﬁlm, this was chosen as the
candidate for comparison with BAMLET in cell-viability studies (Figure 6.14, page 63),
where trypan blue was used to stain dead cells.
Triton was used as a standard for maximum cell death.75,76 From Figure 6.14 it seems
like neither native aLa or oleic acid had much inﬂuence on cell-viability, but aLa-Auint
killed a similar amount of HeLa cancer cells as did BAMLET. This indicates that aLa-
Auint might have anticancer activity.
HAMLET interacts with several parts of cells, and several of these interaction can
contribute to cell death. However, not all these interaction contributes to apoptosis.40
Cell death caused by aLa-AuNCs is not necessarily due to apoptosis, but can be due
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Figure 6.14: Cell-viability studies with oleic acid, aLa, aLa-Auint , BAMLET and Triton. Protein
concentration = 1.0 mg/ml, oleic acid concentration = 1.6 mM, and Triton concentration = 2.7
mM. Typical cell counts were 7x105 cells/ml
to disruption of the cell membrane as well. Such a disruption as a plausible cause of cell
death is in accordance with the Langmuir and AFM studies that revealed aLa-Auint ability
to disturb membranes at neutral conditions. Membrane disturbing features are also seen
for HAMLET.49
Dependent on which one of the two different synthesis protocols presented here was
used, either aLa-Auint or aLa-Auext were formed. While aLa-Auext are single aLa molecules
modiﬁed with sub-nanometer gold clusters, exhibiting hydrophobic properties, aLa-Auint
consists of multiple AuNC-modiﬁed aLa assembled around ~20 nm AuNP cores, and is
hydrophilic. Both types of constructs are ﬂuorescent due to the AuNCs, but aLa-Auint
show LSPR as well due to the AuNPs. Moreover, aLa-Auint show lipid-speciﬁc interac-
tion, and an ability to induce cell death in HeLa cancer cells at the same level as BAMLET.
These results are very promising for further medical research since optical and interfacial
properties of protein-gold nanoconstructs can be tuned, and thus provide constructs that
make it possible to simultaneously image and kill cancer cells.

65
7. Concluding remarks and future
work
By combining nanomaterials with proteins, bionanomaterials are formed. Such materials
are very interesting within therapeutic and diagnostic research. In this thesis, bionano-
materials were made by modifying different proteins with AuNPs and AuNCs. The aim
of this thesis can be divided into steps. The ﬁrst step was to study if gold nanoconstructs
could alter the structure of the proteins studied here. The next step was to study which
properties, such as optical properties or interfacial activity, these new biomaterials ex-
hibit. The goal of making the bionanomaterials was to utilize them in medical research,
and some of the constructs were studied further for medical relevance.
Throughout this work, it was found that by adsorbing proteins onto gold nanoparti-
cles, new membrane-affecting properties emerge, which are not seen for neither protein
nor gold alone. Increased ﬁlm-penetration ability and the ability to induce ﬁlm miscibil-
ity are among the emergent properties that make protein-gold nanoparticles interesting as
potential tools for drug delivery (papers I and II). However, the use of AuNPs has some
drawbacks. When the AuNPs are larger than the protein it is at present problematic to tune
the conformation of single proteins, as several proteins usually adsorb per gold nanopar-
ticle. If the size of the protein-AuNP constructs exceeds ~100 nm, the size can also be
a problem for cellular uptake via the vasculature.7 The problems with using AuNPs can
be circumvented by making small gold nanoclusters within the proteins instead, but then
the beneﬁts of LSPR are lost. Papers III and IV show that both intrinsic and extrinsic
reducing agents are well suited for making protein-stabilized gold nanoclusters. Under
some conditions gold nanoparticles stabilized by protein-AuNCs were made as well. It
has been shown that, by varying the reaction conditions, it is possible to tune the gold
nanoconstructs formed from small AuNCs, via large AuNCs, and all the way to AuNPs.
This tunability in gold nanoconstruct formation provides for a good tunability of protein
conformation, as well as protein activity. The latter was illustrated by LYZ digestion of
cell-walls. Moreover, the formation of different gold nanoconstructs makes it possible to
incorporate ﬂuorescent markers, a property useful in both diagnostics and treatment. Of
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the proteins studied here, aLa provided for the best tunability in protein conformation and
type of gold nanoconstruct formed. aLa-gold nanoconstructs formed by the intrinsic pro-
cedure (aLa-Auint) develop very different interfacial activities compared to those made by
the extrinsic protocol (aLa-Auext). While aLa-Auext is hydrophobic and in general more
surface active than native aLa, aLa-Auint is hydrophilic and show little activity towards
an air-water surface. However, aLa-Auint displays phospholipid-speciﬁc interaction, and
kills cancer cells at the level of BAMLET. This is very promising for further cancer re-
search, as the contrast agent used to image the cancer cells also can kill them. In this way,
treatment and imaging can be performed simultaneously.
The tunability in protein conformation, and the very different interfacial activities of
the constructs created, might also be useful in the research on protein misfolding diseases
as well. One possibility is to modify these constructs further by exchanging/adding differ-
ent molecules, and use the new constructs to detect misfolded dimers, or early aggregates
(see Figure 2.3, page 7) typical for neurodegenerative diseases such as Alzheimer’s dis-
ease. Treatment could potentially start at a much earlier stage than today, and some of the
severe consequences of neurodegeneration could be postponed or even eliminated.
As seen from section 4.3 and section 4.4 the toxicity of gold nanoconstructs remains
to be ascertained. The constructs should be toxic towards e.g. cancer cells, but not for the
patients. It is likely that a potential toxicity of gold nanoconstructs depends on construct
size, surface ligands, route of administration and concentration, but still the information
is scarce. Thus, toxicology studies must be implemented before aLa-gold nanoconstructs
can be used in diagnostics or treatment in a way that exposes the patient directly to the
constructs.
REFERENCES 67
References
[1] Kane, R. S.; Stroock, A. D. Biotechnology Progress, 2007, 23, (2), p. 316–319.
[2] Selvan, S. T.; Tan, T. T. Y.; Yi, D. K.; Jana, N. R. Langmuir, 2010, 26, (14), p.
11631–11641.
[3] De, M.; Ghosh, P. S.; Rotello, V. M. Advanced Materials, 2008, 20, (22), p. 4225–
4241.
[4] Wang, H.-H.; Su, C.-H.; Wu, Y.-J.; Lin, C.-A. J.; Lee, C.-H.; Shen, J.-L.; Chan, W.-
H.; Chang, W. H.; Yeh, H.-I. International Journal of Gerontology, 2012, 6, (1), p.
1–4.
[5] Wang, Y.; Wang, Y.; Zhou, F.; Kim, P.; Xia, Y. Small, 2012, 8, (24), p. 3769–3773.
[6] Stewart, M. E.; Anderton, C. R.; Thompson, L. B.; Maria, J.; Gray, S. K.;
Rogers, J. A.; Nuzzo, R. G. Chemical Reviews, 2008, 108, (2), p. 494–521.
[7] Glomm, W. R. Journal of Dispersion Science and Technology, 2005, 26, (3), p. 389
– 414.
[8] Sardar, R.; Funston, A. M.; Mulvaney, P.; Murray, R. W. Langmuir, 2009, 25, (24),
p. 13840–13851.
[9] Huang, X.; Jain, P. K.; El-Sayed, I. H.; El-Sayed, M. A. Nanomedicine, 2007, 2,
(5), p. 681–693.
[10] Hainfeld, J. F.; Slatkin, D. N.; Focella, T. M.; Smilowitz, H. M. British Journal of
Radiology, 2006, 79, (939), p. 248–253.
[11] Kunzmann, A.; Andersson, B.; Thurnherr, T.; Krug, H.; Scheynius, A.; Fadeel, B.
Biochimica et Biophysica Acta (BBA) - General Subjects, 2011, 1810, (3), p. 361–
373.
68 REFERENCES
[12] Kowlgi, K. N. K.; Koper, G. J. M.; Picken, S. J.; Lafont, U.; Zhang, L.; Norder, B.
Langmuir, 2011, 27, (12), p. 7783–7787.
[13] Huang, H.-C.; Barua, S.; Sharma, G.; Dey, S. K.; Rege, K. Journal of Controlled
Release, 2011, 155, (3), p. 344–357.
[14] NCBI, Genes and Disease - The p53 tumor suppressor protein.,
http://www.ncbi.nlm.nih.gov/books/NBK22268/, Accessed: 30.10.2012.
[15] Hardy, J.; Allsop, D. Trends in Pharmacological Sciences, 1991, 12, (10), p. 383–
388.
[16] Lyubchenko, Y. L.; Sherman, S.; Shlyakhtenko, L. S.; Uversky, V. N. Journal of
Cellular Biochemistry, 2006, 99, (1), p. 53–70.
[17] Berg, J. M.; John L, T.; Stryer, L. Biochemistry, 5th ed.; W. H. Freeman and
Company: New York, 2001.
[18] Tyka, M. Beautiful Proteins, http://beautifulproteins.blogspot.no/2010/06/insulin-
hexamer.html, Accessed: 20.06.2012.
[19] Creighton, T. E. Proteins - Structures and Molecular Properties, 2nd ed.; W. H.
Freeman and Copmany: New York, 1993.
[20] Branden, C.; Tooze, J. Introduction to protein structure, 2nd ed.; Garlan Publish-
ing, Inc.: New York, 1998.
[21] Svensson, M.; Håkansson, A.; Mossberg, A.-K.; Linse, S.; Svanborg, C. Proceed-
ings of the National Academy of Sciences of the United States of America, 2000,
97, (8), p. 4221–4226.
[22] Faber, K. Biotransformations in Organic Chemistry, 5th ed.; Springer-Verlag:
Berlin, 2004.
[23] Ohgushi, M.; Wada, A. FEBS Letters, 1983, 164, (1), p. 21–24.
[24] Halskau, Ø.; Perez-Jimenez, R.; Ibarra-Molero, B.; Underhaug, J.; Muñoz, V.;
Martínez, A.; Sanchez-Ruiz, J. M. Proceedings of the National Academy of Sci-
ences of the United States of America, 2008, 105, (25), p. 8625–8630.
[25] Bañuelos, S.; Muga, A. Journal of Biological Chemistry, 1995, 270, (50), p.
29910–29915.
REFERENCES 69
[26] Uversky, V. N.; Dunker, A. K. Biochimica Et Biophysica Acta-Proteins and Pro-
teomics, 2010, 1804, (6), p. 1231–1264.
[27] Mercer, N.; Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K. PLoS one, 2011, 6,
(10), p. e26093.
[28] Chowdhury, F. A.; Raleigh, D. P. Protein Science, 2005, 14, (1), p. 89–96.
[29] Qasba, P. K.; Safaya, S. K. Nature, 1984, 308, (5957), p. 377–380.
[30] Wohlkönig, A.; Huet, J.; Looze, Y.; Wintjens, R. PLoS one, 2010, 5, (11), p.
e15388.
[31] Raven, P. H.; Johnson, G. B.; Losos, J. B.; Singer, S. R. Biology, 7th ed.; McGraw
Hill: New York, 2005.
[32] Giurleo, J. T.; He, X. L.; Talaga, D. S. Journal of Molecular Biology, 2008, 381,
(5), p. 1332–1348.
[33] Reynaud, E. Nature Education, 2010, 3, (9), p. 28.
[34] Ehrnhoefer, D. E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.;
Engemann, S.; Pastore, A.; Wanker, E. E. Nature structural & molecular biology,
2008, 15, (6), p. 558–566.
[35] Aisenbrey, C.; Borowik, T.; Bystrom, R.; Bokvist, M.; Lindstrom, F.; Misiak, H.;
Sani, M. A.; Grobner, G. European Biophysics Journal with Biophysics Letters,
2008, 37, (3), p. 247–255.
[36] Giacomelli, C. E.; Norde, W. Macromolecular Bioscience, 2005, 5, (5), p. 401–
407.
[37] Selkoe, D. J. Nature Cell Biology, 2004, 6, (11), p. 1054–1061.
[38] Svensson, M.; Sabharwal, H.; Håkansson, A.; Mossberg, A.-K.; Lipniunas, P.; Lef-
ﬂer, H.; Svanborg, C.; Linse, S. Journal of Biological Chemistry, 1999, 274, (10),
p. 6388–6396.
[39] Håkansson, A.; Andreasson, J.; Zhivotovsky, B.; Karpman, D.; Orrenius, S.; Svan-
borg, C. Experimental Cell Research, 1999, 246, (2), p. 451–460.
[40] Mossberg, A.-K.; Hun Mok, K.; Morozova-Roche, L. A.; Svanborg, C. FEBS Jour-
nal, 2010, 277, (22), p. 4614–4625.
70 REFERENCES
[41] Permyakov, S. E.; Knyazeva, E. L.; Khasanova, L. M.; Fadeev, R. S.; Zhadan, A. P.;
Roche-Hakansson, H.; Håkansson, A. P.; Akatov, V. S.; Permyakov, E. A. Biologi-
cal Chemistry, 2012, 393, (1-2), p. 85–92.
[42] Kohler, C.; Håkansson, A.; Svanborg, C.; Orrenius, S.; Zhivotovsky, B. Experi-
mental Cell Research, 1999, 249, (2), p. 260–268.
[43] Kohler, C.; Gogvadze, V.; Håkansson, A.; Svanborg, C.; Orrenius, S.; Zhivo-
tovsky, B. European Journal of Biochemistry, 2001, 268, p. 186–191.
[44] Svensson, M.; Mossberg, A.-K.; Pettersson, J.; Linse, S.; Svanborg, C. Protein
Science, 2003, 12, (12), p. 2805–2814.
[45] Svensson, M.; Fast, J.; Mossberg, A.-K.; Düringer, C.; Gustafsson, L.; Hall-
gren, O.; Brooks, C. L.; Berliner, L.; Linse, S.; Svanborg, C. Protein Science,
2003, 12, (12), p. 2794–2804.
[46] Wilhelm, K.; Darinskas, A.; Noppe, W.; Duchardt, E.; Mok, K. H.; Vukojevic, V.;
Schleucher, J.; Morozova-Roche, L. A. FEBS Journal, 2009, 276, (15), p. 3975–
3989.
[47] Tuei, V. C.; Ha, J. S.; Ha, C. E. Life Sciences, 2011, 88, (17-18), p. 810–818.
[48] Lišková, K.; Auty, M. A. E.; Chaurin, V.; Min, S.; Mok, K. H.; O’Brien, N.;
Kelly, A. L.; Brodkorb, A. European Journal of Lipid Science and Technology,
2011, 113, (10), p. 1207–1218.
[49] Mossberg, A.-K.; Puchades, M.; Halskau, Ø.; Baumann, A.; Lanekoff, I.; Chao, Y.;
Martínez, A.; Svanborg, C.; Karlsson, R. PLoS ONE, 2010, 5, (2), p. e9384.
[50] Baumann, A.; Gjerde, A. U.; Ying, M.; Svanborg, C.; Holmsen, H.; Glomm, W. R.;
Martínez, A.; Halskau, Ø. Journal of Molecular Biology, 2012, 418, (1-2), p. 90–
102.
[51] Fang, B.; Zhang, M.; Jiang, L.; Jing, H.; Ren, F. Z. Protein Journal, 2012, 31, (7),
p. 564–572.
[52] Kataev, A. A.; Zherelova, O. M.; Grishchenko, V. M. Biologicheskie Membrany,
2012, 29, (4), p. 276–283.
[53] Mossberg, A.-K.; Wullt, B.; Gustafsson, L.; Månsson, W.; Ljunggren, E.; Svan-
borg, C. International Journal of Cancer, 2007, 121, (6), p. 1352–1359.
REFERENCES 71
[54] Gustafsson, L.; Leijonhufvud, I.; Aronsson, A.; Mossberg, A.-K.; Svanborg, C.
New England Journal of Medicine, 2004, 350, (26), p. 2663–2672.
[55] Aili, D.; Gryko, P.; Sepulveda, B.; Dick, J. A. G.; Kirby, N.; Heenan, R.;
Baltzer, L.; Liedberg, B.; Ryan, M. P.; Stevens, M. M. Nano Letters, 2011, 11,
(12), p. 5564–5573.
[56] Xie, J.; Zheng, Y.; Ying, J. Y. Journal of the American Chemical Society, 2009,
131, (3), p. 888–889.
[57] Guével, X. L.; Hötzer, B.; Jung, G.; Hollemeyer, K.; Trouillet, V.; Schneider, M.
The Journal of Physical Chemistry C, 2011, 115, (22), p. 10955–10963.
[58] Guével, X. L.; Daum, N.; Schneider, M. Nanotechnology, 2011, 22, (27), p.
275103/1–275103/7.
[59] Link, S.; Beeby, A.; FitzGerald, S.; El-Sayed, M. A.; Schaaff, T. G.; Whetten, R. L.
The Journal of Physical Chemistry B, 2002, 106, (13), p. 3410–3415.
[60] Link, S.; El-Sayed, M. A. International Reviews in Physical Chemistry, 2000, 19,
(3), p. 409–453.
[61] de Heer, W. A. Reviews of Modern Physics, 1993, 65, (3), p. 611–676.
[62] Hayat, M. A. Colloidal Gold: Principles Methods and Applications; Academic
Press, INC: New York, 1989; Vol. 1.
[63] Lakowicz, J. R. Principles of Fluorescence Spectroscopy, 3rd ed.; Springer: New
York, 2006.
[64] Creighton, J. A.; Eadon, D. G. Journal of the Chemical Society-Faraday Transac-
tions, 1991, 87, (24), p. 3881–3891.
[65] Hiemenz, P. C.; Rajagopalan, R. Principles of Colloid and Surface Chemistry, 3rd
ed.; CRC Press Taylor & Francis Group: Boca Raton, 1997.
[66] Berne, B. J.; Pecora, R. Dynamic Light Scattering: With Applications to Chemistry,
Biology and Physics; Dover Publications: New York, 2000.
[67] van de Hulst, H. C. Journal of Colloid Science, 1949, 4, (1), p. 79–87.
[68] Volden, S.; Kjøniksen, A.-L.; Zhu, K.; Genzer, J.; Nyström, B.; Glomm, W. R. ACS
Nano, 2010, 4, (2), p. 1187–1201.
72 REFERENCES
[69] Mulvaney, P. Langmuir, 1996, 12, (3), p. 788–800.
[70] Templeton, A. C.; Pietron, J. J.; Murray, R. W.; Mulvaney, P. The Journal of Phys-
ical Chemistry B, 2000, 104, (3), p. 564–570.
[71] Aili, D.; Enander, K.; Rydberg, J.; Lundström, I.; Baltzer, L.; Liedberg, B. Journal
of the American Chemical Society, 2006, 128, (7), p. 2194–2195.
[72] Kerker, M. Journal of Colloid and Interface Science, 1985, 105, (2), p. 297–314.
[73] Shan, J.; Chen, H.; Nuopponen, M.; Viitala, T.; Jiang, H.; Peltonen, J.; Kaup-
pinen, E.; Tenhu, H. Langmuir, 2006, 22, (2), p. 794–801.
[74] Shiang, Y. C.; Huang, C. C.; Chen, W. Y.; Chen, P. C.; Chang, H. T. Journal of
Materials Chemistry, 2012, 22, (26), p. 12972–12982.
[75] Retnakumari, A.; Jayasimhan, J.; Chandran, P.; Menon, D.; Nair, S.; Mony, U.;
Koyakutty, M. Nanotechnology, 2011, 22, (28), p. 285102/1–285102/11.
[76] Retnakumari, A.; Setua, S.; Menon, D.; Ravindran, P.; Muhammed, H.;
Pradeep, T.; Nair, S.; Koyakutty, M. Nanotechnology, 2010, 21, (5), p. 055103/1–
055103/12.
[77] Forestier, J. Annals of the Rheumatic Diseases, 1949, 8, (2), p. 132–134.
[78] Liu, Y.; Mounkes, L. C.; Liggitt, H. D.; Brown, C. S.; Solodin, I.; Heath, T. D.;
Debs, R. J. Nature Biotechnology, 1997, 15, (2), p. 167–173.
[79] Feldherr, C. M.; Akin, D. Journal of Cell Science, 1999, 112, (12), p. 2043–2048.
[80] Tkachenko, A. G.; Xie, H.; Coleman, D.; Glomm, W.; Ryan, J.; Anderson, M. F.;
Franzen, S.; Feldheim, D. L. Journal of the American Chemical Society, 2003, 125,
(16), p. 4700–4701.
[81] Tkachenko, A. G.; Xie, H.; Liu, Y.; Coleman, D.; Ryan, J.; Glomm, W. R.; Ship-
ton, M. K.; Franzen, S.; Feldheim, D. L. Bioconjugate Chemistry, 2004, 15, (3), p.
482–490.
[82] Ryan, J. A.; Overton, K. W.; Speight, M. E.; Oldenburg, C. N.; Loo, L.; Ro-
barge, W.; Franzen, S.; Feldheim, D. L. Analytical Chemistry, 2007, 79, (23), p.
9150–9159.
REFERENCES 73
[83] Iosin, M.; Toderas, F.; Baldeck, P.; Astilean, A. Journal of Molecular Structure,
2009, 924-926, p. 196–200.
[84] Lee, J.-S.; Green, J. J.; Love, K. T.; Sunshine, J.; Langer, R.; Anderson, D. G. Nano
Letters, 2009, 9, (6), p. 2402–2406.
[85] Guo, S.; Huang, Y.; Jiang, Q.; Sun, Y.; Deng, L.; Lian, Z.; Du, Q.; Xing, J.;
Zhao, Y.; Wang, P. C.; Dong, A.; Liang, X.-J. ACS Nano, 2010, 4, (9), p. 5505–
5511.
[86] Dorsett, Y.; Tuschl, T. Nature Reviews Drug Discovery, 2004, 3, (4), p. 318–329.
[87] Elbakry, A.; Zaky, A.; Liebl, R.; Rachel, R.; Goepferich, A.; Breunig, M. Nano
Letters, 2009, 9, (5), p. 2059–2064.
[88] Aili, D.; Stevens, M. M. Chemical Society Reviews, 2010, 39, (9), p. 3358–3370.
[89] Izquierdo-Lorenzo, I.; Sanchez-Cortes, S.; Garcia-Ramos, J. V. Langmuir, 2010,
26, (18), p. 14663–14670.
[90] Chen, T. H.; Tseng, W. L. Small, 2012, 8, (12), p. 1912–1919.
[91] Chen, H.; Li, B.; Ren, X.; Li, S.; Ma, Y.; Cui, S.; Gu, Y. Biomaterials, 2012, 33,
(33), p. 8461–76.
[92] Hu, L. Z.; Han, S.; Parveen, S.; Yuan, Y. L.; Zhang, L.; Xu, G. B. Biosensors &
Bioelectronics, 2012, 32, (1), p. 297–299.
[93] Zhang, J.; Sajid, M.; Na, N.; Huang, L. Y.; He, D. C.; Ouyang, J. Biosensors &
Bioelectronics, 2012, 35, (1), p. 313–318.
[94] Guével, X. L.; Hotzer, B.; Jung, G.; Schneider, M. Journal of Materials Chemistry,
2011, 21, (9), p. 2974–2981.
[95] Brewer, S. H.; Glomm, W. R.; Johnson, M. C.; Knag, M. K.; Franzen, S. Langmuir,
2005, 21, (20), p. 9303–9307.
[96] Glomm, W. R.; Halskau, Ø.; Hanneseth, A.-M. D.; Volden, S. The Journal of Phys-
ical Chemistry B, 2007, 111, (51), p. 14329–14345.
[97] De, M.; You, C.-C.; Srivastava, S.; Rotello, V. M. Journal of the American Chemi-
cal Society, 2007, 129, (35), p. 10747–10753.
74 REFERENCES
[98] Malmsten, M. Biopolymers at interfaces, 2nd ed.; Marcel Dekker, Inc.: New York,
2003; Vol. 110.
[99] Haynes, C. A.; Norde, W. Colloids and Surfaces B-Biointerfaces, 1994, 2, p. 517–
566.
[100] Vertegel, A. A.; Siegel, R. W.; Dordick, J. S. Langmuir, 2004, 20, (16), p. 6800–
6807.
[101] Lundqvist, M.; Sethson, I.; Jonsson, B. H. Langmuir, 2004, 20, (24), p. 10639–
10647.
[102] Roach, P.; Farrar, D.; Perry, C. C. Journal of the American Chemical Society, 2006,
128, (12), p. 3939–3945.
[103] Cedervall, T.; Lynch, I.; Lindman, S.; Berggård, T.; Thulin, E.; Nilsson, H.; Daw-
son, K. A.; Linse, S. Proceedings of the National Academy of Sciences of the United
States of America, 2007, 104, (7), p. 2050–2055.
[104] Wang, Y. S.; Aili, D.; Selegard, R.; Tay, Y.; Baltzer, L.; Zhang, H.; Liedberg, B.
Journal of Materials Chemistry, 2012, 22, (38), p. 20368–20373.
[105] Turkevich, J. Gold Bulletin, 1985, 18, (3), p. 86–91.
[106] Bredig, G. Angewandte Chemie, 1898, 11, (41), p. 952.
[107] Baignet, C.; Muller, G. Experimentia, 1980, 36, p. 472.
[108] Kurihara, K.; Kizling, J.; Stenius, P.; Fendler, J. H. Journal of the American Chem-
ical Society, 1983, 105, (9), p. 2574–2579.
[109] Connor, E. E.; Mwamuka, J.; Gole, A.; Murphy, C. J.; Wyatt, M. D. Small, 2005,
1, (3), p. 325–327.
[110] Lynch, I.; Salvati, A.; Dawson, K. A. Nature Nanotechnology, 2009, 4, (9), p.
546–547.
[111] Haynes, C. L. Analytical and Bioanalytical Chemistry, 2010, 398, (2), p. 587–588.
[112] Uboldi, C.; Bonacchi, D.; Lorenzi, G.; Hermanns, M. I.; Pohl, C.; Baldi, G.;
Unger, R. E.; Kirkpatrick, C. J. Particle and Fibre Toxicology, 2009, 6, (18), p.
1–12.
REFERENCES 75
[113] Choi, S. Y.; Jeong, S.; Jang, S. H.; Park, J.; Park, J. H.; Ock, K. S.; Lee, S. Y.;
Joo, S.-W. Toxicology in vitro, 2012, 26, (2), p. 229–37.
[114] Geffroy, B.; Ladhar, C.; Cambier, S.; Treguer-Delapierre, M.; Brethes, D.; Bour-
dineaud, J. P. Nanotoxicology, 2012, 6, (2), p. 144–160.
[115] Sonavane, G.; Tomoda, K.; Makino, K. Colloids and Surfaces B: Biointerfaces,
2008, 66, (2), p. 274–280.
[116] Harwood, L.; Moody, C.; Percy, J. Experimental Organic Chemistry - Standard
and Microscale, 2nd ed.; Blackwell Science, 2005.
[117] Schmid, F.-X. Encyclopedia of Life Sciences, 2001, http://www.els.net [doi:
10.1038/npg.els.0003142].
[118] Herberhold, H.; Marchal, S.; Lange, R.; Scheyhing, C. H.; Vogel, R. F.; Winter, R.
Journal of Molecular Biology, 2003, 330, (5), p. 1153–1164.
[119] Glomm, W. R.; Volden, S.; Sjöblom, J.; Lindgren, M. Chemistry of Materials,
2005, 17, (22), p. 5512–5520.
[120] Moskovits, M.; J. S, S. Journal of Physical Chemistry, 1984, 88, (27), p. 5526–
5530.
[121] Baalousha, M.; Lead, J. R. Environmental Science & Technology, 2012, 46, (11),
p. 6134–6142.
[122] Xia, H.; Xiao, Y. Y.; Huang, H.; Tao, S. H.; Lin, X. Journal of Colloid and Interface
Science, 2012, 367, p. 527–530.
[123] Jans, H.; Liu, X.; Austin, L.; Maes, G.; Huo, Q. Analytical Chemistry, 2009, 81,
(22), p. 9425–9432.
[124] Khlebtsov, B.; Khlebtsov, N. Colloid Journal, 2011, 73, (1), p. 118–127.
[125] Hermanson, G. T. Bioconjugate Techniques, 2nd ed.; Pierce Biotechnology,
Thermo Fisher Scientiﬁc: Rockford, 2008.
[126] Kalluri, J. R.; Arbneshi, T.; Khan, S. A.; Neely, A.; Candice, P.; Varisli, B.; Wash-
ington, M.; McAfee, S.; Robinson, B.; Banerjee, S.; Singh, A. K.; Senapati, D.;
Ray, P. C. Angewandte Chemie - International edition, 2009, 48, (51), p. 1–5.
76 REFERENCES
[127] Liu, X.; Dai, Q.; Austin, L.; Coutts, J.; Knowles, G.; Zou, J.; Chen, H.; Huo, Q.
Journal of the American Chemical Society, 2008, 130, (9), p. 2780–2782.
[128] Stenius, P. Forest Products Chemistry; Fapet Oy: Helsinki, 2000; Vol. 3.
[129] Kim, T.; Lee, K.; Gong, M.-s.; Joo, S.-W. Langmuir, 2005, 21, (21), p. 9524–9528.
[130] Nellist, P. D. Scanning Transmission Electron Microscopy, 1st ed.; Springer: New
York, 2011.
[131] Wall, J.; Langmore, J.; Isaacson, M.; Crewe, A. V. Proceedings of the National
Academy of Sciences of the United States of America, 1974, 71, (1), p. 1–5.
[132] Browning, N.; Buban, J.; Chi, M.; Gipson, B.; Herrera, M.; Masiel, D.;
Mehraeen, S.; Morgan, D.; Okamoto, N.; Ramasse, Q.; Reed, B.; Stahlberg, H.
Modeling Nanoscale Imaging in Electron Microscopy, 1st ed.; Nanostructure Sci-
ence and Technology; Springer: New York, 2012.
[133] Togashi, D.; Ryder, A.; O’Shaughnessy, D. Journal of Fluorescence, 2010, 20, (2),
p. 441–452.
[134] Tiera, M. J.; dos Santos, G. R.; Tiera, V. A. d. O.; Vieira, N. A. B.; Frolini, E.;
da Silva, R. C.; Loh, W. Colloid & Polymer Science, 2005, 283, (6), p. 662–670.
[135] Gabellieri, E.; Strambini, G. B. Biophysical Journal, 2006, 90, (9), p. 3239–3245.
[136] Semisotnov, G. V.; Rodionova, N. A.; Razgulyaev, O. I.; Uversky, V. N.; Gri-
pas’, A. F.; Gilmanshin, R. I. Biopolymers, 1991, 31, (1), p. 119–128.
[137] Togashi, D. M.; Ryder, A. G. Experimental and Molecular Pathology, 2007, 82,
(2), p. 135–141.
[138] Togashi, D.; Ryder, A. Journal of Fluorescence, 2008, 18, (2), p. 519–526.
[139] Xie, H.; Tkachenko, A. G.; Glomm, W. R.; Ryan, J. A.; Brennaman, M. K.; Pa-
panikolas, J. M.; Franzen, S.; Feldheim, D. L. Analytical Chemistry, 2003, 75, (21),
p. 5797–5805.
[140] Lakowicz, J. R. Topics in Fluorescence Spectroscopy - Protein Fluorescence;
Kluwer Academic/Plenum Publishers: New York, 2000; Vol. 6.
[141] APL, Alliance Protein Laboratories Home Page, http://www.ap-
lab.com/circular_dichroism.htm, Accessed: 10.09.2012.
REFERENCES 77
[142] Warnke, I.; Furche, F. Wiley Interdisciplinary Reviews: Computational Molecular
Science, 2011, 2, (1), p. 150–166.
[143] Whitmore, L.; Wallace, B. A. Biopolymers, 2008, 89, (5), p. 392–400.
[144] Sethuraman, A.; Vedantham, G.; Imoto, T.; Przybycien, T.; Belfort, G. Proteins,
2004, 56, (4), p. 669–678.
[145] Sreerama, N.; Venyaminov, S. Y.; Woody, R. W. Protein Science, 1999, 8, p. 370–
380.
[146] Holmberg, K.; Jönsson, B.; Kronberg, B.; Lindeman, B. Surfactants and Polymers
in Aqueous Solution, 2nd ed.; John Wiely & Sons: West Sussex, 2007.
[147] Rogalska, E.; Bilewicz, R.; Brigaud, T.; Moujahid, C. E.; Foulard, G.; Portella, C.;
Steébé, M.-J. Chemistry and Physics of Lipids, 2000, 105, (1), p. 71–91.
[148] Glomm, W. R.; Volden, S.; Halskau, Ø.; Ese, M. H. G. Analytical Chemistry, 2009,
81, (8), p. 3042–3050.
[149] Glomm, W. R.; Volden, S.; Ese, M.-H. G.; Halskau, Ø. Journal of Dispersion
Science and Technology, 2011, 32, (2), p. 150 – 158.
[150] Junghans, A.; Champagne, C.; Cayot, P.; Loupiac, C.; Köper, I. Langmuir, 2010,
26, (14), p. 12049–12053.
[151] Kaganer, V. M. Reviews of Modern Physics, 1999, 71, (3), p. 779–819.
[152] Ekelund, K.; Sparr, E.; Engblom, J.; Wennerström, H.; Engström, S. Langmuir,
1999, 15, (20), p. 6946–6949.
[153] Sparr, E.; Ekelund, K.; Engblom, J.; Engström, S.; Wennerström, H. Langmuir,
1999, 15, (20), p. 6950–6955.
[154] Sparr, E.; Eriksson, L.; Bouwstra, J. A.; Ekelund, K. Langmuir, 2001, 17, (1), p.
164–172.
[155] Gillgren, H.; Stenstam, A.; Ardhammar, M.; Norden, B.; Sparr, E.; Ulvenlund, S.
Langmuir, 2002, 18, (2), p. 462–469.
[156] KSV, Brewster Angle Microscopy, http://www.ksvnima.com/brewster-angle-
microscopy, Accessed: 01.08.2012.
78 REFERENCES
[157] Jalili, N.; Laxminarayana, K. Mechatronics, 2004, 14, (8), p. 907–945.
[158] Kada, G.; Kienberger, F.; Hinterdorfer, P. Nano today, 2008, 3, (1-2), p. 12–19.
[159] Butt, H.-J.; Cappella, B.; Kappl, M. Surface Science Reports, 2005, 59, (1-6), p.
1–152.
[160] Gan, Y. Surface Science Reports, 2009, 64, (3), p. 99–121.
[161] Gadegaard, N. Biotechnic and Histochemistry, 2006, 81, (2-3), p. 87–97.
[162] Tennant, J. R. Transplantation, 1964, 2, (6), p. 685–694.
[163] Strober, W. Current Protocols in Immunology (Trypan Blue Exclusion Test of Cell
Viability); Current Protocols in Immunology; John Wiley & Sons, Inc., 2001.
[164] Lokhov, P. G.; Balashova, E. E. Journal of Cancer, 2010, 1, p. 230–41.
[165] Halskau, Ø.; Frøystein, N. Å.; Muga, A.; Martínez, A. Journal of Molecular Biol-
ogy, 2002, 321, (1), p. 99–110.
[166] Chenal, A.; Vernier, G.; Savarin, P.; Bushmarina, N. A.; Gèze, A.; Guillain, F.;
Gillet, D.; Forge, V. Journal of Molecular Biology, 2005, 349, (4), p. 890–905.
[167] Cornell, D. G.; Patterson, D. L.; Hoban, N. Journal of Colloid and Interface Sci-
ence, 1990, 140, (2), p. 428–435.
[168] Nielsen, S. B.; Wilhelm, K.; Vad, B.; Schleucher, J.; Morozova-Roche, L. A.;
Otzen, D. Journal of Molecular Biology, 2010, 398, (2), p. 351–361.
[169] Shugar, D. Biochimica et Biophysica Acta, 1952, 8, (0), p. 302–309.
[170] Berti, L.; Burley, G. A. Nature Nanotechnology, 2008, 3, (2), p. 81–87.
[171] Feldheim, D. L.; Eaton, B. E. ACS Nano, 2007, 1, (3), p. 154–159.
[172] Yano, Y. F.; Uruga, T.; Tanida, H.; Terada, Y.; Yamada, H. Journal of Physical
Chemistry Letters, 2011, 2, (9), p. 995–999.
[173] Yano, Y. F.; Uruga, T.; Tanida, H.; Toyokawa, H.; Terada, Y.; Takagaki, M.; Ya-
mada, H. Langmuir, 2009, 25, (1), p. 32–35.
[174] Rytömaa, M.; Kinnunen, P. K. J. The Journal of Biological Chemistry, 1995, 270,
(7), p. 3197–3202.
REFERENCES 79
[175] Mattila, J.-P.; Sabatini, K.; Kinnunen, P. K. J. Langmuir, 2008, 24, (8), p. 4157–
4160.

81
Paper I
Paper II
Paper III
Paper IV
Paper V
Appended papers
82 Appended papers
Contributions
Paper I was planned in cooperation with Ph.D. Volden and Associate Professor Glomm.
Volden did several preliminary experiments. Except for the Bradford experiments, which
were conducted by Associate Professor Yasuda, Lystvet did most of the experimental
work presented in paper I. Glomm, Volden, and Lystvet wrote most of the article, but all
authors contributed to the interpretation of data and writing.
All experiments in Paper II are performed by Lystvet, and planned by Lystvet, Volden
and Glomm. They also wrote most of the article, but all authors contributed to the inter-
pretation of data and writing.
Some of the preliminary studies to Paper III were done by Volden, who also did all
the preliminary studies for Paper IV. Paper III was mainly planned by Lystvet and Volden.
The STEM imaging in paper III was performed by Ph.D. Singh. Yasuda helped with
the lysozyme activity studies. The remaining data was collected by Lystvet. Associated
Professor Halskau contributed much to the completion of the CD experiments and inter-
pretation of these results (this is also true for paper IV and V). Lystvet, Glomm and Volden
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the experiments for Paper IV. Glomm and Volden did most of the writing. Most of Paper V
was planned by Lystvet, Volden and Glomm. AFM studies were conducted by Singh, and
the cell-viability experiments were planned and conducted by Ida Maria Rundgren and
Hanzhen Wen. The remaining experiments were conducted by Lystvet. Lystvet, Glomm
and Volden did most of the writing, but all authors contributed in this process.
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Paper I
Emergent membrane-affecting properties of BSA-gold
nanoparticle constructs

Emergent membrane-affecting properties of BSA–gold nanoparticle
constructs
Sina M. Lystvet,*a Sondre Volden,a Masahiro Yasuda,b Øyvind Halskau Jrc and Wilhelm R. Glomm*a
Received 6th December 2010, Accepted 19th January 2011
DOI: 10.1039/c0nr00948b
By adsorbing bovine serum albumin (BSA) on gold nanoparticles (Aunps) with diameters 30 nm and 80
nm, different degrees of protein unfolding were obtained. Adsorption and adlayer conformation were
characterized by UV-vis spectroscopy, z-potential measurements, steady-state and time-resolved
ﬂuorescence. The unfolding was also studied using 1-anilino-8-naphthalene sulfonate (ANS) as an
extrinsic probe, showing that BSA unfolds more on 80 nm Aunp than on 30 nm Aunp. Langmuir
monolayer studies using two distinct methods of introducing the BSA and BSA–Aunp constructs
accompanied with Brewster Angle Microscopy (BAM) and Digital Video Microscope (DVM) imaging
demonstrated that BSA–Aunp constructs induce ﬁlm miscibility with L-a-phosphatidylethanolamine
not seen for BSA or Aunp alone. The changes induced by partial unfolding clearly give better ﬁlm-
penetration ability, as well as disruption of liquid crystalline domains in the ﬁlm, thereby inducing ﬁlm
miscibility. Gold or protein only does not possess the nanoscale ﬁlm-affecting properties of the protein–
gold constructs, and as such the surface-active and miscibility-affecting characteristics of the BSA–
Aunp represent emergent qualities.
Introduction
As a large number of biological reactions take place at interfaces
where lipids and proteins are the main constituents, under-
standing how to inﬂuence lipid ﬁlm miscibility, domain forma-
tion and constituent packing is important for a number of
applications ranging from pharmacology (e.g. countering inter-
facial formation of amyloidal plaque and oligomers in Alz-
heimer’s) and enzymatic catalysis to emulsion formation in
food.1,2 Langmuir phospholipid monolayers are often used as
model systems for half of a cell membrane,3,4 as they mimic the
interface between the membrane phospholipid and the
surrounding aqueous medium.4 In addition to control of the
molecular arrangement, orientation and composition at the
surface, this versatile technique also allows different ways to
introduce protein into the ﬁlm. Glomm et al.4 have reported that
how the protein is introduced into a lipid ﬁlm greatly affects the
result. The most common approach for studying protein–lipid
interactions using the Langmuir monolayer technique is dis-
solving the protein in the subphase followed by spreading of the
lipid on the air–water surface—hereafter referred to as the
subphase method (see e.g. Glomm4 et al. and references therein).
While this approach is suitable for the study of interaction
between small-molecule solutes and a lipid ﬁlm, the amphiphilic
nature of proteins makes it difﬁcult to avoid inducing mixed
protein–lipid behavior if the protein is present in the subphase
prior to spreading. Another approach more in line with the use of
Langmuir monolayers as a model for half of a cell membrane is
to inject a protein solution under an already-formed, compressed
lipid ﬁlm (hereafter referred to as the injected method). Here, the
lipid ﬁlm can be tuned to the desired state prior to introduction
of other ﬁlm-forming species, enabling the study of the interac-
tion between proteins from the subphase with the lipid ﬁlm
without any artefacts emanating from lateral interactions
between monolayer domains. Also, this approach will preclude
formation of mixed protein–lipid ﬁlms, a concern when the
solute is itself highly surface active.4
In recent years, there has been a lot of research focused on
protein–gold nanoparticle constructs for applications in intra-
cellular delivery.5–9 By using gold nanoparticles (Aunps) as
scaffolds for proteins and other biomolecules, the unique optical
properties of nanosized gold can be used as a diagnostic tool to
track the nanoparticle construct and the surrounding physico-
chemical environment. Gold nanoparticles can carry proteins,
DNA, peptides as well as small compounds and penetrate into
individual cells,5–7,10 and the mechanisms reported to mediate
these imports must reasonably involve encounters between
protein–Aunp constructs and biological membranes. Bovine
serum albumin (BSA) is often used in the preparation of protein–
Aunp constructs.10–12 Since it is the most abundant plasma
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protein, BSA can act as an immunoprotective layer on the
inorganic particle, and further modiﬁcation of the protein i.e.
with targeting peptides or oligonucleotides is straightforward.5,13
The interaction between BSA and aqueous Aunp suspensions
has been shown to be predominantly electrostatic in nature.11,14 It
is also known that upon binding, BSA might undergo some
conformational changes10,11,15,16 with the degree of conforma-
tional changes/unfolding being inversely proportional to particle
curvature,15 i.e. smaller particles promote a native-like structure
of the surface-bound protein. To the best of our knowledge,
however, there have been no studies of the interaction between
protein–Aunp constructs and Langmuir monolayers of phos-
pholipids compared to that of the native protein. Depending on
how the protein is oriented on the nanoparticle surface, its
interaction with a lipid ﬁlm might be signiﬁcantly altered
compared to the native protein. Conformational changes in the
surface-bound protein should also result in an increased inter-
facial activity of the protein, owing to partial exposure of
hydrophobic residues and a loosening of the tertiary structure
which permits a more efﬁcient adaption to a non-bulk environ-
ment relative to the compact, folded native protein. Thus, we
undertake this study to examine to which extent protein–nano-
particle constructs have enhanced interfacial activity and how
they affect the monolayer membrane model. Such properties
would be ‘‘emergent’’ if they could not be found to a signiﬁcant
extent in the individual components making up the system under
scrutiny. Differences in physical and optical properties of BSA
only compared to those of BSA–Aunp constructs were moni-
tored using z-potential measurements, UV-vis and ﬂuorescence
spectroscopies. Aunps of two different sizes were used (30 nm
and 80 nm) to study how the curvature can inﬂuence unfolding
and interfacial activity of the protein. Steady-state ﬂuorescence
and time-correlated single photon counting (TCSPC) using
intrinsic (Trp) and extrinsic (ANS) probes indicate that BSA
unfolds more on 80 nm Aunp than on 30 nm Aunp. Thereafter,
the interfacial activity and interaction of the BSA–Aunp
constructs with Langmuir monolayers of phospholipids were
compared to those of the native protein. In order to assess effects
imparted by the protein introduction method on interfacial
activity, ﬁlm-penetrating properties and ﬁlm miscibility, both the
injected and the subphase methods4 as deﬁned above were used.
We found that the BSA–Aunp constructs display different
interfacial and lipid interaction properties from what is found in
either the Aunps only or the native protein. Signiﬁcant differ-
ences were also found with respect to the protein introduction
method. Using the subphase method, BSA and lipid formed
separate domains. However, when BSA was adsorbed on gold,
the constructs appeared to enhance lipid ﬁlm miscibility, yielding
mixed ﬁlms where no domains were observable via optical
microscopy. For the injected method neither the protein nor the
protein–gold constructs penetrated the lipid ﬁlm, but rather
interacted mostly with the charged polar headgroups of the lipid.
Materials and methods
Materials and solutions
Bovine serum albumin (BSA), 1-anilino-8-naphthalene sulfonate
(ANS) and L-a-phosphatidylethanolamine were purchased from
Sigma. The Aunps (30 nm and 80 nm) were purchased from Ted
Pella. The 80 nm Aunp suspension contains 1.1 1010 Aunps per
ml and the 30 nm Aunp suspension contains 2  1011 Aunps per
ml.
The solutions and suspensions used for ﬂuorescence, UV-vis,
and z-potential measurements were all made in the same manner.
For pure BSA samples a stock solution (1 mg ml1 in ultrapure
Milli-Q water,13.7 mM)was adjusted to pH 7 with NaOH (0.25
M). This solution was then diluted to 3.6 mMwith Milli-Q water,
pH was checked and UV-vis was used to control the concen-
tration. The molar absorptivity for BSA at 278 nm is 44 000
mol11 cm1.17
The BSA–Aunp suspensions were made by mixing gold (1 ml)
with BSA (0.525 ml, 13.7 mM, pH 7). The suspensions were then
allowed to equilibrate for 1 hour before Milli-Q water (0.475 ml)
was added, and the pH adjusted to 7 again. Suspensions were
allowed to equilibrate overnight prior to analysis. The concen-
tration of BSA in BSA–Aunp suspensions is chosen in line with
Kaufman et al. who used a protein : gold ratio equal to 2000 : 1,
on 12.8 nm Aunps,14 giving a BSA/gold nm2 ratio ¼ 3.9. This
corresponds to a BSA : gold ratio equal to 10 986 : 1 for the 30
nm Aunp and 78 125 : 1 for the 80 nm Aunp. The BSA
concentration was kept constant at 3.6 mM in all solutions and
suspensions, so that any change observed would be due to the
amount of adsorbed BSA. For ﬂuorescence measurements with
ANS, ANS (10 ml, 5 mM) was added to a BSA solution (3 ml, 3.6
mM) and to BSA–Aunp suspensions (3 ml) made as described
above. The ﬁnal concentration of ANS was 17 mM. ANS is
commonly used as an extrinsic ﬂuorescence probe for studying
proteins.18–20
UV-vis spectroscopy
UV-vis spectra were collected using a Shimadzu UV-2401PC
spectrophotometer over the wavelength range of 200–800 nm.
z-Potential measurements
The z-potential and size (dynamic light scattering, DLS)
measurements of BSA and the protein–gold constructs were
measured on a Zetasizer Nano-ZS instrument from Malvern
instruments using DTS software.
Fluorescence
The ﬂuorescence measurements were performed on a Fluorolog-
3 HORIBA Jobin Yvon apparatus. For the steady-state
measurements of BSA solutions and BSA–Aunp conjugates, the
excitation wavelength was lex ¼ 295 nm. If BSA is excited with
lex ¼ 280 nm, tyrosine and phenylalanine contribute to the
emission signal. By using lex ¼ 295 nm only signals from tryp-
tophan (Trp) are measured.21 For intrinsic ﬂuorescence
measurements the slits were 10 nm, and polarizator was used.
For all samples containing ANS the excitation wavelengths were
lex ¼ 370 nm and lex ¼ 388 nm. The excitation wavelength lex ¼
388 nm was chosen as speciﬁed by the supplier. The secondary
excitation wavelength lex ¼ 370 nm was chosen based on earlier
studies of ANS as a ﬂuorescence probe for proteins.19 For all the
ﬁgures shown here, the excitation wavelength was lex ¼ 388 nm
and slits ¼ 1 nm.
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Time correlated single photon counting (TCSPC) of samples
without ANS a 280 nm LED lamp was used. The prompt was
recorded with the emission monochromator (Em. mono) ¼ 280
nm, and the samples using Em. mono ¼ 350 nm. The bandpass
was 5 nm. For samples with ANS the LED lamp for the TCSPC
measurements had lex ¼ 370 nm. The prompt was recorded with
the Em. mono¼ 370 nm, and the samples using Em. mono¼ 470
nm. The bandpass was 14 nm. Detailed descriptions of this
technique can be found elsewhere.13,22 Brieﬂy, relaxation from
the radiative excited states was modeled using a weighted sum of
exponential decays:
Y ðtÞ ¼
XN
i¼1
Bie
ð tTiÞ (1)
where N is the total number of ﬂuorescent components and Bi
represents the amplitude (population) associated with lifetime Ti.
The ﬁnal ﬁt was approached using an iterative process where
exponentials were added until no signiﬁcant improvements in the
c2 value of the ﬁt could be seen.
Bradford assays
The amount of adsorbed protein on Aunps was determined using
a Bradford assay. First, size determination of BSAwas performed
using a Zetasizer 3000HSA from Malvern instruments. The size
was determined in three different buffers. Acetate buffer (pH 3.8)
gave a size of 7.9 nm,phosphate buffer (pH7) gave a size of 5.6 and
ﬁnally borate buffer (pH 9) gave a size of 8.9. The size of BSA in
citrate was assumed to be 8, 6 or 4 nm. A stock solution of BSA
(7.2 mM; 600 ml, 300 ml or 150 ml) was mixed with gold colloid
suspension (600 ml) to give ﬁnal concentrations of BSA of 3.6 mM,
1.8 mM or 0.9 mM. Following equilibration, the samples were
centrifuged to precipitate the BSA–Aunp constructs, and the
remaining protein concentration in the supernatantwasmeasured
using the Bradford method.23 The size measurements and Brad-
ford assays were then combined to give a layer calculation.
Langmuir isotherms
Surface pressure–area measurements were recorded using a KSV
Langmuir Minitrough double barrier system (KSV LTD, Fin-
land) controlled through the manufacturer’s own software. The
trough was made of Teﬂon, with barriers of Delrin. Two
different methods for investigating protein–lipid interactions
were applied, both adopted from Glomm et al.4 For the injected
method the subphase used was Milli-Q water adjusted to pH 7
with NaOH. The surface was swept with a vacuum pump-con-
nected Pasteur pipette and then compressed and decompressed to
check for impurities at the surface prior to introduction of the
lipid ﬁlm (L-a-phosphatidylethanolamine, 1 mg ml1 in chloro-
form, 30 ml). The ﬁlm was spread with a 50 ml Hamilton syringe.
Initial compression to 5 mNm1 was started 15 minutes after ﬁlm
introduction. Film compression was carried out with a constant
barrier speed of 5 mmmin1 while an electrobalance recorded the
surface tension through means of a paper probe. The sample was
then introduced under the lipid ﬁlm from outside and under the
barriers (Scheme 1). The system was allowed to equilibrate for
one hour at a constant trough area before the compression
continued to 40 mNm1. When lipid was not present the barriers
were moved to position 10 mm, and the sample introduced under
the air–water surface. The rest of the procedure was executed as if
lipid was present. In all cases the ﬁnal BSA concentration was 50
nM, and the trough volume was 250 ml.
The different samples injected were:
1. BSA (1 ml, 12.5 mM, pH 7).
2. BSA–Aunp construct (0.5 ml, 50% (v/v) gold suspension, 25
mM BSA, pH 7). This was done with both 30 nm Aunps and 80
nm nanoparticles.
For the subphase method the BSA–Aunp suspensions (1.2 ml,
50% (v/v) gold suspension, 12.5 mM BSA, pH 7) were diluted to
300 ml for both the 80 nm Aunp and the 30 nm Aunp. The
protein only subphase was made by diluting a BSA solution (0.3
ml, 50 mM) to 300 ml.
Directly after the subphase was poured into the trough, the
surface was vacuumed. For experiments without lipid the
subphase was then compressed and decompressed. After the
decompressing, the lipid ﬁlm was spread on top. After 15 minutes
a new cycle of compressing/decompressing was started. For
illustration of these two methods, see Scheme 1. All the Lang-
muir experiments were simultaneously monitored by Brewster
Angle Microscopy.
Brewster Angle Microscopy (BAM)
BAM was used to visualize monolayers using a KSV BAM 300.
The instrument consists of a standard 10 mW He–Ne laser,
emitting p-polarized light at a wavelength of l¼ 632.8 nm by the
use of a high-quality Glan–Thomson polarizer. The reﬂected
light is imaged onto a computer controlled CCD camera with 768
 44 pixels through a 10 magniﬁcation objective, yielding
a spatial resolution of 2 mm. A black wedge-shaped glass plate
is placed at the bottom of the trough to reﬂect any light that is
transmitted through the subphase out of the optical axis and to
minimize convection in the trough. The method is adopted from
Glomm et al.4
To obtain DVM pictures, ﬁrst a Langmuir–Blodgett ﬁlm was
deposited with the equipment described above for the Langmuir
experiments. A microscope slide was washed with ethanol and
blown dry with air before being submerged vertically into the
Scheme 1 Situation before (left column) and after (right column)
introduction of protein or protein–gold constructs to the lipid ﬁlm. The
upper pictures (a and b) show the injected method, and the lower pictures
(c and d) show the subphase method. Solutes in bulk indicated by white
spheres, while solutes interacting with lipid monolayer headgroups
indicated by black ellipsoids. Solutes spreading along the air–water
interface indicated by blurred ellipsoids (Adapted from Glomm et al.4).
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subphase, which was vacuumed ﬁrst. Compression to 25 mNm1
was started 15 minutes after ﬁlm introduction. While the pressure
was kept constant at 25 mN m1, the microscope slide was lifted
up with a speed of 1 mm min1. The deposited ﬁlm was then
studied using cross-polarized light and a Digital Video Micro-
scope (DVM). The microscope used was Nikon eclipse ME 600,
and the camera was a CoolSnap Proof Monochrome, an inte-
grated solution from Media Cypernetics, ‘‘the imaging
experts’’. The software used was Image-Pro Plus5.0.
Lipid only was studied at both 25 mN m1 and 30 mN m1.
DVM pictures were also taken using the injected method, where
the lipid ﬁlm was compressed to 5 mN m1 before the BSA or
BSA–Aunp conjugate was introduced and allowed to equilibrate
as for the Langmuir isotherm recordings. After one hour the
system was compressed to 25 mNm1 and the dipping procedure
continued as for the subphase experiments.
Results and Discussion
In the following sections, the results are presented in terms of
protein binding to Aunp surfaces, the interaction between BSA–
Aunp constructs and Langmuir lipid ﬁlms, and the ability of the
BSA–Aunp constructs to enhance ﬁlm miscibility and disrupt
lipid monolayers.
Immobilization onto Aunps modulates BSA conformation
Sample preparation and characterization. UV-vis showed a 3
nm bathochromic (red) shift in the localized surface plasmon
resonance (LSPR) band for both 30 nm and 80 nm Aunps upon
introduction of BSA. The red shifts displayed by the BSA–Aunp
constructs as compared to unmodiﬁed particles are consistent
with a change in the dielectric function on the nanoparticle
surface upon protein adsorption.24–26 Introduction of BSA to the
particle suspension did not signiﬁcantly alter the lineshape of the
absorption spectra, indicating that the BSA–Aunp constructs
remained as single colloids rather than ﬂocs under these condi-
tions.
To quantify the amount of BSA adsorbed on the Aunps,
Bradford assays were performed.23 At pH 7 and at a protein
concentration of 3.6 mM, BSA adsorption resulted in a mono-
layer coverage on the Aunps, with BSA : Aunp ratios of60 and
400 for 30 nm and 80 nm Aunps, respectively. The BSA
diameter was estimated to be 6 nm as determined by dynamic
light scattering (DLS). This is in agreement with other DLS
results showing that for both Aunp sizes studied here the particle
diameter increased with 10 nm upon BSA adsorption. It should
be noted that in ultrapure (Milli-Q) water without any pH
adjustment (pH 5.5), the layer calculation showed an equiva-
lent of 11.5 and 24.7 layers for 80 and 30 nm Aunps, respectively.
This corresponds well with ﬁndings of Kaufman et al.14where the
authors observed multilayer formation for binding of BSA to
negatively charged Aunps, with an irreversibly bound inner layer
surrounded by loosely associated protein molecules.
The z-potential measurements of BSA–Aunp constructs
showed for both sizes of Aunp a reduction of the absolute value
compared to Aunps only (zz 45 mV for Aunp only and zz
37 mV for BSA–Aunp constructs. For BSA only, the z-
potential was 26 mV under these conditions). The negative
surface charge of Aunps emanates from a layer of stabilizing
citrate molecules remaining from the particle synthesis. These
changes in z-potential value together with the red shift of the
LSPR conﬁrm that BSA is associated with the Aunp. Binding of
BSA to Aunps is thought to occur primarily through electrostatic
interactions between the citrate-covered particles and oppositely
charged patches on the protein surface.11,27
Steady-state ﬂuorescence. UV-vis and z-measurements show
that binding occurs but reveal little about any conformational
changes in the adsorbed layer. To get a better understanding of
what happens with BSA upon binding to gold, both intrinsic
(Trp) and extrinsic (1-anilino-8-naphthalene sulfonate; ANS)
ﬂuorescence were measured (Fig. 1). Fig. 1a shows Trp emission
spectra of BSA, both free in solution and immobilized on Aunps.
It is well known that the Trp ﬂuorescence is highly inﬂuenced by
changes in the local environment.21 As the intensity and position
of the peak maximum are sensitive to solvent exposure, the Trp
ﬂuorescence is often used to indicate changes in protein confor-
mation. BSA contains two Trp residues: one buried in the
hydrophobic interior and one residing closer to the surface.12
From Fig. 1a, it can be seen that upon introduction of Aunps, the
Trp emission is reduced, with the magnitude of signal reduction
being proportional to Aunp diameter. This again conﬁrms
adsorption, as interaction between protein and Aunps will cause
a reduction of ﬂuorescence due to static quenching when the
protein is physi- or chemisorbed to gold.16 As BSA is present in
large excess compared to surface coverage, the emission spectra
contain contributions from free and immobilized BSA. Any
Fig. 1 (a) Steady-state ﬂuorescence measurements of BSA and BSA–Aunp constructs (lex¼ 295 nm). (b) Steady-state measurements of ANS with BSA
and with BSA–Aunp constructs (lex ¼ 388 nm).
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changes in lineshape or position of the emission maximum
emanating from the surface-bound protein will likely be drowned
by spectral contributions from the free protein. Thus, the Trp
ﬂuorescence only provides conﬁrmation of protein binding in
this study.
ANS is a frequently used extrinsic ﬂuorescence probe for
studying changes in protein conformation.1,18–20,28,29 To the best
of our knowledge there are presently no studies using ANS to
follow BSA adsorption on Aunps. ANS is highly ﬂuorescent
when associated with the hydrophobic interior of the protein, but
is almost completely quenched in water due to solvent effects.21
Consequently, ANS ﬂuorescence is expected to decrease if the
protein unfolds on the surface, reducing access to hydrophobic
domains. From Fig. 1b, it can be seen that there is an intensity
loss upon introduction of Aunps which is larger for 80 nm than
for 30 nm Aunp. Suspensions containing only ANS or gold with
ANS in water gave negligible signal intensity compared to the
protein-containing samples. The BSA concentration was kept
constant, so the reduction in emission intensity from the BSA–
Aunp constructs compared to the free protein is likely due to
reduced access to hydrophobic domains. These results could be
due to unfolding of the adsorbed protein, leading both to solvent
exposure and compression of the protein adlayer. The emission
intensity decrease is signiﬁcantly more pronounced for the larger
Aunp core. Assuming that the observed reduction in emission
intensity is due to unfolding of the adsorbed BSA, the results
obtained here ﬁt well with the well-established observation that
the propensity for surface-induced unfolding is inversely
proportional to the curvature.15
Time-correlated single photon counting (TCSPC). Calculated
lifetimes and corresponding populations for intrinsic and ANS
ﬂuorescence are shown in Table 1. In the case of intrinsic ﬂuo-
rescence, the acquired data were best modeled using a biphasic
decay, revealing one short and one long lifetime, T1 and T2, with
relative populations B1 and B2, respectively. Since a 280 nm
LED was used for lifetime measurements other intrinsic ﬂuo-
rophores such as tyrosine were excited as well as tryptophan.
However, the response is expected to be dominated by the
tryptophan emission. No signiﬁcant changes in lifetimes were
observed for the BSA–Aunp constructs relative to the free
protein. Immobilization of BSA onto Aunps results in an
increase in the relative population B1 corresponding to the short
lifetime (T1 in Table 1). No signiﬁcant changes in relative pop-
ulations can be observed between the two particle sizes applied
here. An increase in the fraction of ﬂuorophores corresponding
to the short lifetime compared to free BSA indicates an increased
exposure to solvent for the BSA–Aunp constructs. The increase
in B1 upon adsorption on gold is likely due to conformational
changes of the surface-bound protein compared to the free BSA.
The total available surface area in the 30 nm Aunp suspension is
5.65 cm2 ml1, while for 80 nm Aunp it is only 2.21 cm2 ml1. As
both particle concentration and available surface area are lower
for the 80 nm Aunp, changes in protein conformation are likely
larger for the 80 nm BSA–Aunp construct in order to elicit the
same population changes as the 30 nm BSA–Aunp constructs.
This is in accordance with the steady-state ﬂuorescence results, in
that a lower curvature appears to promote a higher degree of
unfolding of the protein.
Time resolved ﬂuorescence data of ANS associated with BSA
and BSA–Aunp constructs are shown in Table 1 (lower panel).
Decay times in aqueous ANS solutions were best modeled with
a tri-exponential ﬁt, in accordance with literature.21 The lifetimes
of ANS only were found to be signiﬁcantly different from the
lifetimes obtained in the presence of BSA and BSA–Aunp
constructs (Table 1). This is expected as the quantum yield of
aqueous ANS is negligible compared to when ANS resides in the
hydrophobic interior of BSA, which is in accordance with the
steady-state results (Fig. 1). Hence, only contributions fromANS
associated with BSA were found to be statistically signiﬁcant in
this study. A two-state model comprised of one short and one
long lifetime was found to yield the best ﬁt of ANS in the pres-
ence of BSA or BSA–Aunps (Table 1). Similar to the results
obtained for intrinsic ﬂuorophores, the lifetimes and corre-
sponding populations are interpreted as emanating from states
close to and shielded from the solvent, respectively. The short
lifetime (T1) increases progressively upon introduction of Aunps
and with increasing particle size, whereas the long lifetime (T2)
remained unchanged for all three systems. This slight increase in
T1 can probably be attributed to close packing of BSA on the
Table 1 Fluorescence lifetimes and corresponding populations of BSA, BSA–Aunp constructs and samples with added ANS. T ¼ lifetimes in
nanoseconds (ns), B ¼ populations in %a
T1 (ns) B1 (%) T2 (ns) B2 (%) c2
Protein–gold constructs (lex ¼ 280 nm)
BSA 4.0 23  4 7.1 77  4 0.86
BSA + 30 nm Aunp 3.8 32  3 7.1 68  3 1.21
BSA + 80 nm Aunp 3.7 30  4 6.9 70  4 1.11
ANS and protein–gold constructs (lex ¼ 370 nm)
BSA 4.7 6  1 18.5 94  1 0.99
BSA + 30 nm Aunp 5.7 8.4  0.1 19.0 91.6  0.1 1.00
BSA + 80 nm Aunp 6.6 11.4  0.6 19.1 88.7  0.6 0.98
a For aqueous ANS the lifetime in nanoseconds was T1¼ 5.4 0.8, T2¼ 18 2, and T3¼ 0.27 with the corresponding populations B1¼ 8 1, B2¼ 12
 2, and B3 ¼ 80  2, respectively.
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Aunp surfaces, which is expected to increase with increasing core
diameter. Analogous with results obtained from intrinsic ﬂuo-
rophores, there is an increase in population when BSA is
immobilized on Aunps. Moreover, the population of T1
increases with Aunp diameter, indicating that ANS is more
exposed to water upon immobilization, and with increasing
particle diameter.
The steady-state and TCSPC measurements for both intrinsic
and extrinsic probes indicate that BSA exposes more of its
hydrophobic residues to the solvent when adsorbed. On 80 nm
Aunps this is more pronounced than on 30 nm particles, indi-
cating that a lower curvature promotes larger changes in the
protein adlayer. We interpret these changes as unfolding of BSA
when immobilized on gold, with the extent of conformational
change being proportional to Aunp core diameter. Larger
unfolding of the protein on the bigger Aunp is in agreement with
literature.15 Hence, for a given set of Aunp surface characteris-
tics, the conformation and polarity of the protein adlayer and
concomitant interfacial activity of protein–Aunp constructs
might be tunable by varying the Aunp diameter.
Immobilization onto Aunps modulates BSA interfacial activity
Film-forming properties of BSA–Aunp constructs relative to
reference systems. Two different protein introduction procedures
were employed: the injected and subphase methods, respectively.4
In the injected method, the lipid layer was ﬁrst compressed to
a surface pressure of 5 mNm1 before either the protein or BSA–
Aunp constructs were injected under the lipid layer from outside
the barriers. Conversely, in the subphase method BSA was
already mixed into the subphase before lipid was introduced. For
more details on the different methodologies employed see the
Materials and methods section and also illustrated in Scheme 1.
Surface pressure–area (P–A) isotherms of the reference
systems—lipid, BSA and BSA–Aunp constructs—are given in
Fig. 2a and b for the injected and subphase methods, respectively.
Suspensions of unmodiﬁed (citrate coated) Aunps did not result
in measurable ﬁlm formation at these concentrations, irre-
spective of the introduction method (injected or subphase). From
the compression part of the P–A isotherm of the lipid, the mean
molecular area (MMA), determined from the inﬂection point
marking the transition from a 2D gaseous to a liquid state, was
found to be 52 A˚2 per molecule. The collapse pressure of the pure
lipid ﬁlm (i.e. the highest surface pressure to which a monolayer
can be compressed without collapsing and/or forming multi-
layers) was found to be 51 mN m1. The compression–expan-
sion isotherm of the lipid (Fig. 2) shows a narrow hysteresis loop,
with a steep slope indicating a low compressibility of the
monolayer.
In all the systems where BSA or BSA–Aunp constructs are
used, the resulting P–A isotherms contain contributions from
ﬁlm-forming species which do not fulﬁll the criteria for a Lang-
muir monolayer. Speciﬁcally both BSA and BSA–Aunp
constructs are soluble in the subphase. Thus, all P–A isotherms
are shown as surface pressure versus trough area. As seen from
Fig. 2a and b, introduction of BSA or BSA–Aunp constructs via
the injected or subphase method resulted in strong ﬁlm formation
with surface pressures exceeding 25 mN m1 at full compression.
Due to both BSA and BSA–Aunp being soluble in the subphase,
the maximum surface pressures never exceeded 30 mN m1.
Thus, as shown by Glomm et al.,4 spreading of lipid after
introduction of another ﬁlm-forming agent, such as in the
Fig. 2 Langmuir isotherms where (a) and (b) are without the lipid present when protein or protein–Aunp construct is introduced. In (c) the lipid is
introduced ﬁrst and the protein/construct injected underneath. (d) The panel depicts a subphase containing protein/construct added ﬁrst and the lipid
introduced on top. Isotherm for a pure lipid ﬁlm has been included in all ﬁgures for an easier comparison. For each dataset the upper line corresponds to
compression and the lower line represents expansion.
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subphase method, will lead to a mixed monolayer behavior.
Compared to the lipid, BSA and BSA–Aunp constructs result in
a more compressible ﬁlm with a broader hysteresis loop (Fig. 2a
and b). For the injected method, no signiﬁcant differences could
be observed between the isotherms for BSA and BSA–Aunp
constructs.
At lower trough areas (<100 cm2) the isotherms for the
subphase method (Fig. 2b) closely resemble those of the injected
method. Unlike what was found for the injected method, clear
differences in the compression–expansion isotherms for BSA and
BSA–Aunp constructs are observable when using the subphase
method (Fig. 2b). Compared to the parent protein, the initial
surface pressure of the BSA–Aunp constructs is lower and the
hysteresis loop is signiﬁcantly narrower. Moreover, the
compression–expansion isotherms for the two sizes of BSA–
Aunp constructs are clearly discernible with the initial surface
pressure increase starting at lower trough areas and yielding
a narrower hysteresis loop for the larger Aunp core. This indi-
cates that the less ﬁlm-forming material is present at the surface
for the BSA–Aunp systems compared to the native protein, and
that the surface concentration of the BSA–Aunp constructs is
lowest for the larger Aunp core. When using a BSA solution or
a BSA–Aunp suspension as a subphase, a bulk–surface equilib-
rium is assumed to be in place.4 In the subphase method the
surface is vacuumed and P set to zero immediately following
introduction of the (ﬁlm-forming) subphase. Thus, the baseline
prior to compression does not represent a ﬁlm-free surface.
Depending on the interfacial activity of ﬁlm-forming species in
the subphase, different concentrations will be present at the
surface when this is vacuumed. From Fig. 2b, it is evident that
less material is available for compression of the BSA–Aunp
constructs than of the native protein, indicating a higher surface
activity for the former. Additionally the surface activity increases
with the larger Aunp core size. Immobilization of BSA on Aunps
alters the proteins’ hydrophobicity, and by applying larger
particles a larger change in interfacial activity can be induced.
This corresponds well with steady-state ﬂuorescence and TCSPC
measurements.
Fig. 2c and d illustrate compression–expansion isotherms for
mixed systems using the injected and subphase method, respec-
tively. For none of these systems the isotherms distinguish
between the protein and the protein–Aunp constructs. When
using the injected method (Fig. 2c) the mixed ﬁlms display mostly
lipid characteristics. This indicates that when interacting with
a precompressed ﬁlm, the BSA and BSA–Aunp constructs reside
mostly under the lipid, near the polar headgroups. The differ-
ences between the isotherms are representative of the inherent
uncertainties for the injected method.4 Using the subphase method
(Fig. 2d) the resulting isotherms for mixed systems all display
protein-like behavior, with lipid characteristics only being prev-
alent at high compression. Since protein is much more
compressible than the lipid, the protein (or BSA–Aunp
constructs) will dominate the ﬁlm behavior as long as the protein
is on the surface. But when the pressure is high enough most of
the protein will be solubilized into the subphase and the
isotherms will adopt more of a lipid character. Depending on the
introduction method used, the resulting mixed isotherm displays
either a lipid-like (injected) or a protein-like (subphase) behavior.
Miscibility and domain properties of mixed ﬁlms. Brewster
Angle Microscopy (BAM) can be used to visualize the
morphology and heterogeneity of a ﬁlm at air–water surfaces.4,30–33
Fig. 3 BAM images of BSA/BSA–Aunp constructs interacting with lipid Langmuir ﬁlms. (a) Injected methodwith BSA, (b) subphase methodwith BSA,
and (c) subphase method with BSA on 30 nm Aunp.
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In this study the BAM pictures in Fig. 3 provide complementary
information about the ﬁlm morphology. For clarity, dark
regions represent ﬁlm-free surfaces, whereas bright regions show
ﬁlm-forming material. BAM images of mixed ﬁlms using the
injected (3a) and subphase method for BSA (3b) and BSA–Aunp
constructs (3c) are shown in Fig. 3. The upper panels represent
the ﬁlm conditions immediately prior to compression, i.e.
a mixed lipid–BSA or lipid–BSA–Aunp ﬁlm. In the injected
method, the lipid ﬁlm was precompressed to 5 mN m1, whereas
no precompression was done in the subphase method. Prior to
compression of the pure lipid ﬁlm, no ﬁlm formation was evident,
as represented by a homogeneous dark surface (not shown).
Upon compression, a monolayer is formed, with a morphology
similar to the two lower panels of Fig. 3a. The bright structures
observed for the lipid ﬁlm might be indicative of liquid crystal
structures. For BSA or BSA–Aunp constructs only there is
already a complete monolayer present prior to compression,
similar to the upper panels of Fig. 3. Upon compression, the
images grew increasingly brighter, indicating formation of an
increasingly thicker ﬁlm. BAM images of mixed ﬁlms obtained
using the injected method (Fig. 3a) appear indistinguishable from
those of lipid only at surface pressures exceeding 5 mN m1. No
distinctive differences could be observed between BSA and BSA–
Aunp constructs. This corroborates the assumption drawn from
the compression–expansion isotherms, in that the proteins (or
protein–Aunp constructs) interact mainly with the lipid head-
groups.
BAM images of mixed ﬁlms using the subphase method are
shown in Fig. 3b and c for BSA and BSA–Aunp constructs,
respectively. For BSA interacting with the lipid ﬁlm (Fig. 3b, top
panel), the ﬁlm morphology at low surface pressures is indistin-
guishable from that of protein-only. At higher lateral pressures
(Fig. 3b, middle panel), the BAM images show two distinct
domains: one corresponding to the lipid (structured regions) and
one corresponding to BSA (light, homogeneous regions). At
40 mN m1, the lipid-like domains appear unchanged, whereas
the protein-like domains are signiﬁcantly brighter, indicating
a denser/thicker protein ﬁlm. Thus, introduction of BSA via the
subphase method results in mixed-ﬁlm behavior, with immiscible
lipid-like and protein-like domains.4 Conversely, BSA–Aunp
constructs interacting with the lipid ﬁlm (Fig. 3c) show no
domain formation at any surface pressure. Rather, the
morphology of the BSA–Aunp construct-lipid ﬁlm appears
indistinguishable from that of a BSA ﬁlm only, save for some
small regular structures towards maximum compression (Fig. 3c,
lower panel). This absence of distinguishable domains was
observed for both sizes of Aunps used here.
As the protein concentration was kept constant, the pictures in
Fig. 3b and c indicate that the BSA–Aunp constructs promote
ﬁlm miscibility. We believe that this feature of the BSA–Aunp
constructs can be attributed to a difference in conformation of
the immobilized BSA compared to the native protein, as indi-
cated by the steady-state and time-resolved ﬂuorescence dis-
cussed above. Hence, modulating the protein fold by attachment
to colloidal structures might result in an altered interfacial
activity and concomitant lipid ﬁlm interaction.
BSA–Aunp constructs disrupt liquid crystal lipid domains
Digital video microscopy (DVM) birefringence. The BAM
images of the lipid used here displayed features which might be
attributed to liquid crystalline domains. A liquid crystalline
phase is classiﬁed as having short-range disorder but some
distinct ordering over larger distances, with a liquid-like state of
the alkyl chains.34 To ascertain whether the lipid formed liquid
crystalline domains under the conditions studied here, cross-
polarized light microscopy images of Langmuir–Blodgett ﬁlms
deposited on microscope slides were acquired. The sample image
shown in Fig. 4 clearly indicates that the lipid ﬁlm contains liquid
crystalline domains, as represented by the bright regions.
When only lipid ﬁlm was studied, there were many larger
structures of liquid crystals. Introduction of BSA only by either
method, or BSA–Aunp constructs by using the injected method,
yielded no observable effect on these structures. However, when
applying BSA–Aunp constructs of either size to the lipid ﬁlm
using the subphase method, the liquid crystalline domains were
signiﬁcantly reduced both with respect to size, brightness and
number. This indicates that BSA–Aunp constructs disrupt the
ordered lipid structures, as no such effect was observed for the
native protein, coinciding well with the BAM images showing
that BSA–Aunp constructs induce ﬁlm miscibility.
Conclusion
UV-vis, z-potential, and ﬂuorescence measurements all show
that BSA adsorbs on Aunps, forming monolayers at neutral pH.
From the steady-state and time-resolved ﬂuorescence measure-
ments using intrinsic and extrinsic probes, surface-bound BSA is
partially unfolded compared to the native protein. The ANS
ﬂuorescence approach, often used to probe the extent of protein
unfolding and the identiﬁcation of intermediately folded states
such as the molten globule state,35,36 can also be used in assessing
the degree of unfolding on protein–Aunp systems although some
care must be taken when assessing potential steric effects the
Aunps has on quencher access. When studying the interactions of
BSA and BSA–Aunp constructs with a lipid monolayer using the
Langmuir technique, the resulting isotherms were found to
depend greatly on whether the protein (or protein–Aunp
constructs) was injected under a pre-compressed lipid monolayer
(injected method) or introduced into the subphase prior to
spreading of the lipid (subphase method). Speciﬁcally, the
behavior of the mixed ﬁlm is largely dependent on the amount of
Fig. 4 DVM image of the lipid ﬁlm using cross-polarized light.
Magniﬁcation 50.
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protein embedded in the monolayer. BAM images reveal that
when applying the subphase method, BSA and lipid form an
immiscible monolayer with distinct lipid and protein domains.
However, when BSA was adsorbed onto Aunps, the resulting
BSA–Aunp constructs resulted in ﬁlm miscibility, indicating that
the BSA–Aunp constructs are more effective at lipid ﬁlm pene-
tration than the native protein. Moreover, cross-polarized
microscopy images show that unlike the native protein, the BSA–
Aunp constructs disrupt liquid crystalline domains seen in the
lipid ﬁlm at a high lateral compression. The results show that
modiﬁcation of a protein by immobilization onto nanoparticles
may affect its ability to penetrate lipid ﬁlms and affect ﬁlm
miscibility, which holds great potential for biomedical applica-
tions of protein–nanoparticle constructs.
That protein conformational changes take place at interfaces is
established for many systems.27,37–41 In this study, two effects of
these conformational changes are documented and explored: (i) the
modulation of the surface activity of BSA–Aunps and (ii) the
enhanced ﬁlm miscibility of the BSA–Aunp mixed monolayers.
Both these characteristics of theBSA–Aunps appear tobe emergent
qualities of the construct, as the protein component and the nano-
particle component alone do not have these characteristics at the
conditions tested here. There exist conﬂicting reports as to whether
BSA unfolding is consistent with a simple two-state model.42–44 It is
thus possible to envision conditions (i.e. denaturating conditions)
where BSA has similar characteristics. However, protein–Aunp
constructs have the advantages of multifunctionality and optical
traceability of the construct,8 as well as heat-induced apoptosis via
excitation of the localized surface plasmon resonance (LSPR)
band.25,45 Moreover, the Aunp-induced characteristics are gained
independently of any non-physiological condition or reagent. The
degree of unfolding appears to increase with increasing Aunp
diameter, which agrees with earlier studies.15 This, together with
modiﬁcationof the adlayer characteristics, offers theopportunityof
controlling the construct properties further. The surface activity of
such constructs may play an important role in drug delivery and
targeting, as ahighafﬁnity formembranes relative tonativeproteins
has been strongly implicated in the activity of drugs based on
intermediately folded protein states.46,47 The emergent qualities of
BSA–Aunps must stem from how the protein exposes its hydro-
phobicmotifs to the solvent.The exact details of the conformational
changes are beyond both the scope of this study and the resolution
of the applied techniques. Indeed, only a few such studies exist for
nanoparticle–protein constructs, one notable example being Engel
et al.37 BSA is a zinc- and small organic molecule-binding protein
constructed from three homologous helical domains,48 each con-
taining two sub-domains, which in principle provides many possi-
bilities for partial unfolding and speciﬁc orientation upon
adsorption to Aunps. It would be interesting to apply the approach
of Engel et al., which provides information on which parts of the
protein retain a native fold and/or are shielded by the nanoparticle,
provided that efﬁcient displacement procedures and protein size
limitations could be managed properly.
Acknowledgements
The authors acknowledge the Department of Chemical Engi-
neering, NTNU, for ﬁnancial support. Wilhelm R. Glomm and
Sondre Volden acknowledge ﬁnancial support from the Research
Council of Norway (NFR).
References
1 D. Togashi, A. Ryder and D. O’Shaughnessy, J. Fluoresc., 2010,
20(2), 441–452.
2 A. Junghans, C. Champagne, P. Cayot, C. Loupiac and I. K€oper,
Langmuir, 2010, 26(14), 12049–12053.
3 T. Nylander, Protein–Lipid Interactions, in Studies in Interface
Science 7, ed. D. M€obius and R. Miller, Elsevier Science, B.V.,
1998, pp. 385–429.
4 W. R. Glomm, S. Volden, Ø. Halskau andM. H. G. Ese,Anal. Chem.,
2009, 81(8), 3042–3050.
5 C. M. Feldherr and D. Akin, J. Cell Sci., 1999, 112, 2043–2048.
6 A. G. Tkachenko, H. Xie, D. Coleman, W. Glomm, J. Ryan,
M. F. Anderson, S. Franzen and D. L. Feldheim, J. Am. Chem.
Soc., 2003, 125(16), 4700–4701.
7 A. G. Tkachenko, H. Xie, Y. Liu, D. Coleman, J. Ryan,
W. R. Glomm, M. K. Shipton, S. Franzen and D. L. Feldheim,
Bioconjugate Chem., 2004, 15(3), 482–490.
8 W. R. Glomm, J. Dispersion Sci. Technol., 2005, 26(3), 389–414.
9 J. A. Ryan, K. W. Overton, M. E. Speight, C. N. Oldenburg, L. Loo,
W. Robarge, S. Franzen and D. L. Feldheim, Anal. Chem., 2007, 79,
9150–9159.
10 M. Iosin, F. Toderas, P. L. Baldeck and A. Astilean, J. Mol. Struct.,
2009, 924–926, 196–200.
11 S. H. Brewer, W. R. Glomm, M. C. Johnson, M. K. Knag and
S. Franzen, Langmuir, 2005, 21, 9303–9307.
12 A. Housni, M. Ahmed, S. Liu and R. Narain, J. Phys. Chem. C, 2008,
112, 12282–12290.
13 H. Xie, A. G. Tkachenko, W. R. Glomm, J. A. Ryan,
M. K. Brennaman, J. M. Papanikolas, S. Franzen and
D. L. Feldheim, Anal. Chem., 2003, 75(21), 5797–5805.
14 E. D. Kaufman, J. Belyea, M. C. Johnson, Z. M. Nicholson,
J. L. Ricks, P. K. Shah, M. Bayless, T. Petterson, Z. Feldt€o,
E. Blomberg, P. Claesson and S. Franzen, Langmuir, 2007, 23,
6053–6062.
15 R. S. Kane and A. D. Stroock, Biotechnol. Prog., 2007, 23(2), 316–
319.
16 T. Sen, K. K. Haldar and A. Patra, J. Phys. Chem. C, 2008, 112,
17945–17951.
17 C. N. Pace, F. Vaidos, L. Fee, G. Grimsley and T. Grey, Protein Sci.,
1995, 4, 2411–2423.
18 M. J. Tiera, G. R. d. Santos, V. A. d. O. Tiera, N. A. B. Vieira,
E. Frolini, R. C. d. Silva and W. Loh, Colloid Polym. Sci., 2005,
283, 662–670.
19 E. Gabellieri and G. B. Strambini, Biophys. J., 2006, 90, 3239–3245.
20 G. V. Semisotnov, N. A. Rodionova, O. I. Razgulyaev,
V. N. Uversky, A. F. Gripas’ and R. I. Gilmanshin, Biopolymers,
1991, 31(1), 119–128.
21 J. R. Lakowicz, Principles of Fluorescence Spectroscopy, Springer,
New York, 2006.
22 W. R. Glomm, S. J. Moses, M. K. Brennaman, J. M. Papanikolas and
S. Franzen, J. Phys. Chem. B, 2005, 109(2), 804–810.
23 M. M. Bradford, Anal. Biochem., 1976, 72(1–2), 248–254.
24 S. Volden, A.-L. Kjøniksen, K. Zhu, J. Genzer, B. Nystr€om and
W. R. Glomm, ACS Nano, 2010, 4(2), 1187–1201.
25 P. Mulvaney, Langmuir, 1996, 12, 788–800.
26 A. C. Templeton, J. J. Pietron, R. W. Murray and P. Mulvaney,
J. Phys. Chem. B, 2000, 104, 564–570.
27 W. R. Glomm, Ø. Halskau, A. M. D. Hanneseth and S. Volden,
J. Phys. Chem. B, 2007, 111(51), 14329–14345.
28 D. M. Togashi and A. G. Ryder, Exp. Molec. Pathol., 2007, 82(2),
135–141.
29 D. Togashi and A. Ryder, J. Fluoresc., 2008, 18(2), 519–526.
30 W. R. Glomm, M.-H. G. Ese, S. Volden, C. Pitois, A. Hult and
J. Sj€oblom, Colloids Surf., A, 2007, 299(1–3), 186–197.
31 Q. He and J. Li, Adv. Colloid Interface Sci., 2007, 131(1–2), 91–98.
32 G. Sui, M. Micic, Q. Huo and R. M. Leblanc, Colloids Surf., A, 2000,
171(1–3), 185–197.
33 Ø. Brandal, T. Viitala and J. Sj€oblom, J. Dispersion Sci. Technol.,
2007, 28(1), 95–106.
1796 | Nanoscale, 2011, 3, 1788–1797 This journal is ª The Royal Society of Chemistry 2011
Paper I 93
34 K. Holmberg, B. J€onsson, B. Kronberg, and B. Lindman, Surfactants
and Polymers in Aqueous Solution, John Wiley & Sons, West Sussex,
2nd edn, 2007.
35 A. P. D. A. Bom, M. S. Freitas, F. S. Moreira, D. Ferraz, D. Sanches,
A. M. O. Gomes, A. P. Valente, Y. Cordeiro and J. L. Silva, J. Biol.
Chem., 2010, 285, 2857–2866.
36 T. Koshiba, M. Yao, Y. Kobashigawa, M. Demura, A. Nakagawa,
I. Tanaka, K. Kuwajima and K. Nitta, Biochemistry, 2000, 39(12),
3248–3257.
37 M. F. M. Engel, A. Visser and C. P. M. van Mierlo, Proc. Natl. Acad.
Sci. U. S. A., 2004, 101(31), 11316–11321.
38 C. E.Giacomelli andW.Norde,Macromol. Biosci., 2005, 5(5), 401–407.
39 A. Kondo, S. Oku and K. Higashitani, J. Colloid Interface Sci., 1991,
143(1), 214–221.
40 A. M. Moulin, S. J. O’Shea, R. A. Badley, P. Doyle and
M. E. Welland, Langmuir, 1999, 15(26), 8776–8779.
41 P. Roach, D. Farrar and C. C. Perry, J. Am. Chem. Soc., 2005,
127(22), 8168–8173.
42 S. K. Singh and N. Kishore, J. Phys. Chem. B, 2006, 110(19), 9728–
9737.
43 C. Giancola, C. De Sena, D. Fessas, G. Graziano and G. Barone, Int.
J. Biol. Macromol., 1997, 20(3), 193–204.
44 A. A. Moosavi-Movahedi, A. K. Bordbar, A. A. Taleshi,
H. M. Naderimanesh and P. Ghadam, Int. J. Biochem. Cell Biol.,
1996, 28(9), 991–998.
45 D. Pissuwan, S. M. Valenzuela and M. B. Cortie, Trends Biotechnol.,
2006, 24(2), 62–67.
46 A.-K. Mossberg; M. Puchades; Ø. Halskau; A. Baumann;
I. Lanekoff; Y. Chao; A. Martinez; C. Svanborg; R. Karlsson,
PLoS One5((2)), 2010, e9384.
47 A. V. Agasøster, Ø. Halskau, E. Fuglebakk, N. A. Frøystein,
A. Muga, H. Holmsen and A. Martınez, J. Biol. Chem., 2003, 278,
21790–21797.
48 C. A. Blindauer, I. Harvey, K. E. Bunyan, A. J. Stewart, D. Sleep,
D. J. Harrison, S. Berezenko and P. J. Sadler, J. Biol. Chem., 2009,
284, 23116–23124.
This journal is ª The Royal Society of Chemistry 2011 Nanoscale, 2011, 3, 1788–1797 | 1797
94 Paper I
Paper II 95
Paper II
Immobilization onto gold nanoparticles alters α-lactalbumin
interaction with pure and mixed phospholipid monolayers
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Binding to colloidal structures such as gold nanoparticles (Aunps) is known to affect protein
conformation, potentially altering the function and bioinvasiveness of the biopolymer. As the use of
protein–Aunp constructs is widespread and increasing, an improved understanding of the invasiveness
of nanomaterials is of fundamental interest and crucial for the burgeoning ﬁelds of nanotherapy and
nanotoxicology. Here, we report on the interaction of bovine a-lactalbumin (BLA) modiﬁed 30 nm
Aunps with neutral, negatively charged and mixed neutral : negative phospholipid Langmuir
monolayers at pH 7.4, where little or no interaction has been reported for native BLA. The resulting
equilibria and ﬁlm properties were studied using surface pressure–area isotherms. Interaction of BLA
with Aunps was investigated using UV-vis and ﬂuorescence (steady-state and time-resolved, using
intrinsic and extrinsic probes) spectroscopies. We ﬁnd that upon binding to the Aunps, BLA partially
unfolds, which in turn imparts higher interfacial activity and a stronger afﬁnity towards phospholipid
monolayers compared to the native protein.
Introduction
Understanding protein adsorption in general and protein phos-
pholipid interactions in particular, is important to biomedical1,2
and biochemical1 research to e.g. better understand protein
misfolding diseases,2 drug design based on proteins,3 and better
incorporation of medical implants.4 Although even cytosolic
proteins with a well-deﬁned fold will have some afﬁnity to
surfaces,5 the so-called amphitropic proteins are expected to have
a greater potential for surface binding as their function involves
both being soluble and associated with membranes.6 The func-
tion of amphitropic proteins is regulated by their reversible
binding to the phospholipid bilayer.7 Since their classiﬁcation in
1988,8 there has been an increase in publications on amphitropic
proteins such as cytochrome C9,10 and a-lactalbumin (BLA)1,11–15
and their interaction with phospholipid membranes.16 BLA is
a 14.2 kDa globular calcium-binding protein with isoelectric
point (pI) 4.5, and is a part of the lactose synthase complex that
binds to galactosyltransferase and promotes synthesis of
lactose.17 An oleic acid stabilized conformer of human a-lactal-
bumin (human a-lactalbumin made lethal to tumours,
HAMLET) has been shown to induce apoptosis in immature
cells and cancer cells, while having lesser or no effects on healthy
cells.18 An analogous conformer of bovine a-lactalbumin
(BAMLET) shows a similar effect.13,19 The pharmacological
potential of this phenomenon has been tested with positive
results for bladder cancer, human xenograft glioblastomas in
rats, and for skin papillomas.20–22 While the exact mechanism
behind HAMLET and BAMLET function remains unknown,
and many processes beyond the initial contact with the outer
cellular membrane are seen, one working hypothesis is that the
initial step involves a direct interaction between HAMLET and
the phospholipid membrane.14 HAMLET has been shown to
have a broad and high afﬁnity to phospholipid membranes in
vesicle systems, cell remnants and whole cells, while the native
protein shows much lower tendencies to interact with these
systems at physiological conditions.22 In HAMLET and similar
preparations, oleic acid may be an example of a folding manip-
ulator which alters protein function.23 It is thus possible that
stabilizing alternative folds of BLA can lead to greatly altered
protein characteristics.
In this study, we’re interested in exploring whether a protein–
nanoparticle construct can be prepared so as to enhance the
ability of native BLA to interact with and perturb phospholipid
monolayers. We have recently documented that nanoparticles
change the interfacial properties of bovine serum albumin (BSA)
and induce ﬁlm miscibility.24
BLA binding to a phospholipid membrane is known to depend
on protein–phospholipid charge density matching, calcium
concentration, membrane curvature, pH,25 and phospholipid
composition and degree of acyl chain saturation.6,13 Earlier
Langmuir monolayer and vesicle leakage studies have shown
that BLA interacts signiﬁcantly with negatively and mixed neu-
tral : negative phospholipid membranes close to the pI,13,16,26 but
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at pH 7, only negligible interactions have been reported.25 The
curvature of the phospholipid ﬁlm is important: while negatively
charged Langmuir monolayers and large unilamellar vesicles
(LUV) show no interaction with BLA above pH 6, small uni-
lamellar vesicles (SUV) display BLA-interaction at a wider range
including pH 7.25At pH 7, BLA has a global negative charge, and
the lack of interaction between BLA and negative or neutral :
negative phospholipid ﬁlms has been predominantly attributed
to electrostatic repulsion.25,26 However, it is well known5,24,27–29
that proteins—including BLA—interact strongly with negatively
charged surfaces well above their pI.5 Thus, electrostatic repul-
sion between the phospholipid headgroups and the global
protein charge cannot solely account for the interaction patterns
observed for BLA and phospholipid ﬁlms. In addition to the
phospholipid composition and charge, pH and curvature, the
introduction method, i.e., whether the protein is present in
the system upon spreading of the phospholipid ﬁlm, is of great
importance.6,30
In order to investigate how binding to a ‘‘folding manipulator’’
such as Aunps changes BLA interfacial activity, phospholipid
interaction, selectivity and penetration ability compared to the
native protein, we have investigated the interaction of BLA and
BLA–Aunp constructs with Langmuir phospholipid monolayers
at pH 7.4, where the native protein has been reported to display
little or no interaction. We also investigate how adsorption onto
Aunps changes BLA conformation and subsequently inﬂuences
the surface activity of the resulting Aunp constructs, which
despite the high interest in BLA has not been reported before.
The study presented here includes both BLA and BLA–Aunp
interactions with neutral, negative and mixed 1 : 1 neutral :
negative phospholipid Langmuir monolayers. In this study, we
demonstrate using the Langmuir monolayer method that BLA–
Aunp constructs have higher surface activities and display
a stronger afﬁnity towards phospholipid monolayers compared
to the native protein when injected under pre-compressed
phospholipid ﬁlms. This activity correlates well with extrinsic
ﬂuorescence data and TCSPC measurements of ﬂuorescence
lifetimes that indicate an altered protein fold for adsorbed
protein.
Materials and methods
Materials and solutions
Bovine a-lactalbumin (BLA) type I, L-a-phosphatidylcholine,
type XVI-E approximately 99% purity TLC, lyophilized powder
(EYPC), and 1-anilino-8-naphthalene sulfonate (ANS) were
purchased from Sigma. Porcine brain phosphatidylserine (PBPS)
was purchased from Avanti Polar Lipids. The citrate-coated 30
nm gold nanoparticles (Aunps) were purchased from Ted Pella
and the suspension contains 2  1011 Aunp ml1. Potassium di-
hydrogen phosphate (KH2PO4), potassium chloride (KCl), and
di-potassium hydrogen phosphate (K2HPO4) were purchased
from Merck. The buffer solution (PBS) was made by adding the
potassium di-hydrogen phosphate and potassium chloride solu-
tion (KH2PO4 50 mM, KCl 150 mM) into a di-potassium
hydrogen phosphate and potassium chloride solution (K2HPO4
50 mM, KCl 150 mM) until pH ¼ 7.4. The BLA-stock solution
(25 mM)was made of a-lactalbumin (0.0133 g,0.9 mmol) in PBS
(37.5 ml), then the solutions and suspensions used for ﬂuores-
cence, and UV measurements were made by diluting the BLA-
stock solution to 3.6 mM in PBS pH 7.4. The isoelectric point (pI)
for BLA is 4.5. The concentration of BLA in BLA–Aunp
suspensions is chosen in line with Kaufman et al. who used
a protein : gold number ratio equal to 2000 : 1, for 12.8 nm
Aunps,31 corresponding to a protein : gold molar ratio equal to
11 000 : 1 for the 30 nm Aunp. It should be noted that the
molar ratio does not correspond to the number of proteins
adsorbed per gold nanoparticle, but the sum of adsorbed and free
protein in the system. Taking the total surface area into
consideration, the BLA-concentration should be 3.6 mM for
a suspension containing 50% citrate-coated gold stock-solution.
This is in correspondence with a previous article concerning
bovine serum albumin (BSA).24 The BLA–Aunp suspension was
made by adding BLA (25 mM, 432 ml) to 30 nm Aunp suspension
(1.5 ml). After one hour the solution was diluted with PBS pH 7.4
(1.068 ml). This gave a ﬁnal BLA concentration of 3.6 mM.
For extrinsic ﬂuorescence ANS (10 ml, 5 mM) was added to
a BLA-solution (3 ml, 3.6 mM) and to BLA–Aunp suspensions
(3 ml), so that the ﬁnal ANS concentration was 17 mM. ANS is
a commonly used extrinsic-ﬂuorescence probe for studying
proteins.32–34
For the Langmuir experiments the BLA-stock solution was
diluted to 12.5 mM in PBS before injection. The BLA–Aunp
suspension for the Langmuir experiments was made by mixing 30
nm Aunp (7.5 ml) with BLA solution (25 mM, 7.5 ml). Three
phospholipid in chloroform solutions were used: EYPC (0.25 mg
ml1), PBPS (0.25 mg ml1) and a 1 : 1 EYPC : PBPS solution
made by mixing the EYPC solution (0.25 mg ml1, 1.5 ml), with
PBPS solution (0.25 mg ml1, 1.5 ml). Molecular weight for
EYPC is 760.9 g mol1, and for PBPS it is 812.05 g mol1.
UV-visible spectroscopy
A Shimadzu UV-2401PC spectrophotometer was used to collect
the UV-vis spectra. The wavelength range was 200–800 nm.
Dynamic light scattering (DLS)
The DLS was measured using a Malvern Zetasizer Nano-ZS
instrument, and the manufacturers own software.
Fluorescence
The ﬂuorescence measurements were executed on a Fluorolog-3
HORIBA Jobin Yvon apparatus. For intrinsic ﬂuorescence
steady-state measurements the slits were 10 nm, and a polarizator
was used. The excitation wavelength was l¼ 295 nm. The choice
of wavelength was such that mainly tryptophan was excited and
contribution from tyrosine and phenylalanine avoided.35 It was
observed that if ﬂuorescence was measured on the same sample
more than once, the intensity increased. This is probably due to
protein denaturation, and then aggregation induced by the
strong light.36 The aggregation will lead to Trp being buried in
a more hydrophobic environment, hence increasing the intensity.
For extrinsic ﬂuorescence on ANS the excitation wavelength was
lex ¼ 370 nm, slits 5 nm, and the measurements were done
without the polarizator. The excitation wavelength lex ¼ 370 nm
11502 | Soft Matter, 2011, 7, 11501–11509 This journal is ª The Royal Society of Chemistry 2011
98 Paper II
was chosen based on earlier studies of ANS as the ﬂuorescence
probe for proteins.24,33
For intrinsic lifetime studies time correlated single photon
counting (TCSPC) was performed using a 280 nm LED lamp,
the bandpass was 5 nm, the prompt was recorded with the
emission monochromator (Em. mono) ¼ 280 nm, and the
samples using Em. mono ¼ 350 nm. For extrinsic ﬂuorescence
a LED-lamp with lex ¼ 370 nm was used, and the bandpass was
14 nm. As the prompt was recorded the Em. mono was 370 nm,
and for the samples the Em. mono was 470 nm. More details
about the TCSPC technique can be found elsewhere.28,37
Langmuir isotherms
For the surface pressure–area measurements a KSV Langmuir
Minitrough double barrier system (KSV LTD, Finland)
controlled through the manufacturer’s own software was used.
While the barriers were made of Delrin, the trough (250 ml) was
made of Teﬂon. The Injected protocol for investigating protein–
phospholipid interactions was adopted from Glomm et al.24,30
The subphase used was a PBS buffer pH 7.4. Prior to the
introduction of the phospholipid ﬁlm the surface was swept with
a vacuum pump-connected Pasteur pipette. Three different
phospholipid solutions (60 ml, 0.25 mg ml1) were used (see
above). Initial compression to 5 mN m1 with a constant barrier
speed of 5 mm min1 started 15 minutes after the ﬁlm was spread
with a 100 ml Hamilton syringe. BLA or BLA–Aunp suspensions
(12.5 mM protein, 1 ml) were injected directly under the pre-
compressed phospholipid ﬁlm from outside the barriers using an
angled syringe needle. At constant trough area the system was
then allowed to equilibriate for one hour before compression
started. During the measurements an electrobalance recorded
the surface tension using a paper probe. For both BLA and
BLA–Aunp, the experiments without phospholipid being present
were also performed. The barriers were then moved to a position
10 mm from complete expansion, and the sample was introduced
as described above under the air/water surface. Equilibration
and compression were done as if phospholipid was present.
Stability for the ﬁlms was measured by spreading the phospho-
lipid (60 ml, 0.25 mg ml1) on the surface, waiting 15 minutes
before compressing the phospholipid ﬁlm to 25 mNm1 and then
recording what changes in trough area occurred for the next two
hours.
Results and discussion
This section includes the characterization of BLA on citrate-
coated gold nanoparticles using UV-vis and ﬂuorescence spec-
troscopies, and the subsequent unfolding additionally studied
with ANS as an extrinsic ﬂuorescence probe. Film-forming
properties of pure systems, i.e., phospholipid Langmuir mono-
layers and Gibbs monolayers of protein and protein–Aunp
constructs are then described using the Langmuir monolayer
method. Finally, the interaction between native BLA and pure
and mixed phospholipid monolayers is then compared with
BLA–Aunp–phospholipid interactions using the Injected
method,30 wherein the protein or protein–Aunp constructs are
injected into the subphase under a phospholipid ﬁlm pre-
compressed to a target surface pressure.
Characterization of BLA–Aunp constructs
In assembling protein–nanoparticle constructs, the ﬁnal prop-
erties of the system depend on (i) whether the protein binds to the
nanoparticle scaffolds, (ii) the extent of surface-induced
conformational changes, (iii) average protein orientation, and
(iv) the ﬂocculation state of the protein–nanoparticle constructs
(i.e., single particles versus ﬂocs).38,39
UV-vis spectra showed that introduction of BLA to the gold
nanoparticle (Aunp) solution did not signiﬁcantly alter the
lineshape of the gold nanoparticle localized surface plasmon
resonance (LSPR) band with respect to absorption intensity and
full-width at half maximum (FWHM), but resulted in a slight
red-shift of the LSPR band (1 nm), which is in agreement with
earlier studies.24 From dynamic light scattering measurements of
the Aunps before and after introduction of BLA, the estimated
particle diameter increased by 2 nm. This reveals that BLA is
adsorbed onto the Aunps, and that the BLA–Aunps reside as
single particles.24,27,28 In an earlier study, we have investigated the
binding of bovine serum albumin (BSA) to citrate-coated Aunps
and surfaces.27 Here, the data were found to support that BSA
binding was predominantly electrostatic in nature, but with
contributions from hydrophobic interactions. Thus our
hypothesis is that BLA binding to Aunps is primarily electro-
static. Since UV-vis and dynamic light scattering indicate
binding, but do not reveal much about adsorption induced
conformational changes, the BLA–Aunp constructs were further
investigated by steady-state ﬂuorescence (Fig. 1) using both the
intrinsic (Trp) and extrinsic (ANS) ﬂuorescence.
As the protein is present in excess with respect to maximum
surface coverage, the ﬂuorescence shown in Fig. 1 emanates both
from free and bound protein. However, as the BLA concentra-
tion was kept constant, alterations to the spectral signatures of
both Trp and ANS can be attributed to adsorbed protein.24
Intensity and position of the Trp emission peak depend on the
local environment35 and changes in ﬂuorescence spectra indicate
a combination of conformational changes and steric blockage as
some of the Trp groups can be turned towards the gold surface.
Fig. 1a reveals a loss in intrinsic ﬂuorescence for BLA–Aunp
constructs compared to native BLA. This trend is the same as
seen for BSA–Aunp constructs studied previously.24 Two factors
gives rise to this loss. One reason is that as BLA adsorbs onto
Aunps, the gold nanoparticles will quench some of the
Fig. 1 (a) Intrinsic steady state measurements of BLA and BLA–Aunp,
lex¼ 295 nm. (b) Extrinsic steady state measurements of BLA and BLA–
Aunp using ANS as probe, lex ¼ 370 nm.
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ﬂuorescence from Trp.40Moreover, as BLA–Aunp constructs are
formed BLA can partially unfold, as was observed for the
adsorption of BSA onto Aunps of similar size.24 This unfolding
might expose Trp to a more hydrophilic environment and
decrease the intensity.35 Unfolding is traditionally accompanied
by a red-shift of the Trp signature when the protein is in free-
space conditions.35 No spectral shifts were observed for the
BLA–Aunp constructs. However, for the systems studied here,
two factors counteract this effect: (i) The collected signal
contains contributions from free and bound protein, and thus
a spectral shift from (quenched) adsorbed species will likely be
drowned by signals from bulk species. (ii) Adsorbed proteins will
most likely reside in a more or less close-packed state. Hence, the
protein is enclosed by surrounding proteins as well as in contact
with the nanoparticle scaffold, leaving only one protein face
exposed to the solvent. Thus, intrinsic ﬂuorescence conﬁrms
adsorption (as reported previously for BSA), but does not
elucidate changes in the adsorbed layer.24
To gain more information about conformational changes,
extrinsic (ANS) ﬂuorescence was measured (Fig. 1b). ANS is
highly ﬂuorescent in a hydrophobic environment, but has a very
low quantum yield in water and is often used as an extrinsic
probe in protein studies.32–34,41–43 ANS is also quite soluble in
water and will stay close to a polar environment. Exposure to
a less polar environment such as hydrophobic patches on
a protein results in an increased quantum yield of the probe, as
well as a shift of the emission proﬁle. Upon protein unfolding,
the intensity will decrease as ANS will be released from the
hydrophobic interior of the protein into the surrounding buffer
which quenches the signal.35 As seen in Fig. 1b the emission
intensity of ANS is lower for the BLA–Aunp constructs than
with native BLA. Solutions of ANS in buffer, or ANS in aqueous
Aunp suspensions showed negligible ﬂuorescence (data not
shown), which is in accordance with an earlier report.24 In Fig. 1b
there is also a change in lineshape of the emission spectra. The
loss of intensity can be explained by quenching of ANS as it
becomes exposed to water when BLA partially unfolds at the
gold surface. The change in lineshape is best explained by partial
energy transfer between the ANS donor and the Aunp acceptor,
as the LSPR of 30 nm Aunp falls within the spectral range of
ANS emission.35,37
TCSPC (time correlated single photon counting) was used as
a ﬂuorescence lifetime measuring technique to further investigate
the properties of the protein adlayer. The data were best modeled
using biphasic decay, and the calculated lifetimes are shown in
Table 1. In this context, biphasic decay can be interpreted as the
relaxation from the excited states corresponding to two sets of
populations with distinctive relaxation dynamics, representing
two different chemical environments.24,28,37
Since a 280 nm LED was used for the intrinsic measurements,
not only tryptophan but also other ﬂuorescent amino acid resi-
dues such as tyrosine, contributed to the observed lifetimes.
TCSPC for both intrinsic and extrinsic ﬂuorescence shows one
short (T1) and one long (T2) lifetime, and for both methods the
short lifetime has the highest associated population (B1). Here,
the calculated lifetimes are inversely proportional to the degree
of quenching. For the intrinsic ﬂuorescence the lifetimes remain
unchanged within their respective conﬁdence intervals, but there
are signiﬁcant changes in the associated populations upon
introduction of Aunps. For the short lifetime (T1) there is
a decrease in the associated population (B1), whereas adsorption
onto Aunps results in a corresponding population increase for
the long lifetime (B2) from 8.5% to 18.7%. This indicates that
upon binding to Aunps, Trp and Tyr residues on BLA are pro-
tected from the solvent compared to free-space conditions, which
is consistent with close-packing of the proteins on the Aunp
surface. Also for the extrinsic ﬂuorescence there is no signiﬁcant
change in T1, but in contrast to intrinsic ﬂuorescence B1
increases upon BLA–Aunp formation. The long lifetime and its
population also differ from those of the intrinsic ﬂuorescence.
For the extrinsic ﬂuorescence T2 increases when BLA-Aunps are
formed, and B2 decreases.
The short lifetime population (B1) is highest for intrinsic and
ANS ﬂuorescence. As BLA is a small protein (14.2 kDa) with two
of four Trps exposed to the solvent, its intrinsic ﬂuorescence is
efﬁciently quenched. For the BLA–Aunp constructs, the long
lifetime population (B2) for intrinsic ﬂuorescence increased due
to displacement of water as the protein adsorbs to the Aunp,
shielding the ﬂuorophores from the solvent. The extrinsic ﬂuo-
rescence population associated with the short lifetime, B1, is
higher for BLA–Aunp constructs since ANS is partitioned out
from the hydrophobic interior of the protein and into more
hydrophilic surroundings. For the ANS still trapped in the
protein in the BLA–Aunp constructs, the T2 increases from 7.5
ns to 8.8 ns because the water expulsion ensures a more hydro-
phobic environment for the remaining ANS. These techniques let
us describe a rough picture of the protein conformation, packing
and environment close to the Aunp surface. Relative to the
native protein at bulk conditions, there exists a larger volume
fraction which is protected from solvent quenchers. The results
obtained here are consistent with surface-induced conforma-
tional changes, as has been reported earlier.5,24 Based on the
intrinsic ﬂuorescence quenching behaviour, i.e., from the
increase in the long lifetime population upon binding to Aunps,
the adsorbed proteins appear to be densely packed, leaving the
overall properties of the BLA–Aunp constructs dependent on the
exposed side of the protein and the degree of unfolding relative to
the native state.
Gibbs- and Langmuir monolayer studies of protein and
phospholipids
As the ﬂuorescence results indicate partial unfolding of the
surface bound BLA, as well as a high degree of Aunp coverage,
this is expected to result in altered surface activity and phos-
pholipid afﬁnity relative to the native protein. To explore this
Table 1 TCSPC of intrinsic emission was measured with LED 280 nm,
and extrinsic emission was measured with LED 370 nm. T1 and T2
denote lifetimes, and B1 and B2 are the corresponding populations
Intrinsic Extrinsic
BLA BLA–Aunp BLA BLA–Aunp
T1 (ns) 0.86  0.01 0.85  0.04 0.37  0.01 0.35  0.01
T2 (ns) 5.0  0.2 4.6  0.3 7.5  0.2 8.8  0.3
B1 (%) 91.5  0.1 81.3  0.1 86.1  0.1 91.8  0.1
B2 (%) 8.5  0.1 18.7  0.1 13.9  0.1 8.2  0.1
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aspect of the BLA–Aunp construct, we studied its ﬁlm-forming
properties relative to the native protein, as well as the Langmuir
monolayer properties of the zwitterionic and anionic phospho-
lipids employed in the subsequent phospholipid protein inter-
action studies. For all experiments the Injected protocol
described by Glomm et al.30 was used, thus ensuring that the
solute interacted with an already formed monolayer, rather than
from partitioning at the air–water interface due to the inherent
surface activity of the protein or protein–Aunp constructs.
Interactions were studied towards three sets of phospholipid
ﬁlms: EYPC (L-a-phosphatidylcholine), PBPS (porcine brain
phosphatidylserine) and EYPC : PBPS 1 : 1 molar ratio. As
a reference, Langmuir monolayers of phospholipids only were
studied. The isotherms for these systems, as well as the Gibbs
monolayers of the BLA and BLA–Aunp constructs, are found in
Fig. 2a.
The compression–expansion proﬁles of EYPC, PBPS and
EYPC : PBPS (Fig. 2a) are all similar, with rapid increase in
surface pressure and a narrow hysteresis. The shape of the
phospholipid isotherms and the steep incline after onset of ﬁlm
formation, show that the ﬁlms are rigid. Stability studies, where
the phospholipid was precompressed to 25 mN m1, showed that
all three water insoluble phospholipid ﬁlms were stable during
the timescale of the experiments. The ﬁlm miscibility of the
EYPC : PBPS phospholipid ﬁlm was studied using the excess
function DAXS.
DAXS ¼ A12  (c1A1 + c2A2) (1)
where DAXS is the excess function, A12 is the mean molecular
area (MMA) occupied by the mixed ﬁlm at a given surface
pressure, c1 and c2 are the mole fractions of phospholipid one
and two respectively, and A1 and A2 are the MMA occupied by
pure phospholipid one and two at the same surface pressure as
A12. If DAXS < 0, then there is attraction between the phospho-
lipids, and if DAXS > 0, then there is repulsion between the
phospholipids.44 The DAXS are shown in Fig. 3.
DAXS is positive all through the compression conﬁrming
repulsion between the phospholipids in the mixture. As the
trough area decreases EYPC and PBPS are forced closer
together, resulting in an increased repulsion as illustrated by the
increasing DAXS.
In addition to pure phospholipid systems unmodiﬁed Aunps,
native BLA and BLA–Aunp interactions towards a water–air
surface were studied as well. Unmodiﬁed Aunps precipitated out
of solution under these conditions and so did not contribute to
the recorded surface pressure. However the pure native BLA and
BLA–Aunp systems are found in Fig. 2a together with
phospholipid systems, and the equilibration curves, i.e., the time-
dependent surface pressure following the injection under an
air–water surface for BLA and BLA–Aunp, are represented in
Fig. 2b. From Fig. 2b it is evident that the equilibrium curve for
BLA–Aunp increases more rapidly initially than for native BLA,
but they both end up at approximately the same surface pressure
(8 mN m1). For the BLA–Aunp experiment there will be
contributions from free BLA as well as from the BLA–Aunp
constructs. It is likely that the rapid increase in the beginning is
due to bound BLA, and that the end surface pressure is similar in
both experiments because the total amount of BLA is the same in
both. For the pure system with protein, the small slope in surface
pressure as the trough area decreases, indicates that BLA was
dissolved in the subphase. In Fig. 2a, no collapse pressure can be
observed for the Gibbs ﬁlms of protein or protein–gold
constructs due to their inherent solubility in the subphase.30 For
native BLA the lower surface pressure (P) upon expansion can
be attributed to loss of ﬁlm-forming material from solubilization
of BLA into the subphase at low trough areas.24,30 All the Gibbs-
and Langmuir monolayer studies show a higher surface pressure
for BLA–Aunp constructs than for native BLA, indicating
a higher surface activity. This effect can be attributed to exposure
of more hydrophobic groups, and to the constructs being less
water soluble. The result is also in agreement with the ﬂuores-
cence data that implied a partial protein unfolding. While
Fig. 2 (a) Compression and expansion isotherms in the absence of phospholipid–protein interactions(P¼ surface pressure). (b) Equilibrium for native
protein, and for protein on gold the ﬁrst hour after injection under an air/water surface.
Fig. 3 Calculated excess area (DAXS) as a function of the surface pres-
sure (P) for phospholipid monolayers.
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unmodiﬁed Aunp precipitated under these conditions, we have
previously shown that citrate-coated Aunps do not possess any
measurable surface activity in the absence of a passivating
protein layer.24 The protein–gold constructs possess qualities not
seen for either of the components alone.
Langmuir monolayer interaction studies—BLA–Aunp constructs
interact more with phospholipid monolayers than native protein
does
Earlier studies have shown that BLA interaction with a phos-
pholipid ﬁlm is optimal at a neutral:charged phospholipid ratio
of 1 : 1, as compared to phospholipid ﬁlms consisting of only one
type of phospholipid or in other ratios.13 This theory can also be
enhanced by the excess area studies (Fig. 3), which showed that
there is repulsion between the individual phospholipid molecules
in the monolayers. Some differences (but far from all) in the
results presented here compared to earlier studies can be attrib-
uted to different protein introduction methods being used. The
most common protein introduction method for Langmuir
monolayer studies of protein–phospholipid interactions is the so-
called Subphase method, in which the phospholipid is spread on
top of a protein-containing subphase.13,30 Due to the intrinsic
surface activity of any protein, which is high for the only
marginally stable amphitropic BLA,6 the Subphase introduction
method results in mixed protein–phospholipid ﬁlms. Thus, by
using this introduction protocol, the surface pressure–area
isotherms inherently display contributions from lateral protein–
phospholipid interactions as well as from bulk proteins inter-
acting with the phospholipid ﬁlm. Moreover, as the protein is
introduced prior to 2D organization (via lateral compression) of
the phospholipid ﬁlm, the obtained results are not easily
comparable to those obtained via vesicle leakage studies, wherein
the protein is introduced to organized phospholipid structures at
lateral pressures comparable to those of living cells. An alter-
native introduction method more in line with vesicle studies is the
so-called Injected method, wherein the protein is injected under
a pre-compressed (to a target surface pressure) phospholipid
ﬁlm, and the resulting protein–phospholipid interaction is
recorded as a function of time prior to further ﬁlm compression
and expansion.30 Here, interactions between the phospholipid
monolayer and subphase protein can be elucidated with respect
to kinetics, afﬁnity and packing density, and from the concom-
itant compression–expansion isotherms the interaction mode of
the protein (i.e., via insertion or interaction with headgroups) can
be rationalized.
We have used the Injected protocol, while the previous study
by Rødland et al. was done with the Subphase protocol.13,30 In
our study both BLA and BLA–Aunp constructs interact with all
three monolayer ﬁlms, without revealing any clear phospholipid
selectivity. However, there are signiﬁcant differences when
comparing native BLA interactions with phospholipid ﬁlms, and
those for BLA–Aunp constructs (Fig. 4).
Fig. 4 shows the equilibration of BLA (Fig. 4a) and BLA–
Aunp (Fig. 4b) injected under phospholipid ﬁlms precompressed
to 5 mN m1. Upon injection of BLA and BLA–Aunp, there is
a marked increase in surface pressure for all the phospholipid
monolayers studied here, indicating interaction between the
phospholipid ﬁlm and the injected species. All systems studied
here display a single saturation plateau, indicating that the
protein–phospholipid interaction occurs in a single step, with the
BLA–Aunp constructs reaching higher surface pressure at
equilibrium (2–3 mNm1 higher). From Fig. 4, the initial rates of
surface pressure increase are higher for the BLA–Aunp
constructs (Fig. 4b) than for BLA only (Fig. 4a), which is
consistent with enhanced hydrophobic interaction from partial
exposure of hydrophobic residues in the adsorbed protein. No
discernible differences in interaction with the injected species
could be observed for the pure and mixed phospholipid mono-
layers used here. Moreover, the ﬁrst data points for the rate of
migration of BLA–Aunp constructs towards the phospholipid
monolayers occur faster than the instrument response, as evi-
denced by the 2 mN m1 discontinuity in time dependent
surface pressure with respect to the injection pressure of 5 mN
m1. This discontinuity in surface pressure is not seen for BLA
only. This reveals that surface partitioning of BLA is slower than
for the BLA–Aunp constructs. This corresponds well with the
equilibration curves of BLA and BLA–Aunp towards an air–
water surface (Fig. 2) which revealed a higher rate of interfacial
partitioning for the BLA–Aunp constructs. Interestingly, while
there was no signiﬁcant difference in surface pressure at satura-
tion between BLA and BLA–Aunp constructs when injected
under an air–water surface, the BLA–Aunp constructs display
a higher afﬁnity for the phospholipid monolayers than BLA
only. Also, the equilibration of BLA–Aunp towards phospho-
lipid monolayers occurs faster than towards an air–water
surface. Thus, the increased surface migration rates and the
higher saturation plateaus in the presence of a phospholipid
monolayer reveal an enhanced phospholipid afﬁnity for the
BLA–Aunp constructs. Recently, Lystvet et al. have shown that
protein–Aunp constructs display enhanced ﬁlm-penetration
ability compared to the native protein due to partial unfolding on
the Aunp surface.24 From our observations and previous studies
on the interaction between protein–Aunp constructs and phos-
pholipid monolayers, we hypothesize that the BLA–Aunp
constructs most likely reside partially embedded in the phos-
pholipid monolayer.
Compression–expansion isotherms for native BLA and BLA–
Aunp constructs injected under the three different phospholipid
monolayer systems studied here are shown in Fig. 5. As discussed
for the equilibrium curves above (Fig. 4), no discernible differ-
ences could be observed for interaction with different phospho-
lipid monolayers, whereas marked differences were found
between BLA and BLA–Aunp. In Table 2 the difference in slope
is investigated further.
Within each set of experiments (Fig. 5) there seems to be little
difference in interaction when comparing the different phos-
pholipid monolayers even though earlier studies have shown that
a 1 : 1 mixture gives the highest interaction.13 This difference
between previous studies and our study is most likely due to the
introduction protocols. The overall P–A isotherms for BLA–
Aunp (Fig. 5b) closely resemble those of the parent protein
(Fig. 5a), but at low trough areas there seems to be a smaller
slope for the P–A isotherms of BLA–Aunp (Fig. 5d) than for
BLA (Fig. 5c). This is also seen from Table 2, where the slope
found with linear regression is smaller for experiments with
BLA–Aunp than with native BLA. A steep slope indicates a rigid
ﬁlm of water-insoluble species, while a small slope is achieved for
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a more compressible ﬁlm or with water soluble species. It seems
like BLA–Aunp has a greater afﬁnity for, and penetrates more
into, the phospholipid ﬁlm than does BLA only, thereby making
the ﬁlms more compressible. This ﬁts well with the equilibrium
experiments (Fig. 4) which showed that BLA–Aunp has a greater
afﬁnity towards the phospholipid ﬁlms, and also with the
previous ﬁndings for BSA.24 Some of the effect may be increased
by the fact that BLA–Aunp also shows a greater air–water
surface afﬁnity (Fig. 2) and that there is some free spacing
between the phospholipids. The BSA study also showed that the
air–water surface population of the immobilized protein
increased when gold was present, and that larger gold nano-
particles gave a larger surface population of protein. The fact
that adsorption enhances ﬁlm-penetration may be of value
within studies of i.e. drug delivery systems, and also for a better
understanding of protein based drug candidates where folding
seems to matter, like human a-lactalbumin made lethal to tumor
cells (HAMLET). One possible hurdle to further clinical devel-
opment of HAMLET or similar preparations may be their
tendency to lose potency in many clinical situations, probably
due to loss of oleic acid to scavenger proteins such as serum
albumin.45 This would have the effect of both reverting the
protein to its native state and separating the components of
HAMLET, both of which appear to be necessary for activity.23
Adsorption onto nanoparticles may serve a double purpose in
that it stabilizes the non-native fold and provides a protected
environment for the construct as a whole. A more general
consequence of the enhanced membrane-affecting qualities
reported here and in Lystvet et al.,24 is that although a nano-
particle can be inert and the protein-component non-toxic, the
resulting construct may behave as neither component. In
particular, their tendency to be taken up into living systems
depend to a large extent on the surface activity of the
constructs.46 The mechanism of uptake depends on both the
cellular system and the polypeptide coating of the particle.29,47,48
It is possible to tune49 the overall fold and packing of proteins on
a nanoparticle surface, thus ensuring low surface activity for
non-drug applications and high surface activity for medical
applications which require this. Such a tuning can be done by
choice of solution conditions, nanoparticle surface chemistry,
particle curvature50 and by altering the rate of deposition.5
Fig. 4 (a) Equilibration of BLA injected under pure and mixed (1 : 1 molar ratio) phospholipid monolayers (compressed to 5 mN m1). (b) Equili-
bration of BLA–Aunp injected under phospholipid monolayers used here.
Fig. 5 (a) Isotherms of native BLA injected under various phospholipid
ﬁlms. (b) Isotherms of BLA–Aunp injected under various phospholipid
ﬁlms. (c) Magniﬁcation of the compression for native BLA injected under
various phospholipid ﬁlms. (d) Magniﬁcation of the compression for
BLA–Aunp injected under various phospholipid ﬁlms. (c) and (d) are
shown with trend lines.
Table 2 Calculated slopes for compression of phospholipid ﬁlms with either native BLA or BLA–Aunp constructs injected underneath. 1, 2 and 3 stand
for the different sections in Fig. 5c and d, numbering from right to left
EYPC PBPS EYPC : PBPS
1 2 3 1 2 3 1 2 3
Native BLA 0.317 0.278 N/A 0.289 0.185 N/A 0.303 0.185 N/A
BLA–Aunp 0.275 0.151 N/A 0.281 0.165 0.319 0.283 0.158 0.239
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Conceivably, the protein conformation can be continuously
tuned from native-like to fully denatured, although this depends
on the particular folding properties of the protein.51 Proteins
adsorbed to the nanoparticle surface would, on average, have
some parts exposed more than others due to their preferential
orientation.5
Conclusion
The adsorption of BLA onto Aunps, and subsequently the
interaction of BLA and BLA–Aunp constructs with Langmuir
monolayers of neutral, negatively charged and mixed neutral :
negative phospholipids have been studied. Adsorption of BLA
onto Aunps was conﬁrmed by UV-vis and steady-state ﬂuores-
cence measurements. Steady-state and TCSPC measurements,
using both intrinsic and extrinsic ﬂuorescence probes, strongly
indicated that adsorption induced partial unfolding of BLA, in
line with earlier studies.24
Both BLA–Aunp constructs and native BLA were shown to be
strongly ﬁlm-forming, with the BLA–Aunp constructs being the
most surface active species. We attribute this to partial unfolding
of BLA adsorbed onto Aunps, exposing hydrophobic residues
thus enhancing hydrophobic interactions. When injected under
precompressed Langmuir monolayers of the phospholipids
studied here, both BLA and BLA–Aunp constructs revealed
protein–phospholipid interaction, with the BLA–Aunp
constructs displaying the highest afﬁnity for the phospholipid
ﬁlms. This increased bioinvasiveness of protein–gold nano-
constructs is potentially applicable within protein based drugs
and drug delivery, as well as of fundamental interest within
nanotoxicology.
Acknowledgements
The authors acknowledge the Department of Chemical Engi-
neering, NTNU, for ﬁnancial support. Wilhelm R. Glomm and
Sondre Volden acknowledge ﬁnancial support from the Research
Council of Norway (NFR).
References
1 Ø. Halskau, N. A. Frøystein, A. Muga and A.Martınez, J. Mol. Biol.,
2002, 321(1), 99–110.
2 J. Fantini and N. Yahi, Expert Rev. Mol. Med., 2010, 12, e27.
3 C. Pan, L. Cai, H. Lu, L. Lu and S. Jiang, J. Biol. Chem., 2011, 286,
28425.
4 B. Kasemo, Surf. Sci., 2002, 500(1–3), 656–677.
5 W. R. Glomm, Ø. Halskau, A. M. D. Hanneseth and S. Volden, J.
Phys. Chem. B, 2007, 111(51), 14329–14345.
6 Ø. Halskau, A. Muga and A. Martınez, Curr. Protein Pept. Sci., 2009,
10, 339–359.
7 J. E. Johnson and R. B. Cornell, Mol. Membr. Biol., 1999, 16, 217–
235.
8 P. Burn, Trends Biochem. Sci., 1988, 13(3), 79–83.
9 T. Heimburg, P. Hildebrandt and D. Marsh, Biochemistry, 1991, 30,
9084–9089.
10 I. Bertini, P. Turano, P. R. Vasos, A. Bondon, S. Chevance and
G. Simonneaux, J. Mol. Biol., 2004, 336(2), 489–496.
11 S. Ba~nuelos and A. Muga, J. Biol. Chem., 1995, 270(50), 29910–
29915.
12 S. Ba~nuelos and A. Muga, Biochemistry, 1996, 35(13), 3892–3898.
13 I. Rødland, Ø. Halskau, A. Martınez and H. Holmsen, Biochim.
Biophys. Acta, Biomembr., 2005, 1717(1), 11–20.
14 A. V. Agasøster, Ø. Halskau, E. Fuglebakk, N. A. Frøystein,
A. Muga, H. Holmsen and A. Martınez, J. Biol. Chem., 2003, 278,
21790–21797.
15 Ø. Halskau, J. Underhaug, N. A. Frøystein and A. Martınez, J. Mol.
Biol., 2005, 349(5), 1072–1086.
16 W. R. Glomm, S. Volden,M.-H. G. Ese and Ø. Halskau, J. Dispersion
Sci. Technol., 2011, 32(2), 150–158.
17 E. A. Permyakov and L. J. Berliner, FEBS Lett., 2000, 473(3), 269–
274.
18 M. Svensson, H. Sabharwal, A. Hakansson, A.-K. Mossberg,
P. Lipniunas, H. Lefﬂer, C. Svanborg and S. Linse, J. Biol. Chem.,
1999, 274(10), 6388–6396.
19 M. Svensson, J. Fast, A.-K. Mossberg, C. D€uringer, L. Gustafsson,
O. Hallgren, C. L. Brooks, L. Berliner, S. Linse and C. Svanborg,
Protein Sci., 2003, 12(12), 2794–2804.
20 W. Fischer, L. Gustafsson, A.-K. Mossberg, J. Gronli, S. Mork,
R. Bjerkvig and C. Svanborg, Cancer Res., 2004, 64(6), 2105–2112.
21 L. Gustafsson, I. Leijonhufvud, A. Aronsson, A.-K. Mossberg and
C. Svanborg, N. Engl. J. Med., 2004, 350(26), 2663–2672.
22 A.-K. Mossberg, M. Puchades, Ø. Halskau, A. Baumann,
I. Lanekoff, Y. Chao, A. Martinez, C. Svanborg and R. Karlsson,
PLoS One, 2010, 5(2), e9384.
23 A.-K. Mossberg, K. Hun Mok, L. A. Morozova-Roche and
C. Svanborg, FEBS J., 2010, 277(22), 4614–4625.
24 S. M. Lystvet, S. Volden, M. Yasuda, Ø. Halskau, Jr and
W. R. Glomm, Nanoscale, 2011, 3(4), 1788–1797.
25 A. Chenal, G. Vernier, P. Savarin, N. A. Bushmarina, A. Geze,
F.Guillain,D.Gillet andV. Forge, J.Mol. Biol., 2005, 349(4), 890–905.
26 D. G. Cornell, D. L. Patterson and N. Hoban, J. Colloid Interface
Sci., 1990, 140(2), 428–435.
27 S. H. Brewer, W. R. Glomm, M. C. Johnson, M. K. Knag and
S. Franzen, Langmuir, 2005, 21, 9303–9307.
28 H. Xie, A. G. Tkachenko, W. R. Glomm, J. A. Ryan,
M. K. Brennaman, J. M. Papanikolas, S. Franzen and
D. L. Feldheim, Anal. Chem., 2003, 75(21), 5797–5805.
29 A. G. Tkachenko, H. Xie, D. Coleman, W. Glomm, J. Ryan,
M. F. Anderson, S. Franzen and D. L. Feldheim, J. Am. Chem.
Soc., 2003, 125(16), 4700–4701.
30 W. R. Glomm, S. Volden, Ø. Halskau, Jr and M. H. G. Ese, Anal.
Chem., 2009, 81(8), 3042–3050.
31 E. D. Kaufman, J. Belyea, M. C. Johnson, Z. M. Nicholson,
J. L. Ricks, P. K. Shah, M. Bayless, T. Petterson, Z. Feldt€o,
E. Blomberg, P. Claesson and S. Franzen, Langmuir, 2007, 23,
6053–6062.
32 M. J. Tiera, G. R. d. Santos, V. A. d. O. Tiera, N. A. B. Vieira,
E. Frolini, R. C. d. Silva and W. Loh, Colloid Polym. Sci., 2005,
283, 662–670.
33 E. Gabellieri and G. B. Strambini, Biophys. J., 2006, 90, 3239–3245.
34 G. V. Semisotnov, N. A. Rodionova, O. I. Razgulyaev,
V. N. Uversky, A. F. Gripas’ and R. I. Gilmanshin, Biopolymers,
1991, 31(1), 119–128.
35 J. R. Lakowicz, Principles of Fluorescence Spectroscopy, Springer,
New York, 2006.
36 M. Correia,M. T. Neves-Petersen, A. Parracino, A. K. di Gennaro and
S. B. Petersen, J. Fluoresc., 2011, DOI: 10.1007/s10895-011-0963-7.
37 W. R. Glomm, S. J. Moses, M. K. Brennaman, J. M. Papanikolas and
S. Franzen, J. Phys. Chem. B, 2005, 109(2), 804–810.
38 T. Cedervall, I. Lynch, S. Lindman, T. Berggard, E. Thulin,
H. Nilsson, K. A. Dawson and S. Linse, Proc. Natl. Acad. Sci.
U. S. A., 2007, 104(7), 2050–2055.
39 S. Lindman, I. Lynch, E. Thulin, H. Nilsson, K. A. Dawson and
S. Linse, Nano Lett., 2007, 7(4), 914–920.
40 T. Sen, K. K. Haldar and A. Patra, J. Phys. Chem. C, 2008, 112,
17945–17951.
41 D. Togashi, A. Ryder and D. O’Shaughnessy, J. Fluoresc., 2010, 20
(2), 441–452.
42 D. Togashi and A. Ryder, J. Fluoresc., 2008, 18(2), 519–526.
43 D.M.Togashi andA.G.Ryder,Exp.Mol.Pathol., 2007,82(2), 135–141.
44 K. S. Birdi, Lipid and Biopolymer Monolayers at Liquid Interfaces,
Plenum Press, New York, 1989.
45 S. B. Nielsen, K. Wilhelm, B. Vad, J. Schleucher, L. A. Morozova-
Roche and D. Otzen, J. Mol. Biol., 2010, 398(2), 351–361.
46 A. Kunzmann, B. Andersson, T. Thurnherr, H. Krug, A. Scheynius
and B. Fadeel, Biochim. Biophys. Acta, Gen. Subj., 2011, 1810(3),
361–373.
11508 | Soft Matter, 2011, 7, 11501–11509 This journal is ª The Royal Society of Chemistry 2011
104 Paper II
47 A. G. Tkachenko, H. Xie, Y. Liu, D. Coleman, J. Ryan,
W. R. Glomm, M. K. Shipton, S. Franzen and D. L. Feldheim,
Bioconjugate Chem., 2004, 15(3), 482–490.
48 J. A. Ryan, K. W. Overton, M. E. Speight, C. N. Oldenburg, L. Loo,
W. Robarge, S. Franzen and D. L. Feldheim, Anal. Chem., 2007, 79,
9150–9159.
49 S. Dhar, N. Kolishetti, S. J. Lippard and O. C. Farokhzad,Proc. Natl.
Acad. Sci. U. S. A., 2011, 108(5), 1850–1855.
50 R. S. Kane and A. D. Stroock, Biotechnol. Prog., 2007, 23(2), 316–319.
51 Ø. Halskau, R. Perez-Jimenez, B. Ibarra-Molero, J. Underhaug,
V. Mu~noz, A. Martinez and J. M. Sanchez-Ruiz, Proc. Natl. Acad.
Sci. U. S. A., 2008, 105(25), 8625–8630.
This journal is ª The Royal Society of Chemistry 2011 Soft Matter, 2011, 7, 11501–11509 | 11509
Paper II 105

Paper III 107
Paper III
Tunable photophysical properties, conformation and
function of nanosized protein-gold constructs

Cite this: RSC Advances, 2013, 3, 482
Tunable photophysical properties, conformation and
function of nanosized protein–gold constructs
Received 30th August 2012,
Accepted 5th November 2012
DOI: 10.1039/c2ra22479h
www.rsc.org/advances
Sina M. Lystvet,*a Sondre Volden,a Gurvinder Singh,a Masahiro Yasuda,b
Øyvind Halskauc and Wilhelm R. Glomm*a
Protein-stabilized gold nanoconstructs are widely studied due to their potential applications in biosensing,
drug and gene delivery, and bioimaging. While a number of studies have focused on the novel properties
of such materials emanating from the gold, there has been little focus on how the protein shell is affected
by nanocluster formation with respect to conformation, stability and function. Herein, we show the
synthesis of protein-stabilized gold nanoconstructs varying in size from small clusters (~8 Au atoms)
dispersed within proteins to nanoparticles stabilized by multiple proteins by varying the concentration of
gold precursor and reducing agent. Proteins used were bovine serum albumin (BSA), bovine a-lactalbumin
(BLA) and lysozyme (LYZ). Photophysical properties of the gold nanostructures were monitored using UV-
vis and fluorescence measurements, revealing that the gold constructs can be tuned from luminescent
clusters to nanoparticles displaying localized surface plasmon resonance (LSPR). Conformational changes
of the protein following conjugation to gold nanostructures were studied using steady-state and time-
resolved Trp fluorescence measurements and circular dichroism. The degree of conformational
perturbation varied greatly between the proteins used, with BLA being the most tunable in terms of
gradual unfolding, whereas the conformational stability of LYZ was very sensitive to the reducing agent
used. To assess the impact of the gold nanostructures as well as the reducing agent on protein function,
the LYZ–gold nanoconstructs were subjected to an activity test by degradation ofMicrococcus lysodeikticus
cell walls, revealing that the activity of the LYZ–Au constructs was retained and tunable, albeit at
attenuated levels.
Introduction
Hybrid nanomaterials consisting of a gold nanoparticle core
and a protein corona, i.e. protein–gold nanoparticle con-
structs, have attracted much attention over the last decade,
owing to a wide range of potential applications in biological
sensing, drug and gene delivery, and bioimaging. See e.g.
reviews by Rotello and references therein.1–11 The colloidal
gold core provides a versatile scaffold for integrating biological
function onto a colloidal carrier, and dictates the optical
properties. Specifically, gold nanoparticles of diameters larger
than ~3 nm display a collective excitation of conduction
electrons known as a localized surface plasmon resonance
(LSPR) band when irradiated by incident light.6,12 In addition
to the linear combination of the colloidal metal core and the
multivalent protein corona, protein–gold nanoparticle con-
structs (hereafter referred to as protein–AuNP constructs) have
also been reported to display emergent properties, i.e. proper-
ties not present for the protein or the nanoparticle only, such
as an increased propensity for accumulation at interfaces and
lipid miscibility-affecting characteristics.10,11 Recently, a num-
ber of studies have focused on the integration of proteins and
sub-nanometer gold clusters, resulting in protein-stabilized
nanoclusters (hereafter referred to as protein–AuNCs).13–17
While the exact formation mechanism remains to be
elucidated and also depends on whether a reducing agent is
added to the reaction mixture, it is generally agreed that
formation involved initial electrostatic attraction between Au3+
and negatively charged residues, followed by reduction,
growth and passivation within the polypeptide chain by
covalent binding.18–20 Gold nanoclusters (AuNCs) vary in size
from a few atoms to tens of atoms in numbers corresponding
to spherical shell closing of the valence electrons.21 For
protein-stabilized AuNCs, studies have reported that most of
the gold resides as clusters of 8 or 25 atoms within the protein,
with the size of the AuNCs being tunable as a function of
reaction conditions.13–15 Unlike gold nanoparticles, AuNCs do
not display LSPR but luminesce at different wavelengths
according to their size, which is useful as an optical
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marker.14,21,22 Recently, Shiang et al. published a review on
fluorescent properties of gold and silver nanoclusters.17
While a number of studies conclude that conjugation of
proteins to nanomaterials such as gold nanoparticles may
result in partial unfolding of the protein,9–11,23 there is a need
for systematic studies on how nanomaterials can be used to
induce controlled unfolding of the protein with concomitant
monitoring of the effect on protein function, such as
enzymatic activity or ligand transport.
Earlier studies of protein–AuNCs have mainly focused on
the synthesis of the gold nanoclusters and their system-
dependent properties.13–15 Chen et al. showed in a newly
published article that lysozyme modified with gold nanoclus-
ters of 8 atoms (Au8) can be used for detection of glutathione
(GSH) down to ~20 nM,16 but to the best of our knowledge no
study has been published on the effect of nanocluster
formation on protein conformation and how this in turn
affects protein function. Nor has anyone studied how the
synthesis of gold nanoclusters within the protein will affect
proteins with different properties, such as size, isoelectric
point and conformation, and stability.
In this study, AuNCs and AuNPs of varying sizes are made
within three different proteins; bovine serum albumin (BSA),
bovine alpha-lactalbumin (BLA), and chicken egg white
lysozyme (LYZ) by varying the concentrations of gold precursor
and reducing agent, and the concentration ratios between
these two reactants. The proteins were selected so as to allow
for a large variety with respect to variables such as size,
isoelectric point (pI) and conformational stability. Using
dynamic light scattering, we found the hydrodynamic radii
of BSA, BLA and LYZ to be approximately 7 nm, 4 nm and 3
nm, respectively, under the experimental conditions used
here. BSA is a readily available reference protein with the same
pI as the much smaller BLA. This leads to comparable charge
density matching between negatively charged amino acid
residues and Au3+ and opens for protein size-dependent
variations in gold nanocluster stabilization. LYZ is a classical
rigid protein of the same size as BLA, but with a different pI,
which allows for studying how protein charge affects gold
nanocluster formation and stabilization. In addition, LYZ also
provides correlation of perturbation by NC modification and
concomitant protein function via a simple activity assay by
measuring transmittance as LYZ digests the cell walls of
Micrococcus lysodeikticus bacteria.24 The rate of increase in
transmittance reflects the activity of the LYZ–AuNCs compared
to native LYZ. In this study, sodium borohydride (NaBH4) was
used as the reducing agent because it cannot stabilize AuNCs
or AuNPs by itself, implying that all gold nanoconstructs
formed must be protein-stabilized. The fast reaction rate of
NaBH4 also avoids any competition from gold nanoclusters
formed within the protein using amino acid residues such as
tyrosine as reducing agents.15 Native proteins, proteins with
only reducing agent added, and proteins with both gold
precursor and reducing agent were subjected to a palette of
photophysical measuring techniques to investigate gold
nanoconstructs formed, as well as conformational changes
in the protein–gold nanoconstructs. Circular dichroism (CD)
was used for further evaluation of changes in conformation,
while scanning (transmission) electron microscopy (STEM)
was used for size and dispersity studies of the gold
nanoconstructs.
By varying the reaction conditions, protein–gold nanocon-
structs can be tuned from single proteins functionalized with
nanoclusters (small (~Au8) and/or large (~Au25+) depending on
the protein) to protein-stabilized AuNPs, with all the protein
systems displaying conformational tunability. Since the optical
properties change when going from nanoclusters to nanopar-
ticles,22 this enables the creation of biomarkers with a wide
range of optical signatures, from luminescence to LSPR. The
size variation achieved also led to tunability of LYZ function.
Consequently, the protein-stabilized gold nanoconstructs
studied here allow for gradual tuning of protein conformation
and protein function, as well as simultaneous inclusion of a
built-in optical marker.
Experimental methods and materials
Bovine serum albumin (BSA), chicken egg white lysozyme
(LYZ), bovine a-lactalbumin Type I (BLA), sodium borohydride
(NaBH4), and freeze dried Micrococcus lysodeikticus cell
walls were purchased from Sigma Aldrich. Hydrogen
tetrachloroaurate(III)?3H2O (TCAA) was purchased from
Acros organics. Di-potassium hydrogen phosphate (K2HPO4)
and potassium di-hydrogen phosphate (KH2PO4), were pur-
chased from Merck. A phosphate buffer was made by mixing
K2HPO4 (50 mM) with KH2PO4 (50 mM) until pH 7.4.
Proteins (BSA 67 kDa, BLA 14.2 kDa, LYZ 14.3 kDa) were
dissolved in Milli-Q water to make up 25 mM protein stock
solutions. TCAA (74 mg, 0.2 mmol) was dissolved in Milli-Q
water (18.8 ml) to make a stock solution (10 mM). The TCAA
solution was then diluted with Milli-Q water to 3, 1, 0.5 and
0.25 mM. NaBH4 (13.1 mg, 0.35 mmol) was dissolved in ice
cold Milli-Q water (34.63 ml) to make a 10 mM stock solution,
which was diluted to 5 and 1 mM with ice cold Milli-Q water.
The NaBH4 solutions were used shortly after their preparation.
To make the nanoclusters, protein (3 ml, 25 mM), TCAA (3 ml,
variable concentration) and NaBH4 (600 ml, variable concen-
tration) were mixed. The solutions changed color immediately.
After two hours the solutions were dialyzed (cut off ~12 kDa) in
Milli-Q water (300 ml) for two hours, and then dialyzed further
in phosphate buffer (300 ml) in order to ensure that the pH
conditions were identical upon characterization. Table 1 show
the different solutions made. We tried to use the same TCAA
concentration for BLA as for BSA but this led to flocculation
and precipitation, which is why the TCAA concentration is
lower for BLA and LYZ than for BSA. Controls wherein TCAA
was added to the protein and immediately removed via dialysis
did not yield any measurable differences as compared to
protein-only samples.
UV-visible spectroscopy in the range 190–1100 nm was
measured using a Shimadzu UV-2401PC spectrophotometer.
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The software used was UVprobe2.10. UV-vis was measured
both on the sample directly after dialysis (protein concentra-
tion ~11.4 mM), and after further dilution with phosphate
buffer (protein concentration ~2.3 mM). Protein concentration
was calculated, assuming no or negligible loss of protein in the
dialysis process, as the MWCO of the dialysis tubes used was
well below the molecular weight of the proteins studied here.
Scanning (transmission) electron microscopy (STEM)
images were acquired in bright-field STEM mode using a
Hitachi S-5500 electron microscope operating at a 30 kV
accelerating voltage. TEM grids were prepared by placing a
drop (10 mL) of the gold nanoparticle solution on a Formvar
carbon coated copper grid (Electron Microscopy Sciences) and
allowing the solvent to evaporate at room temperature, prior to
imaging.
Steady-state fluorescence was measured on the diluted
samples (2.3 mM protein) using a Fluorolog-3 HORIBA Jobin
Yvon apparatus. The excitation wavelengths used were lex =
295 nm (slit 5 for BLA and LYZ, slit 3 for BSA), lex = 370 nm,
slit 5, and lex = 450 nm, slit 10.
Time correlated single photon counting (TCSPC) was
performed using the same instrument as for steady-state
fluorescence. There were two major sets of lifetimes, one for
the protein itself and one for the nanoclusters inside the
protein. The conditions for measuring protein lifetimes were
light-emitting diodes (LEDs) with wavelength 280 nm, lem 360
nm, bandpass 14.5 nm, and for the nanocluster the conditions
were LED 370,14 lem 460 nm, bandpass 14.5 nm. These
measurements were also performed on the 2.3 mM solutions.
The choice of emission wavelength for gold nanoclusters was
based on a combination of the results from our steady-state
measurements and from the work by Gue´vel et al.,14 which
show that when excited at 370 nm small gold nanoclusters
(Au8) emit at 450 nm, while larger gold nanoclusters (Au25)
emit at 685 nm.
Circular dichroism (CD) measurements were conducted on
an Olis DSM 1000CD apparatus, the lamp power supply was a
LPS-220B from Photon Technology International, the user
interface was an Olis online instrument system, and the
software was OLIS GlobalWorks. A 10 mm cuvette, a grid of
2400 lines/mm, a slit width of 6.32 mm, a scan range from 290
nm to 200 nm, and an increment number of 720 was used.
Each sample was scanned three times. The protein concentra-
tion in the samples containing BLA and LYZ was 2.3 mM, but
the BSA-containing samples were diluted to 0.26 mM to get an
acceptable signal. The phosphate buffer was used as a blank.
TCAA in the buffer was measured under the same conditions
to exclude contribution to the CD signal intensity from the
gold precursor.
A Micrococcus test was performed to study the lysozyme
activity using the same instrumentation as for the UV-vis
measurements. The reference cell contained a Micrococcus
lysodeikticus solution (0.5 g l21) in phosphate buffer (50 mM,
pH 6.2). The sample cell was filled with 750 ml of the
Micrococcus solution, and the two cells were heated to 30 uC
before lysozyme (20 ml, 10 mM) was added to the sample cell.
The solution was mixed quickly using a 200 ml pipette before
measurements began. The transmittance measurements start
at 100% and then increase. This is because the solution
becomes less turbid as the cell walls are digested.
Results and discussion
The following sections are divided into (1) the photophysical
properties of the gold nanoconstructs, (2) properties of BSA,
BLA and LYZ relative to the native proteins, and finally (3) the
resulting changes in protein function, as exemplified by an
activity study of LYZ and LYZ–gold nanoconstructs. While the
photophysical properties of gold nanoclusters are of inherent
interest in biomedical labelling, the main focus of this article
is how incorporation of gold nanoclusters into proteins can be
tuned to give rise to different nanoconstructs with tunable
optical properties as well as tunable protein conformation and
function.
The term ‘‘gold nanoconstructs’’ here either refers to
protein-stabilized gold nanoclusters, protein-stabilized gold
nanoparticles, or a mixture of these. For each protein one high
concentration of gold ions (AuH) and one low concentration
(AuL) was employed. AuL (0.25 mM) and AuH (0.5 mM) are
identical for BLA and LYZ, while higher concentrations were
employed for BSA (AuH = 3 mM, AuL = 1 mM). Three different
concentrations of the reducing agent were combined with
each gold ion concentration, one high (RH), one medium (RM),
and one low (RL). RH, RM and RL are the same for all the
Table 1 Each sample was made up of protein, TCAA (conc. in mM given in
table), and NaBH4 (conc. in mM given in table). The comment refers to the color
after two hours. Au = gold, R = reducing agent, L = low, M = medium, H = high
Protein Sample [TCAA] [NaBH4] Comment
BSA BSA 0 0 Clear
BSA–RH 0 10 Clear
BSA–AuLRL 1 1 Greyish brown
BSA–AuLRM 1 5 Greyish brown, slightly pink
BSA–AuLRH 1 10 Pale greyish brown
(most brown)
BSA–AuHRL 3 1 Purple
BSA–AuHRM 3 5 Dark purple
BSA–AuHRH 3 10 Dark purple
BLA BLA 0 0 Clear
BLA–RH 0 10 Clear
BLA–AuLRL 0.25 1 Orange, slightly pinkish grey
BLA–AuLRM 0.25 5 Orange, slightly grey
BLA–AuLRH 0.25 10 Orange, slightly grey
BLA–AuHRL 0.5 1 Darker greyish orange
BLA–AuHRM 0.5 5 Darker greyish orange
BLA–AuHRH 0.5 10 Darker greyish orange
LYZ LYZ 0 0 Clear
LYZ–RL 0 1 Clear
LYZ–RM 0 5 Clear
LYZ–RH 0 10 Clear
LYZ–AuLRL 0.25 1 Grey
LYZ–AuLRM 0.25 5 Grey
LYZ–AuHRL 0.25 10 Grey
LYZ–AuHRL 0.5 1 Greyish purple
LYZ–AuHRM 0.5 5 Greyish purple
LYZ–AuHRH 0.5 10 Greyish purple
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protein-systems studied here. Following modification, all the
systems were dissolved under identical solvent conditions,
thus avoiding artefacts emanating from solvatochromism. For
a complete description of the experimental conditions and
concentrations, the reader is referred to the Materials and
methods section.
(1) Photophysical properties of the gold nanoconstructs are
tunable
The photophysical properties for all proteins and protein–gold
constructs used here display similar trends. In order to
minimize redundancies in the presented data, BSA was chosen
as an example for UV and STEM results.
Immediately after mixing of the reagents, the solutions
attained color, as shown in Fig. 1 for the BSA systems, together
with the UV-vis spectra.
Fig. 1a reveals that the solutions containing only protein or
protein and reducing agent were clear, while the solutions
containing BSA and a low concentration of TCAA (i.e. AuL in
Fig. 1a) were weakly tinted. At higher TCAA concentrations (i.e.
AuH in Fig. 1a) the BSA containing solutions turned to a deeper
shade of red. In Fig. 1b the band at 280 nm is distorted by a
scattering contribution, which indicates the presence of
multimeric gold following reduction and dialysis. Increasing
the TCAA concentration resulted in an increased production of
AuNPs associated with the proteins, as revealed by the
concentration dependent absorbance between 300 and 500
nm. For the highest TCAA concentration we also see a
localized surface plasmon resonance (LSPR) band at ~530
nm, indicating the formation of gold nanoparticles with
diameters >3 nm (~1300 atoms).22 As NaBH4 does not act as
a passivating ligand, these nanoparticles are likely stabilized
by multiple proteins, forming multivalent protein–AuNP
constructs. The LSPR position is related to nanoparticle
diameter within the framework of Mie–Drude theory, with
the LSPR position shifting towards higher wavelengths with
increasing nanoparticle diameter (for a theoretical treatment,
see e.g. Franzen25 or Mulvaney26–28). For the BSA–gold
nanoconstruct samples, both LSPR position and intensity
varied with the reducing agent concentration used, as: BSA–
AuHRL: lmax = 537 nm, BSA–AuHRM: lmax = 534 nm, and BSA–
AuHRH: lmax = 529 nm. Here, the LSPR position appears to be
inversely correlated with the concentration of the reducing
agent, indicating that the lowest reducing agent concentration
resulted in the largest nanoparticles, which is in agreement
with what has generally been observed for the formation of
colloidal gold.29 For BLA and LYZ, the observed UV-vis
lineshapes were not as evidently dependent on the concentra-
tion of the reducing agent as for BSA (data not shown). Rather,
systematic differences were observed as the concentration of
the gold precursor varied. Unlike other common reducing
agents such as citric or ascorbic acid, NaBH4 does not impart
any electrostatic or steric stability on the gold nanoparticles
created, so the particles will rapidly form large aggregates, and
precipitate out of solution. As the protein–gold nanoconstructs
described here were found to be stable on a timescale of
~weeks, the gold nanostructures formed must be strongly
associated with the protein—either embedded as nanoclusters
within single proteins, or as single nanoparticles coated with a
protein layer.
The UV-vis measurements indicate that the synthetic
protocol used allows for a gradual transition between
protein–AuNCs and protein-stabilized AuNPs. For the latter,
a reducing agent-dependent size difference in the gold
nanoparticles/-clusters was inferred. In order to verify these
observations, the protein–gold nanoconstructs used here were
investigated using STEM, as illustrated in Fig. 2 for BSA–Au
systems. The particles must be larger than 3 nm for
observation with the STEM instrument used in this study,
and no such particles could be observed in any of the samples
with low concentrations of gold precursor.
Fig. 2a shows a STEM image of the BSA sample that
contained the highest gold concentration and the lowest
amount of reducing agent (BSA–AuHRL), while Fig. 2b shows
the same gold precursor concentration but the highest
reducing agent concentration (BSA–AuHRH). The STEM obser-
vations are in agreement with the UV-vis measurements
presented above (Fig. 1b), revealing that the presence of a
well-defined LSPR band can be used to distinguish between
formation of AuNCs and AuNPs. However, while a well-defined
LSPR confirms the presence of AuNPs, it does not confirm or
deny the co-presence of AuNCs associated with the protein
corona. The BSA–AuHRL sample was found to contain particles
in the size range from 5 nm to 15 nm and revealed highly
Fig. 1 (a) Picture of the different BSA–gold nanoclusters samples studied. (b) UV-vis spectra for the corresponding solutions. Here the abbreviations denote the
following; Au = gold, R = reducing agent, L, M, H = low, medium and high concentrations, respectively.
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polydisperse constructs (Fig. 2a), where most of the particles
were >7 nm in size. The suspension containing BSA–AuHRH
revealed particles in the range from 3 nm to 9 nm, with the
majority of the particles having a diameter of 6¡ 2 nm in size
(Fig. 2b). The trend that higher amounts of reducing agent
results in smaller, quite monodisperse gold nanoparticles,
while lower concentrations of NaBH4 yield larger, polydisperse
particles was also observed for BLA and LYZ. This is also in
agreement with the LSPR position as discussed above,
indicating that UV-vis can be used to distinguish between
AuNCs and AuNPs, as well as qualitatively rank particle size for
the latter. Gold nanoparticles were only observed in samples
made with high gold precursor concentrations. Consequently,
the samples in this study that do not display a well-defined
LSPR or show nanoparticles in the STEM images likely contain
gold nanoclusters only. On the other hand, the samples where
both LSPR and STEM reveal nanoparticles might also contain
an unknown number of protein-embedded AuNCs. Moreover,
as the diameter of AuNPs formed typically exceeds the size of
the proteins used, the protein : AuNP ratio must be greater
than one, whereas the opposite must hold for the systems
where only AuNCs can be observed by spectroscopy. In turn,
the fact that we observe stable protein–AuNPs suggests that
sequestration, reduction and protection of gold species likely
occur close to the external surface of the proteins, with
subsequent protein unfolding exposing internal residues,
depending on reaction conditions and conformational flex-
ibility.
UV-vis and STEM measurements allow for the distinction
between nanoclusters and nanoparticles, but provide very little
specific information on the nature of the AuNCs. As AuNCs are
comparable in size to the electron de Broglie wavelength at the
Fermi level (~0.5 nm for Au), they exhibit molecular-like
behavior, including discrete electronic states and size-depen-
dent luminescence.14,15,21 Earlier studies by Xie15 and
Schneider14 have concluded that formation of AuNCs in BSA
typically results in blue-emitting (~450 nm) small AuNCs (Au8)
or red-emitting (~650 nm) large AuNCs (Au25). Irradiation with
UV light at l = 365 nm leads to excitation of both sets of magic
number AuNCs, enabling the identification of small and large
NCs, as well as a linear combination thereof.13 When
irradiated with UV light at l = 365 nm, samples with only
protein, as well as samples containing protein-stabilized gold
nanoparticles, do not reveal any detectable color upon
irradiation, while samples with protein-gold nanoclusters
luminesce, as shown for BSA and BSA-AuNCs in Fig. 3 below,
revealing the presence of magic number Au nanoclusters. The
absence of detectable luminescence from the AuNP-containing
solutions can be attributed to either (i) no AuNCs coexisting
with AuNPs, (ii) the fraction of nanoclusters in the AuNP-
containing samples being too small to provide visible
luminescence, (iii) only Au8 NCs coexisting with AuNPs, with
concomitant quenching of luminescence via Au8 A LSPR
energy transfer, or a combination of these. In order to
investigate the photophysical properties of the AuNCs, the
emission profiles of the systems were investigated using
steady-state fluorescence.
When excited at lex = 350–390 nm, earlier studies have
concluded that small protein-stabilized gold nanoclusters
(Au8) emit at lem ~ 450 nm, while larger nanoclusters (Au25)
show emission at lem ~ 685 nm.
14 Nanoclusters with magic
numbers between 8 and 25 (11, 13, 18 and 22) are likely to emit
somewhere in between. This fact was used to further
investigate the AuNCs formed in BSA, BLA and LYZ (Fig. 4).
Steady-state emission profiles for proteins, proteins with
reducing agent and protein–gold nanoconstructs are shown in
Fig. 4. In the presence of gold (Fig. 4b–d), the intensity is
significantly higher at 450 nm as compared to the native
proteins (Fig. 4a), indicating the presence of small nanoclus-
ters (~8 Au atoms).14 The emission intensity increases with
gold concentration until gold nanoparticles are formed. In
general the emission at ~450 nm from the protein–gold
nanoparticles was lower than for emission from the protein–
gold nanoclusters. This is because AuNPs are not luminescent
and due to Fo¨rster energy transfer they quench the fluores-
cence from AuNCs. The Fo¨rster quenching is most clear for the
BSA stabilized gold nanoparticles (Fig. 4b) as the high TCAA
concentration yields BSA-stabilized AuNPs and the low gold
precursor concentration yields BSA-stabilized AuNCs. For BLA-
and LYZ-stabilized gold constructs there is a more fluent
transition from AuNCs to AuNPs. This can partly be caused by
the concentration of gold precursor being higher in the BSA
Fig. 3 (a) BSA in buffer, (b) BSA–gold nanoclusters. UV-light used was l = 365
nm.
Fig. 2 STEM images of BSA-stabilized gold nanoparticles. (a) BSA–Au constructs
with high concentration of TCAA and low amount of reducing agent (BSA–
AuHRL), (b) BSA–Au constructs with high amount of gold precursor and high
concentration of NaBH4 (BSA–AuHRH). The samples were made with NaBH4
being present for two hours.
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samples than for the other two proteins. BSA is also the only
protein that exhibits bimodal distribution, as sample BSA–
AuLRH has emission maxima at both ~450 nm and ~700 nm,
indicating the presence of both small and large protein–gold
nanoclusters.15 The lem of gold nanoclusters increases with
cluster size, and in the emission wavelength range observed
here the clusters are likely to consist of a magical number of
atoms between 8 and 25 (11, 13, 18 and 22). To simplify the
discussion, the small gold nanoclusters are qualitatively set to
Au8 and the large ones to Au25. This is also in agreement with
the previous results for BSA–AuNCs published by Xie et al.15
The results from the steady-state lex = 370 nm measurements
reveal that the protein–gold nanoconstructs can be tuned from
small protein–gold nanoclusters to protein-stabilized gold
nanoparticles for all of the proteins in this study. Additionally,
BSA allows for tuning from small to large nanoclusters, likely
due to the larger size of the protein, or an optimal
combination of size, isoelectric point and conformational
flexibility. When AuNPs are formed, they are likely to coexist
with AuNCs, but due to the low concentration of AuNCs,
energy transfer from the luminescence of Au8 to the LSPR of
AuNPs, or a combination of these two, the AuNCs do not
provide observable luminescence in these samples. Sample
LYZ–AuLRH was removed from the dataset before measuring
steady-state fluorescence, due to observable instability within
the timeframe of the data collection (~1 week).
UV, STEM and steady-state fluorescence measurements
reveal that by varying the gold precursor concentration it is
possible to vary the size of the gold constructs formed from
small clusters, larger clusters and up to plasmonic nanopar-
ticles. For UV as well as for steady-state fluorescence (lex = 370
nm) the differences between gold nanoclusters and gold
nanoparticles are most clear for BSA, while the differences
were less prominent for BLA and LYZ. Thus, the synthetic
protocol, wherein proteins are exposed to TCAA and NaBH4, is
a good general procedure for the formation of protein-
stabilized nanoclusters and nanoparticles. However, the
concentration ratios of reducing agent and gold precursor to
polypeptide must be adjusted for the individual protein with
respect to size, pI and stability.
(2) Protein conformation can be tuned using gold
nanostructures
Tryptophan (Trp) is an environmentally sensitive intrinsic
fluorophore frequently used to monitor conformational
changes, including protein unfolding.30 Changes in the local
environment of a protein, such as increased solvent exposure
following partial unfolding, is typically accompanied by a shift
of the emission maximum towards longer wavelengths and/or
a decrease in emission intensity. Whereas red-shifts of the
emission profile can be directly attributed to partial protein
unfolding, interpreting changes in emission intensity can be
more ambiguous. However, the UV-vis results for the protein–
gold nanoconstructs studied here (Fig. 1b) reveal that the gold
nanoclusters absorb around 350 nm, enabling quenching of
Trp emission via energy transfer into the AuNCs.
Consequently, the changes in Trp emission profile make it
possible to follow conformational changes in a protein as well
as the presence of gold nanoconstructs using steady-state Trp
fluorescence (Fig. 5). Here the excitation wavelength lex = 295
nm.
The Trp emission profiles depicted in Fig. 5a, c and d reveal
a decrease in intensity for all proteins upon addition of
reducing agent, with the magnitude of the decrease being
Fig. 4 Steady-state fluorescence of proteins and protein–gold constructs. lex = 370 nm. Au = gold precursor (TCAA), R = reducing agent (NaBH4), L, M, H = Low,
Medium and High concentrations, respectively.
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highly protein dependent. This decrease in intensity is
probably due to quenching from increased solvent exposure
of Trp, as NaBH4 partially denatures the proteins. Upon
addition of the highest amount of reducing agent (RH), Trp
emission intensity was mostly maintained for BSA and BLA,
whereas all Trp emission was quenched in the case of LYZ.
This can likely be attributed to the difference in pI of the
proteins used. While BSA and BLA both have pIs below 5, the
pI of LYZ is 10.8, enabling effective charge density matching
between the overall cationic LYZ and the reducing agent. Thus,
LYZ is more exposed to attack from BH4
2 than the other
proteins investigated here. Interestingly, Fig. 5d reveals the
same amount of emission intensity decrease compared to the
native protein for addition of low and medium NaBH4
concentrations, whereas the high amount of NaBH4 led to
complete quenching of LYZ Trp emission. Fig. 5d also reveals
that while the intensity was reduced to almost zero at RH,
intensity was only reduced by 1/3 at RM or RL. This can likely
be linked to unfolding of the protein.11 NaBH4 can reduce
aldehydes, ketones, thiolesters and imines, but it cannot
reduce carboxylates or esters.31 This means that amino acids
susceptible to attack by NaBH4 are basic forms of histidine
(His) and arginine (Arg), which are imines. A reduction of the
imine in His would require a ring opening, which is very
unlikely. However, the imine (guadinium group to be exact) in
Arg can be susceptible to attack by NaBH4. Comparing the
amino acid sequences of BSA, BLA and LYZ, the Arg contents
are 4.3%, 0.8% and 10.8% for BSA, BLA and LYZ, respectively.
Thus, we attribute the strong effect of NaBH4 on LYZ to
reduction of Arg residues.
From the UV-measurements of BLA and LYZ (data not
shown), differences in the absorption profile due to the gold
precursor concentration were obvious, while varying the
NaBH4 concentration seemed to have little effect on the
absorbance properties. From the Trp fluorescence in Fig. 5c
and d, an intensity variation, dependent both on the gold
precursor concentration and the concentration of the reducing
agent, is evident. The intensity changes can be due to both
increased protein unfolding and energy transfer to gold
nanoconstructs. Despite differences in the degree of Trp
emission lineshape distortion, all the three proteins here
followed the same trend: the magnitude of fluorescence
quenching was found to be proportional to the concentration
of gold precursor. Furthermore, the difference between AuH
and AuL was larger for BSA than for the two other proteins.
This is probably due to the higher (36) TCAA concentration in
BSA–AuH as compared to BSA–AuL, whereas for the BLA and
LYZ samples the TCAA concentration was doubled. Conversely,
with the exception of the BSA–AuL suspensions, the fluores-
cence intensity was found to be inversely proportional to the
concentration of the reducing agent. The Trp fluorescence was
quenched more at RL than at RH, likely due to energy transfer
to gold nanostructures. Owing to the high extinction cross-
sections associated with LSPR, gold nanoparticles are vastly
more efficient acceptors for Fo¨rster energy transfer than gold
nanoclusters. As expected, the samples with the most depleted
Trp emission in Fig. 5 contain AuNPs, as determined via UV-
vis, STEM and steady-state lex = 370 nm.
The reduction in Trp emission intensity can also be partially
caused by conformational changes, a hypothesis that is
strengthened by the fact that Trp emission is also red shifted
for all the proteins; a typical sign of conformational change as
Trp is more exposed to solvent.30,32 In the case of BSA, there
seem to be two Trp populations for the nanocluster-containing
Fig. 5 Steady-state fluorescence of proteins and protein–gold constructs. lex = 295, Au = gold precursor (TCAA), R = reducing agent, L, M, H = low, medium and high
concentrations, respectively.
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samples (Fig. 5b), while only one population is evident for the
samples containing gold nanoparticles. Again, this is likely
attributable to the more efficient energy transfer for the
systems containing gold nanoparticles. Moreover, as both the
emission profiles from multimeric gold (Fig. 4) and the Trp
emission profiles (Fig. 5) reveal protein dependent variations,
despite otherwise similar reaction conditions, the observed
effects likely emanate from the properties of the proteins used.
BSA allows for a wide range of tunability with respect to Au
size, varying from small clusters to larger clusters and finally
AuNPs stabilized by multiple proteins, while BLA allows for
significant tunability of protein structure (provided the gold
concentration is not too high). Conversely, LYZ displays a
bimodal behavior, where it is difficult to tune both Au size and
protein conformation, with the resulting nanoconstructs
exhibiting limited stability.
From STEM, lex = 370 nm results (Fig. 4) and Trp emission
(Fig. 5) low NaBH4 concentrations (RL) yield larger AuNCs (and
indeed AuNPs) than RH, with the increased size of the gold
constructs resulting in a higher degree of unfolding.
Fluorescence lifetime measurements (time-correlated single
photon counting (TCSPC), Table 2) were used to further
investigate the local Trp environment.10,11,30 No distinct
lifetimes attributable to the gold nanostructures could be
detected upon excitation at 280 nm for any of the systems
studied here.
As the proteins used here contain different amounts of Trp
residues (BSA = 3 Trp, BLA = 3 Trp, and LYZ = 5 Trp),
interpretation of the TCPSC results with respect to comparison
of proteins is intricate. With the exception of BSA–AuH, a
bimodal fitting was found to provide the best overall fit for the
fluorescence decay profiles of the samples studied here,
yielding one ‘‘short’’ (T1) and one ‘‘long’’ (T2) lifetime, with
corresponding relative populations B1 and B2, respectively. For
the samples BSA–AuHRL and BSA–AuHRM, the short lifetime T1
was found to be outside the range of the LED used, i.e. faster
than the repetition rate. We attribute this reduction of the
short lifetime to a combination of efficient quenching from
the gold nanoparticles formed, as well as unfolding of the
protein.10,11 Overall, formation of gold nanostructures within
BSA results in reduction of the short lifetime (T1), and a large
increase of the short lifetime population (B1) as compared to
the native protein, indicating changes in Trp environment
following formation of gold nanoconstructs. With the excep-
tion of a single sample (BSA–AuHRM), the long lifetime (T2)
also decreased upon the introduction of gold. Specifically, the
population shifts towards shorter lifetimes, and a reduction in
lifetimes indicates either quenching from increased Trp
exposure to water, energy transfer to gold (either NCs or
NPs), or a combination of the two.
All the gold-modified BLA samples (Table 2) reveal a
decrease in the short lifetime population (B1) and a
corresponding increase in the long lifetime population (B2).
No significant changes in the short lifetime (T1) of the BLA
systems could be detected within the estimated uncertainties.
However, the long lifetime (T2) displayed variation towards
longer (particularly BLA–AuHRL) and shorter (BLA–AuLRM and
BLA–AuHRH) lifetimes compared to the native protein, without
any obvious trend with respect to TCAA or NaBH4 concentra-
tion. In general, an increase in the long lifetime, and
particularly its population (T2 and B2, respectively), indicate
that the Trp residues are more protected from quenchers—
hydroxyl or other—following formation of gold nanocon-
structs. The gold-modified LYZ samples generally reveal the
same overall trend as for BSA, albeit with a much stronger
dependence on the reducing agent, as discussed above.
BSA contains three Trp residues, where T1 and T2 (with
populations B1 and B2, respectively) can be attributed to the
external and buried Trp residues, respectively.30 As such,
changes either in lifetime or the associated population can be
rationalized via increased solvent exposure emanating from
protein unfolding and/or from energy transfer to the gold
nanoconstructs.11 However, as both BLA and LYZ contain
several Trp residues (three and five for BLA and LYZ,
respectively) with less well-defined spatial distribution of the
fluorophores, interpretation of TCSPC data for BLA and LYZ is
more complex. In the case of BLA, the overall trend of a relative
increase in the long lifetime population suggests a change in
protein conformation, with the apparent lack of trend with
respect to B1 and B2 values as a function of either TCAA or
NaBH4 concentrations perhaps being attributable to a gradual
distortion of protein structure, which is in agreement with the
steady-state Trp emission results displayed in Fig. 5. As the
BLA systems reveal a gradual transition from NCs to NPs, the
TCSPC results could emanate from a varying size and number
of gold nanoconstructs associated with BLA for different
concentrations of precursor and reducing agent. Overall, the
trend for LYZ is somewhat similar to what was found for BSA,
with the caveat that interaction with the reducing agent only
Table 2 Fluorescence lifetimes and corresponding populations of protein,
protein–AuNPs and protein–AuNCs. T = lifetimes in nanoseconds (ns), B =
populations in %, lex = 280 nm, lem = 360 nm
T1 (ns) B1 (%) T2 (ns) B2 (%)
BSA 4.7 ¡ 0.2 40 ¡ 1 7.5 ¡ 0.1 60 ¡ 1
BSA–RH 4.1 ¡ 0.1 36 ¡ 1 7.5 ¡ 0.1 64 ¡ 1
BSA–AuLRL 0.9 ¡ 0.1 72 ¡ 1 5.1 ¡ 0.1 28 ¡ 1
BSA–AuLRM 1.3 ¡ 0.1 66 ¡ 1 5.5 ¡ 0.1 34 ¡ 1
BSA–AuLRH 1.3 ¡ 0.1 50 ¡ 1 5.9 ¡ 0.1 50 ¡ 1
BSA–AuHRL 0.3 ¡ 0.1
a 57 ¡ 1 5.9 ¡ 0.1 43 ¡ 1
BSA–AuHRM 0.6 ¡ 0.1
a 62 ¡ 1 7.5 ¡ 0.1 38 ¡ 1
BSA–AuHRH 0.9 ¡ 0.1 67 ¡ 1 7.0 ¡ 0.1 33 ¡ 1
BLA 0.9 ¡ 0.1 93 ¡ 1 5.2 ¡ 0.1 7 ¡ 1
BLA–RH 0.9 ¡ 0.1 88 ¡ 1 5.5 ¡ 0.1 12 ¡ 1
BLA–AuLRL 1.1 ¡ 0.1 67 ¡ 1 5.3 ¡ 0.1 33 ¡ 1
BLA–AuLRM 1.0 ¡ 0.1 77 ¡ 1 4.8 ¡ 0.1 23 ¡ 1
BLA–AuLRH 1.0 ¡ 0.1 75 ¡ 1 5.3 ¡ 0.1 25 ¡ 1
BLA–AuHRL 0.9 ¡ 0.1 66 ¡ 1 7.5 ¡ 0.1 34 ¡ 1
BLA–AuHRM 1.1 ¡ 0.1 67 ¡ 1 5.2 ¡ 0.1 33 ¡ 1
BLA–AuHRH 1.1 ¡ 0.1 64 ¡ 1 4.6 ¡ 0.1 36 ¡ 1
LYZ 1.5 ¡ 0.1 70 ¡ 1 3.5 ¡ 0.1 30 ¡ 1
LYZ–RL 0.9 ¡ 0.1 91 ¡ 1 6.9 ¡ 0.1 9 ¡ 1
LYZ–RM 1.0 ¡ 0.1 90 ¡ 1 6.9 ¡ 0.1 10 ¡ 1
LYZ–RH 1.8 ¡ 0.1 42 ¡ 1 11.6 ¡ 0.1 58 ¡ 1
LYZ–AuLRL 1.6 ¡ 0.1 84 ¡ 1 6.6 ¡ 0.1 16 ¡ 1
LYZ–AuLRM 1.7 ¡ 0.1 86 ¡ 1 6.6 ¡ 0.1 14 ¡ 1
LYZ–AuHRL 1.1 ¡ 0.1 64 ¡ 1 11.6 ¡ 0.1 36 ¡ 1
LYZ–AuHRM 1.4 ¡ 0.1 81 ¡ 1 8.4 ¡ 0.1 19 ¡ 1
LYZ–AuHRH 1.5 ¡ 0.1 84 ¡ 1 8.0 ¡ 0.1 16 ¡ 1
a Outside the range of the LED used.
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has a more pronounced effect on Trp emission than the
formation of gold nanoconstructs. This is in agreement with
the steady-state observations in Fig. 5d, where it was evident
that LYZ is very vulnerable to addition of NaBH4. From Table 2
it can be seen that when a small amount of NaBH4 is added to
LYZ the short lifetime goes down and its population increases
dramatically (from ~70% to 90%). Both the absolute value of
the fluorescence lifetimes and their corresponding popula-
tions are sensitive to the surrounding chemical environment
such as the presence of quenchers. Upon exposure to a
hydroxyl quencher, the fluorescence lifetime can be expected
to decrease. Moreover, as the measured signal is a composite
of contributions from buried as well as exposed Trp residues,
an increase in the population of the short lifetime can be
attributed to increased exposure to solvent for all the Trp
residues in the polypeptide chain. Taken together, a decrease
in the absolute value of the short lifetime as well as an increase
in its relative population indicate that the surface Trps are
more exposed to water and that the protein has partially
unfolded. The long lifetime also increases, so it might be that
the structural changes upon reduction of surface amino acids
has led to a shielding of buried Trp residues (there are 5 Trp in
LYZ). An increase from RL to RM had little influence on the
lifetimes and populations, which is in agreement with the Trp
steady-state emission intensities shown in Fig. 5d. However, at
RH the short lifetime almost doubles, its population is
dramatically reduced from ~90% to ~40%, the long lifetime
is almost doubled and its population increases from ~10% to
~60%. The increase in the population of the long lifetime as
well as in both lifetimes indicates that all the Trp residues are
more shielded from quenching. The most parsimonious
explanation for the pronounced effect of the reducing agent
is that the unfolding of LYZ is so severe that denaturation and
subsequent aggregation occurs, trapping Trp within larger
flocks and shielding them from water. An aggregation due to
excessive protein unfolding induced by high amounts of
NaBH4 could also explain why LYZ–AuLRH precipitated early in
the study. The LYZ–AuHRH system remained stable within the
timeframe of these experiments (~2 weeks), likely due to
stabilization imparted by the gold nanoparticles formed.
Fluorescence measurements gave some indication about
structural changes in the protein, but for a more thorough
examination of structural changes, circular dichroism mea-
surements were performed. Changes in intensity and line-
shape indicate structural changes in the protein, as shown in
Fig. 6 for BSA, Fig. 7 for BLA and in Fig. 8 for LYZ. At this point
the LYZ–AuHRL sample was also removed from the dataset due
to precipitation. For CD, as well as for the TCSPC, the addition
of reducing agent seems to affect BLA a bit more than BSA,
while LYZ is most severely altered by NaBH4. To exclude any
effects from gold, CD was measured using the same
concentration of TCAA as in the synthesis of the gold
nanoclusters. There were no contributions to the CD signal
from the TCAA.
To rule out the possibility of changes due to attenuation of
the signal by gold, the relationship between signal intensity at
200 nm and 222 nm was studied for all samples (see Fig. 6d,
7d and 8d). The 200 nm/222 nm ratio varies in a manner not
Fig. 6 (a) CD of samples containing BSA. (b) Mean residual ellipticity of samples containing BSA at 222 nm. Au = gold, R = reducing agent, L = low amount, M =
medium amount, H = high amount. (c) Magnified section of (a). (d) Relationship between mean residual ellipticity (MRE) at 200 nm and 222 nm.
490 | RSC Adv., 2013, 3, 482–495 This journal is  The Royal Society of Chemistry 2013
Paper RSC Advances
Paper III 117
directly correlated to the concentration of the gold precursor
or the corresponding absorbance at these wavelengths (Fig. 1).
Thus, the spectral changes are likely due to changes in the
protein, not attenuation of the signal caused by the presence
of gold.
As for UV (Fig. 1) and the fluorescence studies (Fig. 4, 5 and
Table 2) the CD data in Fig. 6 show that only a small change in
intensity occurred when reducing agent was added to BSA. The
change was larger when small amounts of gold precursor were
also added, and evenmore so when the TCAA concentration was
higher. This confirms that NaBH4 by itself has some, but little,
effect on BSA, and by varying the gold precursor concentration it
is possible to gradually change the protein conformation with
respect to the secondary structure content. The bar chart in
Fig. 6b indicates that the variation in reducing agent concen-
tration within each set of gold concentrations has some effect
on the structure of BSA. The BSA–AuLRH sample stands out with
a mean residual ellipticity closer to the native protein than any
other sample where gold is added; thus more of the original
structure is probably intact. From several of the other
techniques used we have seen that the highest concentration
of reducing agent gave the smallest nanoclusters. Small clusters
give a high curvature, and allow the protein to unfold less.9,33,34
The main trends in the CD measurements are similar for
BLA (Fig. 7) as for BSA (Fig. 6) considering that NaBH4 has a
small effect on the signal intensity, and that addition of a gold
precursor changes the intensity more. For BSA all the samples
with high gold concentration had a more reduced signal,
compared to native protein, than samples with lower TCAA
concentration (Fig. 6b), but for BLA there seems to be an
overlap in signal reduction between high and low gold
precursor concentration (Fig. 7b). This probably means that
NaBH4 has some, but not high influence on the BLA structure
and that formation of gold nanoclusters and gold nanoparti-
cles changes the structure further. Moreover, it seems to be a
gradual transition between nanocluster and nanoparticle
formation within BLA, contrasting with the behavior of LYZ.
This may reflect a higher tunability of the BLA structure.
At this point also sample LYZ–AuHRL is removed from the
dataset, due to the high degree of flocculation. Small
tendencies to flocculation were also observed in samples
LYZ–AuLRL and LYZ–AuHRM. Just like for the steady-state
measurements (Fig. 5), Fig. 8a shows that a small addition of
NaBH4 changed the intensity of the signal slightly and that
adding a medium amount of NaBH4 gave no difference in
results. But when the high amount of reducing agent was
added, the signal was completely quenched. For LYZ the mean
residual ellipticity is more similar to the native protein when
high amounts of gold precursor are used than low. This is the
exact opposite of BSA and BLA; however the difference is quite
small. This deviation might be caused by an onset of
flocculation in the system. The CD results point in the same
direction as the previous results; high amounts of NaBH4
completely perturb the LYZ structure, but when gold nano-
constructs are formed within the protein this partially
stabilizes the structure.
From the CD results and TCSPC we have seen that the effect
of the reducing agent on the protein increases in the order BSA
Fig. 7 (a) CD of BLA samples. (b) Mean residual ellipticity of samples containing BLA at 222 nm. Au = gold, R = reducing agent, L = low amount, M = medium amount,
H = high amount. (c) Magnified section of (a). (d) Relationship between mean residual ellipticity (MRE) at 200 nm and 222 nm.
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, BLA , LYZ, and CD also showed that there is a gradual loss
of alpha helical motifs (reduction in mean residual ellipticity
at 222 nm) as gold nanoconstructs are formed. The change was
most gradual for BLA. This is also seen by the fact that BSA
and LYZ have separated regions in CD and steady-state lex =
295 nm fluorescence experiments for nanocluster and nano-
particle containing proteins, while there is an overlap between
the two regions for BLA. Lysozyme is the least tunable,
meaning that the effect of NaBH4 is more crucial to the
unfolding of the protein than is the formation of gold
nanoconstructs.
BLA and LYZ are of equal size and overall fold, so the large
differences between them might be caused by the differences
in their pI. As mentioned earlier LYZ (pI = 10.5) is more likely
to electrostatically interact with NaBH4 than BLA (pI = 4.5), and
can therefore interact more efficiently. LYZ is also a very rigid
protein compared to BLA35 and the low flexibility makes it
difficult to stabilize when unfolding agents are introduced.
Considerations regarding conformational flexibility can also
be used to explain why BSA is less altered than BLA. BSA and
BLA have equal pI, but BSA is almost five times larger than
BLA, and has three semi-independent but similar domains
that can each respond to a change that is local on the protein
size scale.32
The CD results as well as fluorescence show that the
formation of gold nanoconstructs stabilizes the structure of
LYZ for a while, so that NaBH4 completely destroys the protein
conformation. Over time the LYZ–gold nanoclusters aggregate
and precipitate. For this reason it seems that the gold
nanoclusters are formed on the surface of the protein, and
over time the clusters collide and form gold nanoparticles
instead. The aggregation can then be a combined result of
hydrophobic interactions between exposed amino acids in LYZ
as it has partially unfolded, and crosslink between gold
nanoclusters from different proteins colliding and forming a
gold nanoparticle bridge.
(3) Protein–gold nanoconstructs display tunable functional
retention
Protein function, such as enzymatic activity, is known to be
closely linked to the protein structure, and so any conforma-
tional changes might compromise or otherwise affect the
functionality. In this study, all observables indicate that
NaBH4 alters the LYZ structure, while formation of gold
nanoconstructs allows for at least partial retention of the
native structure (see Fig. 5 and 8). Moreover, it is clearly shown
that protein–gold nanoclusters behave differently from the
individual components, demonstrating emergent properties of
the protein-gold systems, which might be of tremendous use
within biomedicine. LYZ digestion of Micrococcus lysodeikticus
cell walls was used to compare the enzyme activity of modified
LYZ with that of the native protein (Fig. 9). Thus, correlating
information on the conformational changes to LYZ enzyme
activity enables a measure of how much the modification has
affected the structure–function relationship. The transmit-
tance for the measurements depicted in Fig. 9 was set to 100%
for the cell wall suspended in buffer, as described in the
materials and methods section. As LYZ or LYZ–gold nanocon-
structs are added, the cell walls are digested and the
Fig. 8 (a) CD of LYZ samples. (b) Mean residual ellipticity of samples containing LYZ at 222 nm. Au = gold, R = reducing agent, L = low amount, M = medium amount,
H = high amount. (c) Magnified section of (a). (d) Relationship between mean residual ellipticity (MRE) at 200 nm and 222 nm.
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suspension becomes more transparent, resulting in increased
transmittance.
From the kinetic profiles displayed in Fig. 9a, the increase in
transmittance over time is larger when native LYZ is used to
digest the cell walls than when modified LYZ is used,
indicating that the enzymatic activity of native LYZ is higher
than for the modified samples studied here. Fig. 9b reveals
that the cell wall digesting activity of modified LYZ varies with
the concentration of gold precursor and reducing agent. While
steady-state measurements (Fig. 5) and CD measurements
(Fig. 8) showed that only the highest concentrations of NaBH4
resulted in severe loss of structural domains for LYZ, Fig. 9b
reveals that introduction of NaBH4 results in complete loss of
substrate digesting activity, irrespective of the concentration of
the reducing agent. Interestingly, LYZ with both reducing
agent and gold precursor added is able to change the
transmittance, and thus has cell wall digesting properties.
Samples LYZ–AuHRH and LYZ–AuHRM retain approximately 6%
¡ 1% and 4% ¡ 1%, respectively, of LYZ cell wall digesting
activity, whereas sample LYZ–AuLRM retains as much as 14%
¡ 1% enzyme activity as compared to native LYZ. To exclude
any destructive effects from TCAA on the Micrococcus
lysodeikticus cell wall, the activity test was performed with
different TCAA concentrations as well (data not shown). None
of the TCAA concentrations used here had any measurable
effect on the cell walls. These results imply that gold
nanoclusters to some extent are able to stabilize LYZ, and
just as it was possible to tune LYZ conformation by varying the
gold precursor and reducing agent concentrations it is
possible to tune LYZ enzyme activity.
In the Trp steady-state section it was implied that the high
amount of arginine could explain why the LYZ structure is
more vulnerable to NaBH4 than the other two proteins. The
amino acids Glu35 and Asp52 are critical for LYZ activity, but
the amino acids Arg62, Tyr63, Arg101 and Ala107 are also a
part of the active site.36 Thus, two Args are directly involved in
the active site of LYZ and additionally there is Arg108 next to
Ala107 and Arg50 close to Asp52. The density of arginine in the
active site, or very close to amino acids that are in the active
site, is very high. This strengthens the hypothesis about Arg
being the key to why NaBH4 is so harsh on the LYZ structure
and activity compared to BSA and BLA.
Conclusion
The steady-state and time-resolved fluorescence using both the
gold covalent modifications and tryptophan residues as
probes, as well as CD, suggests that the metal and protein
components of the constructs have a mutual influence on each
other. UV-vis, STEM, and the fluorescence measurements
show that it is possible to controllably functionalize single
proteins with gold nanoclusters and also stabilizing gold
nanoparticles by multiple proteins, as well as controlling the
transition between these using one single synthetic protocol.
Our results show that the approach is versatile; by varying the
gold precursor concentration it is possible to tune all the way
from protein–gold nanoclusters to protein–gold nanoparticles,
and by simultaneously changing the reducing agent concen-
tration the size and polydispersity of both kinds of constructs
can be tuned. As an effect of the different construct sizes, the
protein structures are affected to different extents, as shown by
steady-state lex = 295 nm and CD measurements. Of BSA, BLA
and LYZ, BLA is the protein that opens for the best tunability,
while LYZ gets the most disrupted. NaBH4 alone has quite a
severe effect on the LYZ structure and enzymatic activity. The
effect of NaBH4 is, interestingly, reduced as the embedded
nanoclusters and nanoparticles stabilize the protein. LYZ–gold
nanoconstructs were a lot less stable than for the other two
proteins, probably due to the rigid structure of LYZ and its
high Arg content. Strategies for modifying proteins with
AuNCs and AuNPs must thus balance the disruptive and
stabilizing effect the modification has on the modified
protein’s structure and solubility, respectively. The protein
fold is significantly loosened, although not enough to abolish
all activity in the case of LYZ. Additionally, physical blocking of
active sites from the gold species might have attributed to the
reduced activity. Although the function of BLA and BSA was
not assayed, it is reasonable to assume that these proteins may
also be prepared with covalent cluster or particle modification
in a manner that allows retention of at least part of their
function. The spectroscopic data suggest an incremental
perturbation of the protein fold, and it may be that this
feature could be used to kinetically lock proteins in folding
Fig. 9 Cell wall digestion activity of lysozyme, lysozyme with NaBH4 and lysozyme–gold nanoconstructs at pH 6.2 and 30 uC. The change in transmittance starts at
100% and the transmittance increase means that Micrococcus lysodeikticus cell walls are digested. (a) All results, (b) the dataset for the native protein is removed.
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intermediates that would otherwise not be thermodynamically
stable and amenable to investigation. The spectroscopic data
presented here suggest that this possibility is strongest for BLA,
which in support of this has been shown to have a marginal
folding barrier.35 Such a possibility would be of high relevance
for the general study of folding intermediates and particle-
associated states in particular, both problems being relatively
inaccessible to normal techniques.35,37–39 In addition to the
fundamental importance of studying partially folded protein
states, such states are implicated in many detrimental diseases
such as Alzheimer’s and Parkinson’s disease.35 For instance,
b-amyloid plaque and its more cytotoxic precursor annular
oligomers, are formed from marginally stable proteins that are
perturbed either by mutation, oxidation or interference with an
interface, such as a lipid membrane or monolayer.40,41 The
presence of the gold modification could, in addition to its role
as a fluorescence reporter of the local environment, ensure that
a non-native protein state could be explored by steady-state
techniques, which cannot ordinarily be employed due to its
short lifetime in the absence of noble-metal clusters.
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Small noble metal nanoclusters can be formed in situ by direct reduction and stabilization of a metal
precursor by biomolecules such as proteins. Considering the diversity in amino acid composition of
proteins, and hence their reductive ability, a general method for synthesis of gold nanoclusters using
proteins is presented here. A range of proteins (bovine serum albumin, fibrinogen, a-lactalbumin,
lysozyme, cytochrome c, myoglobin, b-lactoglobulin and a-chymotrypsin) have been studied, based
on size, isoelectric point, flexibility and 3-dimensional structure. Results show protein-gold
nanoconstructs with complex protein-specific photophysical properties. The effect on the
3-dimensional conformation of the proteins upon formation of gold nanoclusters and/or
nanoparticles within the protein structure is also shown to be highly protein-dependent. A general
mechanism for the formation of protein-gold nanoconstructs is proposed, based on charge density
matching, yielding a high local concentration of the metal precursor on the protein structure which in
turn can nucleate, grow and be stabilized by amino acid residues in the protein.
Introduction
Protein-stabilized fluorescent gold and silver nanoclusters (NCs)
of subnanometer size have attracted a great deal of interest,
owing to their potential use in a wide range of applications such
as sensing,1 biolabeling and imaging,2–4 and even as enzyme
mimics.5 Unlike gold and silver nanoparticles, NCs are
fluorescent, and do not exhibit localized surface plasmon
resonance (LSPR) or the surface chemistry of the bulk metal.
The NCs are typically of sizes comparable to the Fermi
wavelength (y0.5 nm for Ag and Au) and display molecular-
like, size-dependent fluorescence likely due to the transition
between discrete molecule-like electronic states. Absorption and
emission properties of the NCs can be described as a function of
the number of atoms N as EFermi/N
1/3 according to the Jellium
energy scaling law.6
Recently, Xie et al.7 reported a one-pot, ‘‘green’’ synthetic
route for the preparation of Au NCs using the intrinsic reduction
potential of bovine serum albumin (BSA) at physiological
temperature and basic conditions (pH . 10). The resulting Au
NCs were found to consist mostly of 25 gold atoms (Au25), with
red emission (lmax = 640 nm) and a quantum yield of y6%.
Since this seminal paper, other authors have reported AuNC
formation using a similar biomineralization-inspired procedure
using BSA3,5,8 as well as other proteins such as transferrin,
apoferritin,4 and horseradish peroxidase.1 Modifications to the
original synthesis procedure typically involve the addition of a
reducing agent such as ascorbic acid2,3,8 in order to trigger
nucleation of NCs at lower protein concentrations than initially
reported. Procedures relying on the addition of an extrinsic
reducing agent (hereafter referred to as ‘‘extrinsic’’ protocols)
also offer the advantage of short reaction times and negligible
competition from amino acid residue-induced reduction of the
metal precursor, leading to a well-defined reduction and growth
mechanism. Conversely, biomineralization-inspired synthetic
procedures (hereafter referred to as ‘‘intrinsic’’ protocols) rely
solely on the reduction potential of amino acid residues in the
polypeptide chain under the reaction conditions (pH, tempera-
ture). Here, tyrosine7 and histidine4 have been proposed as the
amino acids responsible for reduction of gold precursor in BSA
and apoferritin, respectively.
As the amino acid composition varies greatly between
proteins, the capacity to produce nanoclusters as well as the
nature of the produced nanoclusters is expected to be protein-
dependent. Here, we present a generally applicable synthetic
procedure for in situ modification of proteins with gold
nanoclusters, yielding protein-AuNCs and AuNPs with tuneable
complex fluorescence. A small library of eight proteins of
different molecular weights, charge properties and conforma-
tional flexibilities has been utilized, showing that nanocluster/
nanoparticle formation, as well as the accompanying conforma-
tional changes and photophysical properties, are highly protein-
dependent. As both the stability and function of the final
protein-gold construct depend critically on the degree of change
in protein conformation as well as the characteristics of the gold
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nanoclusters, the results obtained here can be used for the
rational design of materials for a wide range of applications,
including catalysis, bio-sensing and -labeling, as well as for
imaging purposes. We also present a general mechanism for the
in situ nanocluster formation, which could be beneficial for
research in the aforementioned areas.
Materials and methods
Materials and solutions
Bovine serum albumin (BSA), bovine milk a-lactalbumin type I
(BLA, .85%), (horse heart) myoglobin (Mb, .90%), (chicken
egg white) lysozyme (Lyz), bovine pancreas a-chymotrypsin
(CTR), bovine plasma fibrinogen (Fib) and bovine milk
b-lactoglobulin (BLG) were purchased from Sigma. Bovine
heart cytochrome c (Cyt, .95%) was purchased from
BioChemika, and hydrogen tetrachloroaurate (TCAA) was
purchased from Acros.
PBS-buffer was made by mixing two solutions; i) K2HPO4 (50
mM) and KCl (150 mM) and ii) KH2PO4 (50 mM) and KCl (150
mM), until pH was 7.4. Protein-nanoclusters were made by
mixing protein (0.746 mM, 1 ml, 37 uC) with TCAA (10 mM, 1
ml, 37 uC). After stirring for 2 min NaOH (1 M, 100 ml, 37 uC)
was added.7 After one week at 37 uC, the nanocluster solutions
were dialyzed against PBS (400 ml) for about 60 h, using a
membrane with a molecular weight cut-off of 12.4 kDa. After
measuring UV-vis, the solutions were diluted with PBS to
3.6 mM for UV-vis and fluorescence measurements. Stock
solutions of native protein were made by dissolving protein in
PBS to 25 mM. For UV-vis and steady-state measurements the
protein stock solutions were diluted to 3.6 mM using PBS-buffer.
UV-Visible spectroscopy
UV-vis spectra were collected using a Shimadzu UV-2401PC
spectrophotometer, over the wavelength range of 190–1100 nm.
The path length of the quartz cuvettes used was 2 mm.
Fluorescence
The fluorescence measurements were performed on a Fluorolog-
3 HORIBA Jobin Yvon apparatus. For the steady-state
measurements, excitation was done at l = 295 nm (slit width =
3 nm), l = 370 nm (slit width = 5 nm) and l = 495 nm (slit width
= 10 nm) in order to probe the emission contributions from
tryptophan (Trp), AuNCs (Au8 and Au25) and large AuNCs
(Au25), respectively. Time-correlated single photon counting
(TCSPC) emission measurements to probe the local environment
of Trp residues was done using excitation at l = 280 nm as
previously described.9
Circular dichroism (CD)
Measurements were conducted at room temperature on an Olis
DSM 1000CD apparatus. The lamp power supply was a LPS-
220B from Photon Technology International, the user interface
was an Olis online instrument system, and the software was
OLIS GlobalWorks. The 300 mL cuvette had a path-length of
1 mm, the grid was 2400 lines/mm, slit width was 6.32 mm, the
scan range was from 290 nm to 200 nm, and the increment
number was 720. Each sample was scanned three times. The
concentration of BSA, BSANC,CTR, andCTRNCwas 5 mM, for
Fib and Fib NC the concentration was 2.5 mM, and for BLA, BLA
NC, Lyz, Lyz NC, Cyt c, Cyt c NC, Mb, Mb NC, BLG and BLG
NC the concentration was 25.4 mM. The buffer was used as blank.
Results and discussion
In this study, a single-step procedure for the synthesis of protein-
stabilized gold nanoclusters was investigated for a small library
of eight proteins, chosen on the basis of the following. Bovine
serum albumin (BSA) is much studied as an important
constituent of blood. Albumin is a carrier protein responsible
for transport of thyroid and fat-soluble hormones via the
bloodstream,10 and is also involved in other physiological
functions such as control of serum osmotic pressure and pH
buffering.11 Fibrinogen (Fib) is part of the final step of the blood
clotting cascade, wherein Fib is converted into fibrin by the
protolytic enzyme thrombin.12 Fib is made up of three globular
units connected by two rod regions, each of which consists of
triple-stranded a-helical coiled coils. Bovine a-lactalbumin
(BLA) and lysozyme (Lyz) are homologous proteins with similar
tertiary structures and primary sequence identities of approxi-
mately 35%.13–15 Apart from biological function, BLA and Lyz
differ with respect to their folding and calcium binding proper-
ties. Notably, BLA has the ability to form a stable molten
globule and can strongly bind Ca2+,16 whereas no such stable
state or metal binding has been reported for (chicken egg white)
Lyz. Cytochrome c (Cyt c) shuttles electrons between the two
membrane-associated protein complexes cytochrome c reductase
and cytochrome c oxidase inside the inner mitochondrial mem-
brane and participates in mitochondrial production of ATP.
Molten globule states of Cyt c have been reported under various
conditions both at interfaces and in bulk.17–22 Myoglobin (Mb)
is a monomeric heme-binding protein involved in oxygen-
carrying and can be found in muscle and blood cells. Mb is
known to form a stable molten globule state in the absence
of its heme group under moderately low pH conditions.23
b-Lactoglobulin (BLG) is a globular milk protein which binds
small ligands including palmitic and oleic acids.24,25 Unlike the
other major whey protein BLA, the exact biological function of
BLG has yet to be elucidated. BLG forms an eight-stranded,
antiparallel b-barrel with a three-turn a-helix on the outer
surface and a ninth b-strand flanking the first strand.24 The main
ligand-binding site is located within the central cavity of the
protein. The proteolytic enzyme a-chymotrypsin (CTR) partici-
pates in the breakdown of proteins in the digestive system of
mammals and other organisms.12 Specifically, CTR cleaves
peptide bonds selectively on the carboxyl-terminal side of large
hydrophobic amino acids such as tryptophan, tyrosine, pheny-
lalanine and methionine.
A summary of the molecular properties of the proteins used in
this study is shown in Table 1. By using the same synthesis
procedure for the eight proteins studied here, we can probe the
effects of protein size, overall protein charge (as determined by
their isoelectric point; pI), conformational flexibility as well as
the occurrence of specific amino acid residues on the ability to
reduce and stabilize gold nanostructures – both subnanometer
clusters and nanoparticles.
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The results will be presented in the following order 1)
photophysical properties of the gold nanoclusters, 2) effect of
nanocluster/nanoparticle formation on protein conformation, and
3) a suggested mechanism for protein-directed intrinsic synthesis
of gold nanoclusters.
Photophysical properties of gold nanoclusters are highly protein-
dependent
Following incubation at 37 uC for one week with gold precursor
(tetrachloroauric acid; TCAA), the solutions changed color from
light yellow (TCAA) to yellow, brown or dark red, according to
the nature of the gold structures present and depending on
the protein in question. Upon excitation with UV light (lex =
365 nm), most of the incubated solutions display an intense red
photoluminescence, with the intensity and hue being protein-
dependent, and varying from orange to purple (see Fig. 1),
indicating formation of gold nanoclusters.7 Two of the proteins –
b-lactoglobulin (BLG) and cytochrome c (Cyt c) – emitted a
much weaker blue or purple fluorescence, which could be due to
aromatic amino acid side groups (tryptophan, tyrosine and
phenylalanine), or low concentrations of gold nanoclusters in the
final product (not shown).
UV-vis spectra of the protein-AuNCs as well as the respective
native proteins are shown in Fig. 2. For all the systems studied
here, the spectra of the protein-AuNCs differ significantly from
the native proteins both with respect to lineshape and intensity.
Incorporation of gold nanoclusters results in a broad absorption
below y400 nm which significantly distort or hide the 280 nm
absorption band of the proteins. This can be attributed to
scattering contributions upon formation of supramolecular gold
nanoconstructs, with the resulting lineshape being highly
protein-dependent. For Cyt c and Mb (Fig. 2, lower left panel),
the absorption band at y410 nm is also blue-shifted and
weakened, indicating that in situ formation of gold nanostruc-
tures distorts the environment surrounding the heme groups.
Three of the proteins studied here – BLA, Cyt c and BLG –
display strong absorbance in the 520–550 nm region upon
incorporation of gold. This feature is consistent with localized
surface plasmon resonance (LSPR), revealing that AuNPs of
diameters larger than 3 nm are present upon incorporation of
gold in BLA, Cyt c and BLG (see e.g. Glomm26 and references
therein). As the three proteins in question have similar or smaller
dimensions to the AuNPs formed (for example, the dimensions
of BLA are approximately 4 nm 6 3 nm 6 3 nm), and the
samples remained stable in solution, the systems formed are
likely to be AuNPs stabilized by multiple proteins. Thus, under
otherwise identical experimental conditions, the protein used
determines the resulting gold nanostructure, from nanoclusters
embedded in single proteins to gold nanoparticles stabilized by
multiple proteins.
From the observation that the protein-AuNCs formed display
fluorescence upon excitation with UV light (see Fig. 1 for an
illustration for BLA), there is no clear separation between
proteins supporting AuNCs or AuNPs, respectively. Rather, the
three protein-gold systems displaying LSPR likely contain
AuNCs as well. In order to investigate this, we measured
steady-state fluorescence upon excitation of the gold nanos-
tructures at 370 nm and 495 nm (Fig. 3 and 4, respectively).
Excitation wavelengths were chosen in order to distinguish
between blue-emitting small (Au8) and red-emitting larger (Au25)
AuNCs, respectively.2,8
Table 1 Molecular properties of the proteins used in this study
Protein Abbreviation Molecular weight (kDa) pI
Bovine serum albumin BSA 67.0 4.7–4.9
Bovine plasma fibrinogen Fib 340.0 N/A
Bovine milk holo a-lactalbumin (type I) BLA 14.2 4.5
Chicken egg white lysozyme Lyz 14.3 10.5
Bovine heart cytochrome c Cyt c 12.4 10.1
Horse heart myoglobin Mb 17.2 6.8–7.0
Bovine milk b-lactoglobulin BLG 18.0 3.5–5.2
Bovine pancreas a-chymotrypsin CTR 25.0 8.8
Fig. 1 Photograph of aqueous solutions for five of the proteins used
here (concentration 35.5 mM) upon excitation at lex = 365 nm.
Fig. 2 UV-vis spectra of the proteins and protein-AuNCs used in this
study. For all spectra, protein concentration was 3.6 mM.
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Steady-state fluorescence spectra of the proteins and protein-
AuNCs upon excitation at 370 nm are shown in Fig. 3. The
excitation wavelength used for the spectra in Fig. 3 corresponds
to what was used to obtain the photograph in Fig. 1. All
emission profiles of the protein-AuNCs are markedly different
from those of the native proteins, confirming that the reaction
has occurred between the metal precursor and the proteins. As
was found for the UV-vis results above, emission lineshape and
intensity is highly protein-dependent despite otherwise identical
reaction conditions. With the exception of Fib NC, all the
protein-AuNCs display clearly defined emission maxima around
450 nm, where the emission intensity far exceeds that of
the native protein. The emission at 450 nm has been reported
to emanate from small nanoclusters reported to consist of
y8 atoms2,8 – hereafter referred to as ‘‘small AuNCs’’. Four
of the proteins studied – BSA, BLA, Lyz and CTR – also
produce protein-AuNCs with a clearly defined second (bimodal)
emission maximum between 625 and 675 nm, which has been
reported to correspond to larger AuNCs reported to consist of
y25 atoms,2,7,8 hereafter referred to as ‘‘large AuNCs’’.
Additionally, the emission of BLG is significantly higher than
baseline levels above 600 nm, possibly indicating the presence of
large AuNCs. In order to rank the proteins according to their
capacity for forming small or large AuNCs, the ratio between
emission intensities at 650 nm and 450 nm (I650/I450) upon
excitation at 370 nm for each protein-AuNC system, as well as
the type of gold nanostructure formed, have been listed in
Table 2. Here, the relative population of large AuNCs increases
with increasing values of I650/I450. From Table 2 as well as from
Fig. 3, it is evident that the proteins’ capacity for forming large
AuNCs can be listed in increasing order as (BLG)% Lyz, BLA
¡ CTR % BSA. From the UV-vis results (Fig. 2) and the
steady-state emission spectra upon excitation at 370 nm (Fig. 3),
the three protein-AuNC systems found to contain AuNPs –
BLA, Cyt c and BLG – also contain small, blue-emitting
AuNCs. Among the eight proteins studied here, BLA NC and
possibly BLG NC are the only protein-AuNC systems where
small and large AuNCs are represented in addition to AuNPs.
We have recently shown that the conformation of BLA can be
tuned/unfolded more gradually than its homologue Lyz via
incorporation of gold nanostructures using an extrinsic reducing
agent. This observation is likely to be related to the greater
conformational flexibility, which in turn is linked to its marginal
folding barrier and stable molten globule. The behaviour may
bear a semblance to the phenomenon of HAMLET, where
multiple oleic acid molecules hold the anticancer HAMLET
complex in a molten globule state, which can thereby interact
effectively with cellular and artificial membranes and affect their
morphology and integrity significantly.27,28 The relevance with
respect to NC modifications may be that these provide an
alternative way of loosening the fold and providing an increased
affinity and effect on the lipid membrane. Initial studies suggest
that BLA NC is indeed cytotoxic.
In order to further characterize the large AuNCs, we measured
the steady-state emission upon excitation at higher wavelengths,
where the emission properties of the large AuNCs are expected
to dominate the emission properties of the small AuNCs. Steady-
state fluorescence spectra of the proteins and protein-AuNCs
upon excitation at 495 nm are shown in Fig. 4. Comparing the
emission profiles in Fig. 3 and 4, it is evident that a clearly
Fig. 3 Fluorescence spectra of proteins and protein-nanoclusters upon
excitation at 370 nm. Protein concentration was 3.6 mM for all samples
(in the top right panel, BLA and Lyz are completely overlapping).
Fig. 4 Fluorescence spectra of proteins and protein-nanoclusters upon
excitation at 495 nm. Protein concentration was kept constant at 3.6 mM
(in the top right panel, BLA and Lyz are completely overlapping).
Table 2 Gold nanostructures formed for the different protein-AuNC
systems studied here
Protein-AuNC I650/I450 Gold nanostructure(s) formed
a
BSA NC 3.00 Small AuNCs, Large AuNCs
Fib NC 0.24 N/A
BLA NC 1.24 Small AuNCs, Large AuNCs, AuNPs
Lyz NC 0.72 Small AuNCs, Large AuNCs
Cyt c NC 0.04 Small AuNCs, AuNPs
Mb NC 0.04 Small AuNCs
BLG NC 0.13 Small AuNCs, Large AuNCs, AuNPs
CTR NC 1.25 Small AuNCs, Large AuNCs
a Small AuNCs and large AuNCs denote Au8 and Au25, respectively.
AuNPs denotes gold nanoparticles .3 nm displaying localized surface
plasmon resonance (Fig. 2), stabilized by multiple proteins.
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defined bimodal emission band around 650 nm exists for BSA
NC, BLA NC, Lyz NC and CTR NC, with the relative
intensities between the systems being identical to what was
found for excitation at 370 nm (Fig. 3), confirming the presence
of large AuNCs in these proteins. Additionally, excitation at 495
nm reveals a similar emission band for BLG NC, albeit at
significantly lower intensities, indicating the presence of large
AuNCs for this system as well. Thus, the proteins’ capacity for
forming large AuNCs can be listed in increasing order as BLG%
Lyz , BLA ¡ CTR % BSA.
Formation of gold nanoclusters induces highly protein-dependent
conformational changes
Tryptophan (Trp) is an intrinsic fluorophore frequently used to
monitor changes in the local protein environment such as
unfolding.29 Partial unfolding of a protein and a concomitant
increase in solvent exposure is typically accompanied by a shift
of the emission maximum towards longer wavelengths and/or a
decrease in emission intensity. Whereas red-shifts of the emission
profile can often be directly attributed to partial protein
unfolding, interpreting changes in emission intensity can be
more ambiguous. However, the UV-vis results for the protein-
AuNCs studied here (Fig. 2) reveal that the gold NCs absorb
around 350 nm, enabling quenching of Trp emission via distance-
dependent energy transfer into the AuNCs. Consequently, the
changes in Trp emission profile make it possible to follow
conformational changes in a protein as well as the presence of
gold nanoconstructs using steady-state Trp fluorescence (Fig. 5).
The excitation wavelength lex used was 295 nm.
The Trp emission profiles depicted in Fig. 5 reveal a decrease
in Trp emission intensity compared to the native protein for all
the protein-AuNC systems studied here, with the most severe
relative intensity decrease being observed for BSA NC. Another
common feature for all the protein-AuNC systems studied here is
a red-shift, i.e. a shift towards longer wavelengths, of the Trp
emission relative to the native protein, with the smallest red-
shifts observed for the two largest proteins studied here, BSA
and Fib (Fig. 5, upper left panel). For the two heme-containing
proteins used here, Cyt c and Mb (Fig. 5, lower left panel) the
red-shift is manifested by a large (.50 nm) red-shift of the
secondary emission peak at 350 nm upon incorporation of
AuNCs. While energy transfer into the AuNC band (as seen
from the UV-vis spectra in Fig. 2) could contribute to the
quenching of the Trp emission intensity, this mechanism cannot
account for the observed red-shift of the emission maxima.
Moreover, there is no clear correlation between the absorption
intensity at y350 nm and the distortions in the corresponding
Trp emission spectra for the different systems. Thus, we conclude
that the quenched and red-shifted Trp emission indicates partial
unfolding of the protein upon functionalization with AuNCs.
In order to further probe the local Trp environment, fluorescence
lifetime measurements (time-correlated single photon counting
(TCSPC), Table 3) were performed for all proteins and protein-
AuNC systems. While the excitation wavelength lex = 280 nm
excites all three intrinsic fluorophores in the proteins, Trp will still
be the main contributor to the emission lifetime profile due to a
significantly higher quantum yield as compared to tyrosine and
phenylalanine.29 No distinct lifetimes attributable to the AuNCs
could be detected upon excitation at 280 nm for any of the systems
studied here.
As the proteins used here contain different amounts of Trp
residues, interpretation of the TCPSC results with respect to
comparison of proteins is intricate. A bimodal fitting was found
to provide the best overall fit for the fluorescence decay profiles
of the samples studied here, yielding one ‘‘short’’ (t1) and one
‘‘long’’ (t2) lifetime, with corresponding relative populations B1
and B2, respectively. The lifetimes and populations listed in
Table 3 show that the Trp fluorescence profiles, i.e. both
lifetimes and populations, were altered upon incorporation of
AuNCs for all the systems studied here, indicating changes in the
Trp environment following formation of gold nanoconstructs.
No single trend with respect to shifts in either lifetimes or
populations could be detected for the entire dataset, revealing
that the impact of AuNC formation on the chemical environ-
ment surrounding Trp residues is very protein-dependent.
Additionally, differences in the number of Trp residues as well
as their position and orientation relative to the NC modifications
for the proteins studied here likely play a significant role.
Formation of gold nanostructures within the proteins results in
reduction of the short lifetime (t1) as compared to the native
protein for five of the systems studied here (BSA NC, Fib NC,
Lyz NC, Cyt c NC, CTR NC). Three of these systems (BSA NC,
Fib NC and Cyt c NC) also reveal population shifts towards
shorter lifetimes, indicating either quenching from increased Trp
exposure to water, energy transfer to gold (either NCs or NPs),
or a combination of these effects. The largest observable changes
in the Trp fluorescence lifetime profile upon formation of gold
nanoconstructs was observed for the two milk proteins included
in the dataset; BLA and BLG. Interestingly, BLA and BLG also
display the same changes in Trp fluorescence lifetimes (Table 3);
little or no changes in t1, a significant reduction of t2, and a large
shift in population towards the longest lifetime for both proteins.
Specifically, whereas the population is heavily shifted towards
the short lifetime for both native proteins (94% and 85% for BLA
and BLG, respectively), the AuNC-modified protein systems
reveal an approximately even distribution of the two populations
(B1 for BLA NC and BLG NC are 50% and 55%, respectively).
Fig. 5 Trp emission spectra of proteins and protein-nanoclusters upon
excitation at 295 nm. Protein concentration was 3.6 mM for all samples.
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As such, the fluorescence results illustrate that the effect of
AuNC formation on the microenvironment surrounding the Trp
residues – such as the degree of unfolding and NC modifications
in close proximity– is highly protein-dependent.
For a more thorough investigation of the effect of AuNC
formation on protein secondary structure, circular dichroism
measurements were performed (Fig. 6). Here, changes in intensity
and lineshape compared to the native protein indicate conforma-
tional changes. To rule out the possibility of changes due to
attenuation of the signal by gold, the relationship between signal
intensity at 200 nm and 222 nm was studied for all samples
(Table 3). The 200 nm/222 nm ratio varies in a manner not directly
correlated to the concentration of gold precursor or the corre-
sponding absorbance at these wavelengths (Fig. 2). Thus, the
spectral changes are likely due to changes in the protein, not
attenuation of the signal caused by the presence of gold.
From the CD results presented in Fig. 6, all the AuNC-
containing systems display large differences as compared to the
native proteins with respect to intensity and lineshape, indi-
cating conformational changes upon incorporation of the gold
nanoconstructs. With the exception of BLG, incorporation of
AuNCs resulted in a relative decrease of alpha-helical motifs (i.e.
mean residual ellipticity at 222 nm) compared to the native
protein for the systems studied here. For two of the proteins –
Lyz and BLG – incorporation of AuNCs resulted in a significant
transition from alpha-helical motifs to other secondary struc-
tures (mostly random coils as seen from the increased signal at
y200 nm), compared to the native protein. The values of the
ratios between signal intensity at 200 nm and 222 nm (MRE200/
MRE222, Table 3) were found to increase by more than a factor
of two upon incorporation of AuNCs for all the systems studied
here, further indicating that the changes in lineshapes and signal
intensities, documented by the fluorescence intensities, are due to
changes in protein conformation rather than attenuation of the
signal from the presence of gold. No apparent trend with respect
to the nature of the gold nanoconstructs formed (i.e. small or
large AuNCs or AuNPs) could be identified from either Trp
emission or CD data, revealing that the effect of incorporation of
gold on the degree of conformational change is mainly protein-
dependent. As the stability and indeed function of the protein-
gold nanoconstruct for any intended application is highly
dependent on the structural changes of the protein shell, the
results presented here show that care must be taken to
understand the nanocluster formation on a protein-specific
basis. In order to be able to predict the final properties – both
with respect to nanocluster population and protein conformation
– for a given protein, there is a need for a general mechanism.
Protein-mediated gold nanocluster formation can be attributed to a
general mechanism
Earlier biomineralization-inspired studies have pointed to single
amino acid residues being responsible for reduction and
nucleation of Au3+, tyrosine (Tyr) in the case of BSA,7 and
histidine (His) in the case of apoferritin.4 While Tyr is known to
have a high, albeit strongly pH-dependent redox potential7,30
and mixtures of His and HAuCl4 have been shown to reduce
Au3+ to Au0 via X-ray absorption near-edge structure
(XANES),4 these are either single-protein (in the case of BSA)
Table 3 Fluorescence lifetimes and the corresponding populations for the proteins and protein-AuNCs used in this study. t = lifetimes in nanoseconds
(ns), B = populations in %. lex = 280 nm, lem = 360 nm. The ratio of mean residual ellipticities MRE200/MRE222 for the same systems are listed in the
rightmost column
Protein System t1 (ns) B1 (%) t2 (ns) B2 (%) MRE200/MRE222
BSA Native 5.0 ¡ 0.2 46.5 ¡ 0.1 7.5 ¡ 0.1 53.5 ¡ 0.1 1.6
NC 1.35 ¡ 0.02 48.7 ¡ 0.1 5.19 ¡ 0.03 51.3 ¡ 0.1 3.2
Fib Native 2.30 ¡ 0.04 41.8 ¡ 0.1 7.99 ¡ 0.03 58.2 ¡ 0.1 1.8
NC 1.63 ¡ 0.04 45.6 ¡ 0.1 5.01 ¡ 0.03 54.4 ¡ 0.1 5.3
BLA Native 0.9 ¡ 0.1 93.8 ¡ 0.1 4.5 ¡ 0.1 6.2 ¡ 0.1 3.7
NC 0.90 ¡ 0.02 49.7 ¡ 0.1 4.27 ¡ 0.03 50.3 ¡ 0.1 10.8
Lyz Native 1.52 ¡ 0.03 69.5 ¡ 0.1 3.67 ¡ 0.04 30.1 ¡ 0.1 1.4
NC 0.6 ¡ 0.1 70.0 ¡ 0.1 4.1 ¡ 0.8 30.0 ¡ 0.1 13.5
Cyt c Native 2.15 ¡ 0.04 60.8 ¡ 0.1 7.8 ¡ 0.1 39.2 ¡ 0.1 3.4
NC 0.6 ¡ 0.1 68.8 ¡ 0.1 5.8 ¡ 0.1 31.2 ¡ 0.1 13.3
Mb Native 0.3 ¡ 0.2 55.2 ¡ 0.1 4.6 ¡ 0.1 44.8 ¡ 0.1 2.0
NC 0.7 ¡ 0.1 62.1 ¡ 0.1 4.2 ¡ 0.1 37.9 ¡ 0.1 6.1
BLG Native 1.25 ¡ 0.01 85.4 ¡ 0.1 5.1 ¡ 0.1 14.6 ¡ 0.1 0.2
NC 1.30 ¡ 0.03 55.4 ¡ 0.1 4.24 ¡ 0.03 44.6 ¡ 0.1 8.3
CTR Native 1.09 ¡ 0.02 53.2 ¡ 0.1 3.94 ¡ 0.03 46.8 ¡ 0.1 8.8
NC 0.85 ¡ 0.02 47.6 ¡ 0.1 3.87 ¡ 0.03 52.4 ¡ 0.1 231.0a
a No discernible secondary structure could be detected using CD upon modification with AuNCs.
Fig. 6 CD traces of the protein and protein-AuNCs studied here.
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or single amino acid (in the case of His) studies. Additionally, the
importance of cysteine (Cys) residues in immobilizing/stabilizing
the resulting gold nanoconstructs within the protein via covalent
Au–S bonds has been reported (see e.g. Xie7 and references
therein). Here, we have compared eight different proteins
varying in molecular weights, isoelectric points and conforma-
tional flexibilities with respect to their capability of forming
AuNCs utilizing a single intrinsic, i.e. biomineralization-inspired,
synthesis procedure. From the findings presented above, the type
of gold nanoconstructs formed, the photophysical properties of
the AuNCs and the resulting effect on polypeptide conformation
are highly protein-dependent. No correlation could be found
between the number/percentage of Tyr and His residues and the
propensity for AuNC formation, or for the type of gold nano-
construct (i.e. small and large AuNCs, AuNPs) formed. The
small library employed here includes a protein without any Cys
residues (Mb), which is capable of formation and stabilization of
formation of small AuNCs, showing that Cys residues are not
necessary for stabilization of the gold nanoconstructs.
Based on the strong protein-dependence, as opposed to single
amino acid residue-dependence, of AuNC formation observed
here, we propose that the general protein-templated gold nano-
construct nucleation and growth can be explained via a general
mechanism. Our proposed mechanism is adapted from Berti and
Burley’s postulated mechanism for nucleic acid and nucleotide-
mediated synthesis of inorganic nanoparticles,31 and Feldheim
and Eaton’s SELEX model for biomolecule-mediated crystal
formation,32 and consists of the following four steps:
Step 1: Nucleation. Charge density matching between Au3+
and negatively charged amino acid residues yields high local
metal concentrations, providing the necessary microenvironment
for triggering the nucleation event. Nucleation occurs via
reduction of the gold precursor from surrounding amino acid
residues with a sufficiently high redox potential, including Tyr,
Trp and His. The combination of initial charge density matching
and the local presence of amino acid residues with a sufficient
redox potential implies that the nucleation event is highly
protein-dependent. As this step requires interaction between a
water-soluble metal precursor and polar amino acid residues,
initiation likely occurs close to the external protein surface.
Step 2: Growth. Small nuclei formed close to the protein
surface are capped by anionic amino acid residues, and grow
either (i) from influx of Au3+ ions as determined by charge
density matching with negatively charged amino acid residues in
the immediate vicinity, eventually leading to overlapping
clusters, (ii) from partial unfolding of the polypeptide chain
leading to close contact between adjacent nuclei and subsequent
aggregation, (iii) collisions between proteins leading to contact
between exposed nuclei, or (iv) a combination of (i)–(iii). Here,
the growth is limited by the available amount of metal precursor
relative to the protein concentration for all the growth
mechanisms. Additionally, limitations in steps (i)–(iii) are highly
protein-dependent. Specifically, mechanisms (i)–(iii) are depen-
dent on the size and proximity of large patches of charged amino
acid residues for sequestration of Au3+, mechanism (ii) depends
on the conformational flexibility of the polypeptide chain, and
mechanism (iii) depends on the charge density surrounding the
nucleation sites and the proximity of the nuclei to the surrounding
aqueous environment.
Step 3: Termination. Termination can occur via depletion of
metal precursor from the bulk phase, but more importantly via
capping from anionic amino acid residues in the case of mecha-
nisms (i) and (ii), whereby the surrounding polypeptide chain
acts as a stabilizing electrostatic shell, or via a combination of
electrostatic and steric (i.e. electrosteric) capping in the case of
mechanism (iii), where single nanoparticles are stabilized by
multiple proteins. Upon reaching a critical size, the electrosteric
barrier for bringing clusters into close proximity becomes too
large to overcome, thus preventing further growth.
Step 4: Passivation and solubilization. The capping ligands –
either amino acid residues or proteins depending on the size and
nature of the gold nanoconstructs – suppress defect surface states
by forming covalent bonds (such as in the case of Cys), or simply
forming complexes with empty orbitals and dangling bonds.
Integration into single proteins or capping by multiple proteins
provides the presence of a hydrophilic corona and enables
dispersion in aqueous solution. Limitations to the stability in an
aqueous environment are then linked to the degree of protein
unfolding following nanoconstruct formation, as unfolding is
accompanied by exposure of hydrophobic amino acid residues,
leading to an increased sticking probability and concomitant
propensity for protein aggregate formation.
The general mechanism suggested here accounts for the highly
protein-dependent AuNC formation in that local negative charge,
availability of electron-donors and the local stability of the
secondary structure and overall flexibility of the fold determines
where clusters form and when formation is terminated, as well as
their effect on the protein. The mechanism is also in agreement
with existing literature for comparable systems.31,32
Conclusion
In this work a small library of eight proteins of different
molecular weights, charge properties and conformational flex-
ibilities has been studied with respect to their ability to form gold
nanoconstructs using a single intrinsic, i.e. biomineralization-
inspired, synthetic procedure wherein no extrinsic reducing agent
was added. The type of gold nanostructure formed, the
photophysical properties of the protein-gold constructs as well
as the accompanying conformational changes were found to be
highly protein-dependent. Using a combination of UV-vis
spectroscopy and steady-state fluorescence measurements, we
identified the three primary sets of gold nanoconstructs formed
as fluorescent clusters of y8 and y25 atoms (small and large
AuNCs, respectively) and nanoparticles (AuNPs) of diameters
.3 nm displaying localized surface plasmon resonance (LSPR),
with all three structures occurring within the same system for
the two milk proteins studied here, BLA and BLG (see Table 2).
We also present a general mechanism for the in situ nanocluster
formation, based on nucleation, growth, termination and
stabilization/solubilization events. As such, this work represents
a contribution to the general understanding of how the protein
shell as well as the size and properties of nanoclusters can be
tuned to manipulate conformation and stability of the resulting
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nanomaterial, and how labelling with plasmonic and fluorescent
nano-species can enable easier biolabeling and tracking in
biological systems.
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